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INTRODUCTION 
 
Avant l'apparition du vivant, l'oxygène était quasiment absent de l'atmosphère. Il  n’y  a 
finalement  que  2,5  milliards  d’années  qu’il  est  produit  en  excès  et  qu’il  est  devenu  un 
composant de l’atmosphère terrestre, pour atteindre la proportion de l’ordre de 20% que nous 
connaissons aujourd’hui. Progressivement et à l’exception de certain organismes anaérobies, 
l’oxygène  est  devenu  indispensable  à  la  vie  des  animaux,    plantes  et  bactéries  en  leur 
permettant  de  produire  de  l’énergie. Cette  production  d’énergie  est  caractérisée  par  la 
formation  régulière  de  composés  prooxydants  souvent  délétères,  que  l’on  appelle  Espèces 
Oxygénées et Azotées Réactives (EOR/EAR). Les cellules se sont adaptées à cet 
environnement en se dotant d’un système de défense enzymatique capable de procéder à la 
détoxification de ces métabolites. Néanmoins, les EOR/EAR ne sont pas seulement nocives 
vis-à-vis  de  l’organisme,  elles  exercent également des fonctions indispensables. 
Malheureusement, lorsque ces espèces réactives sont produites en quantité trop importante et 
que la cellule ne parvient plus à réguler cette formation, le compartiment cellulaire connaît 
alors un état appelé « stress oxydant ». Dans plusieurs maladies graves, notamment celles 
liées au vieillissement, le stress oxydant est impliqué dans l’étiologie de la maladie. C’est le 
cas par exemple de cancers, de pathologies oculaires et de maladies neurodégénératives. Par 
conséquent, depuis de nombreuses années les chercheurs tentent de développer différentes 
thérapies afin de limiter les effets néfastes de ce phénomène. L’une des stratégies consiste à 
renforcer le système de défense  cellulaire  par  l’administration  d’antioxydants  naturels  ou 
synthétiques. Malheureusement,  la  prise  d’antioxydants  naturels  n’apporte  pas  toujours  les 
bénéfices escomptés et ces composés peuvent même être prooxydants dans certains cas. Il a 
donc fallu se tourner vers l’élaboration de molécules antioxydantes synthétiques, qui sont très 
souvent des analogues structuraux d’antioxydants naturels. Parmi les analogues synthétiques 
largement utilisés, on peut citer le Trolox qui est un dérivé hydrosoluble de la vitamine E. 
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Une autre voie explorée a consisté à utiliser dans le domaine biologique, des molécules dont 
le rôle initial était de mettre en évidence et de caractériser les radicaux libres sur le plan 
physico-chimique. En  effet,  l’identification  d’espèces  radicalaires  par  Résonance 
Paramagnétique  Electronique  (RPE)  a  permis  d’obtenir  de  précieuses informations sur la 
nature et la structure des radicaux. Cette  technique  très sensible s’appuie sur  le piégeage de 
spin  permettant,  par  addition  d’un  composé  diamagnétique  au milieu  radicalaire,  de  former 
des adduits de spin beaucoup plus stables que  l’on  peut  donc  étudier  facilement.  Cette 
technique  a  permis  d’améliorer  la  compréhension  de  processus  pathologiques  liés  au  stress 
oxydant  et  a  vu  l’émergence  de  nouvelles  molécules  capables  de  piéger  les  radicaux 
libres d’origine  biologiques,  c’est le cas des nitrones. Il existe deux grandes catégories de 
nitrones : les nitrones linéaires dérivés de l’α-Phényl-N-tert-Butyl-Nitrone (PBN) et les 
nitrones cycliques dérivés de 5,5-DiMéthyl-1-Pyrroline-N-Oxide (DMPO).  
 
De nombreuses études ont été réalisées sur les effets protecteurs des nitrones et la PBN s’est 
avérée plus efficace que la DMPO en tant qu’agent à propriétés thérapeutiques. Son caractère 
partiellement amphiphile,  qui  lui  permet  d’être  à  la  fois  soluble  en milieux aqueux et en 
milieux lipidiques, serait à l’origine de sa bonne biodisponibilité in vivo. Plusieurs équipes de 
chercheurs ont tenté d’améliorer l’efficacité thérapeutique de ces antioxydants synthétiques en 
développant différents analogues ou en favorisant leur ciblage vers des sites endommagés par 
la production d’espèces oxydantes.  
C’est  dans  cette  optique  que  depuis de nombreuses années, notre laboratoire développe 
différent type de structures monomoléculaires amphiphiles capables de transporter un principe 
actif dans  l’organisme par modulation de  sa balance hydrophile-lipophile. L’objectif de ces 
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structures est de mieux contrôler le passage transmembranaire d’un principe actif et ainsi lui 
assurer un meilleur ciblage. Cette stratégie a donc été appliquée aux nitrones. Les résultats ont 
montré que le greffage de la PBN ou de la DMPO sur une structure amphiphile augmente 
significativement leur biodisponibilité et leur activité biologique. Ce principe a aussi été 
appliqué  à  d’autres antioxydants et différents types de transporteurs amphiphiles ont été 
synthétisés, dans le but d’améliorer l’activité biologique du principe actif étudié. 
Les travaux menés au cours de ma thèse ont consisté à poursuivre cette thématique de 
recherche en modulant l’activité de la PBN. Le premier chapitre de ce manuscrit est présenté 
sous forme d’introduction bibliographique, faisant l’état de l’art des différentes structures de 
nitrones connues à ce jour. La PBN étant reconnue depuis plusieurs années pour ses activités 
protectrices, plusieurs auteurs ont synthétisé des analogues afin d’améliorer ses propriétés et 
sa biodisponibilité. Leurs  travaux ce sont d’abord focalisés sur des modifications chimiques 
assez simples portant sur la partie N-terminale et aromatique de la PBN, puis les études se 
sont orientées vers la synthèse de nitrones aromatique dérivées de la PBN jusqu’au 
développement de dérivés au ciblage plus spécifique. Dans  ce  chapitre  d’introduction 
bibliographique, l’accent sera mis à la fois sur la capacité des nitrones à piéger les radicaux 
libres ainsi que sur leurs propriétés physico-chimiques et leur activité biologique.  
Dans le second chapitre, nous nous sommes intéressés à différentes modulations autour de la 
PBN  afin  d’améliorer  ses  propriétés  intrinsèques. Ce chapitre est découpé en trois parties. 
Dans un premier temps, nous avons effectué des modifications sur la partie N-tert-butyl de la 
PBN en greffant un, deux ou trois substituant(s) afin d’augmenter la réactivité de la fonction 
nitrone. Ainsi,  nous  avons  étudié  l’influence des différents substituants sur les propriétés 
physico-chimiques et biologiques de nos composés. La seconde partie de notre travail s’est 
portée sur l’étude  de  composés  modifiés en para du groupement phényl, préalablement 
synthétisés au laboratoire. Dans cette partie nous nous sommes focalisés sur  l’influence des 
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effets électroniques générés par les substituants sur les propriétés physico-chimiques. Enfin, 
dans la dernière  partie de ce chapitre, nous avons modifié le groupement tert-butyl par un  
groupement bifonctionnalisé composé d’un cyclohexane et d’une chaîne alkyle substituable. 
D’une part, le cyclohexane présent en α du groupe nitronyl devrait permettre d’augmenter la 
rigidité globale de la molécule, stabiliser le radical formé et ainsi améliorer ses capacités de 
piégeage  d’EOR/EAR.  D’autre  part,  la  fonction  acide  carboxylique présente sur la chaîne 
alkyle  pourra être greffée à un autre composé, permettant ainsi un ciblage spécifique de la 
nitrone. Après exploration de ces trois types de modifications autour de la PBN, l’objectif à 
plus long terme est de combiner les structures les plus intéressantes afin de synthétiser un 
dérivé, substitué à la fois en para du phényl et en N-tert-butyl de la nitrone, présentant des 
propriétés physico-chimiques optimales. 
 
Figure 1. Structure générale de la PBN substituée. 
Dans le troisième chapitre de ce manuscrit, nous nous sommes penchés sur le ciblage 
spécifique de nitrones dans l’organisme. La première partie de ce travail a consisté à greffer le 
motif PBN sur des structures amphiphiles afin de favoriser le passage transmembranaire. 
Nous avons ainsi poursuivit les travaux du laboratoire sur la synthèse de transporteurs 
amphiphiles à fixation latérale comportant un acide aminé jouant le rôle de bras espaceur 
entre la tête hydrophile, la partie hydrophobe et l’antioxydant. La nouveauté dans cette partie 
a été de développer des transporteurs comportant deux acides aminés consécutifs afin de 
greffer deux antioxydants sur un même transporteur amphiphile (structures schématisées ci-
dessous). Nous  avons  d’abord  synthétisé  un  transporteur  amphiphile  portant  deux  motifs 
nitrones, dans le but d’étudier  l’effet  de  divalence. Ensuite, nous avons synthétisé un 
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transporteur amphiphile permettant de coupler deux antioxydants différents, par exemple une 
nitrone et un autre antioxydant, afin d’envisager un effet de synergie.  
       
Figure 2. Représentation schématique des deux transporteurs amphiphiles. 
Enfin, dans la deuxième et dernière partie de ce chapitre, nous avons voulu apporter un 
ciblage actif à nos nitrones et cibler cellules responsables du mélanome, les mélanocytes. En 
collaboration avec l’université de Clermont-Ferrand, nous avons modifié la partie hydrophile 
du transporteur amphiphile par un groupement benzamide capable de cibler spécifiquement 
les mélanocytes. Les dérivés benzamides ont une certaine affinité pour la mélanine, 
synthétisée dans les mélanocytes, qui a elle-même montré un effet protecteur dans la 
dégénérescence  oculaire  liée  à  l’âge. Ce type de pathologie étant également associé à une 
production  excessive  d’EOR, nous avons trouvé intéressant de combiner la PBN à un 
groupement benzamide afin de cibler spécifiquement les mélanocytes. Deux dérivés ont été 
synthétisés et caractérisés, leur activité biologique sur un modèle rétinien est actuellement en 
cours d’étude. 
Nous avons fait le choix de rédiger ce manuscrit en Anglais, sous forme de Thèse d’articles. 
Ainsi, les parties expérimentales sont décrites à la fin de chaque sous-partie. Afin d’éviter les 
redondances nous avons consigné les références bibliographiques à la fin de chaque chapitre. 
Les différentes techniques physico-chimiques utilisées au cours de cette thèse sont présentées 
en annexe de ce manuscrit. 
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Reactive oxygen species (ROS) that are mostly free radicals along with reactive nitrogen 
species (RNS) are known to play a dual role in biological systems, since they can be either 
harmful or beneficial to the living organisms. ROS and RNS at low concentration have been 
demonstrated to regulate a variety of normal functions, such as signal transduction, 
mitogenetic response and defence against infectious agents. ROS/RNS are balanced with an 
endogenous antioxidant system, which includes enzymatic and non-enzymatic defences. 
There is a second class of antioxidant that is obtained from the diet constituting the so-called 
exogenous antioxidant system. However, excessive production or deficient degradation of 
ROS/RNS in cells leads to an in vivo redox unbalance which can be deleterious. This is 
commonly termed as oxidative stress. Indeed ROS/RNS are responsible of severe damages to 
biological macromolecules such as proteins, DNA and lipids. Therefore, this biological state 
is often associated to several pathologies and syndromes such as ischemia-reperfusion, 
chronic inflammation, ageing as well as some genetic diseases to name a few.[1, 2] To 
prevent oxidative damages, therapeutic strategies using natural antioxidants have been 
extremely developed and promising results have been reported. Unfortunately, clinical trials 
have provided inconstant results[3-6] and therefore other antioxidant strategies have been 
developed. Synthetic antioxidants have been developed with two main goals: having more 
potent agents than the natural ones in preventing oxidative stress, and/or having agents that 
exhibit a specific targeting properties so as on site protection is achieved.  
Spin-trapping properties. Nitrones were initially designed as spin traps for detecting 
transient free radicals using electron paramagnetic resonance (for a recent review see 
Villamena & Zweier, 2004).[7] As shown in Figure 1.1, free radicals react with the 
diamagnetic nitrone to from a paramagnetic spin adduct whose half-life is significantly longer 
than that of the parent radical. Among the family of nitrone, two classes have been mainly 
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developed, the cyclic ones derived from the 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) and 
the linear ones derived from the α-phenyl-N-tert-butyl nitrone (PBN) (Figure 1.2). 
 
Figure 1.1. Mechanism of spin trapping by linear PBN.  
Cyclic nitrones have been widely employed as probes for the detection of free radicals 
because of their better ability to trap oxygen-centered radicals compared to linear ones. 
Therefore, several analogues of DMPO have been designed over the past two decades. One 
can cite the phospshorylated analogue 5-diethoxyphosphoryl-5-methyl-1pyrroline N-oxide 
(DEPMPO)[8] as well as the ester analogs, 5-ethoxycarbonyl-5-methyl-1-pyrroline N-oxide 
(EMPO)[9] and 2-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BocMPO).[10] 
Recently, a new amido derivative AMPO was reported to have the highest rate constant of 
superoxide trapping, followed by EMPO, both DEPMPO and DMPO, having the slowest 
reactivity.[11, 12] 
 
Figure 1.2. Chemical structure of linear PBN, cyclic DMPO and some derivatives. 
Although linear nitrones are generally considered to be poorer traps compared to cyclic ones, 
they have been also employed in spin trapping experiments to trap carbon-centered radicals 
either in organic or aqueous phase. Toxicity of nitrone compounds is low rendering their use 
in biological systems possible without inducing any severe side effect.[13-15] However, the 
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use of both the linear PBN series and the cyclic DMPO one as spin-traps in biological milieu 
has encountered some limitation. Indeed, the DMPO-superoxide spin adducts decomposes 
quickly in polar environment and its biological uses to extracellular spin trapping are limited 
by its hydrophilicity.[16-18] On the other hand, because of its lipophilicity, the distribution of 
PBN within tissues and cells is much higher than that of the hydrophilic DMPO[16-18] but its 
spin-trapping properties are rather limited with low spin-adduct stability. 
Synthesis of nitrones. Several methods are available for the synthesis of nitrones.[19, 20] 
The condensation between aldehydes and N-monosubstituted hydroxylamine is the most 
widely used method for the preparation of nitrones. One-pot synthesis is also used through in 
situ reduction of a nitro group to its hydroxylamine, which is subsequently condensed with a 
benzaldehyde derivative. Another method consists in the N-oxidation of an imine intermediate 
directly into nitrone using strong oxidants such as peracids.[21, 22] Finally, N-alkylation of 
aldoximes also leads to nitrone formation.[23, 24] 
Biological properties. Mode of action of nitrones. Since the seminal work of Novelli et 
al.[25] nitrone spin traps have been widely used as antioxidants in several biological models 
and their use as pharmaceutical agents have been extensively reviewed.[26, 27] The 
biological activity of nitrones had been first explained by their radical trapping activity, 
however, experimental evidence have suggested other mechanisms. For instance, the 
concentrations used for spin trapping experiments in chemical media are roughly one 
thousand times higher than those commonly employed in biological studies of protection (10-
50 µM). In addition, concentration of nitrones in target tissues is usually inferior to 50 µM, 
which is not sufficient to quench all the radical species. These findings support the 
invalidation of the spin-trapping mechanism as the primary mode of action of nitrones. In 
addition, there are strong evidence that PBN act to quell signal transduction processes 
providing therefore, potent anti-inflammatory and anti-apoptotic properties.[26, 28] Nitrones 
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also exhibit NO-releasing properties which may be partly responsible for their 
pharmacological properties.[29, 30] Hensley et al. demonstrated that PBN interacts with the 
mitochondrial complex I by inhibiting complex-I stimulated H2O2 flux.[31]  
Considering the very broad activity of nitrones, there has been extensive research on the 
development of novel nitrone-based compounds with improved biological and spin trapping 
properties as well as enhanced intra-cellular compartmentalization. The chemical and 
pharmacological properties of nitrones depend mainly on the connectivity as well as on the 
nature and the position of the substituents on the nitrone group. Several analogs of PBN, and 
to a lesser extend of DMPO, have been synthesized during the last years combining in their 
structures chemical functions that can improve the intrinsic properties of the spin-trap 
compound. Chemical modifications have been made either on the phenyl ring and/or on the 
N-tert-butyl group of PBN so as to improve the reactivity of the nitronyl group and the 
stability of the nitroxide spin-adduct. Modifications have also been applied on the nitronyl 
group such as substitutions on the carbon atom of the nitrone function with a heretoaryl or an 
azulenyl group. Moreover, to target nitrones to specific tissues and/or cellular compartments, 
the nitronyl group was grafted onto specific cargo such as lipophilic cations, peptides or 
amphiphilic carriers. The different strategies used to improve the potency of PBN-Based 
nitrones either as spin-traps or as therapeutics will be described in this chapter.  
 
1. Modifications on the phenyl ring and the N-tert-butyl groups 
?-phosphorylated derivatives. Oxygen-centered radical trapping of nitrones is of particular 
interest as theses radicals are involved in many chemical and biological process. Among the 
most widely employed spin-traps, PBN is much more lipophilic than DMPO, making PBN 
more suitable for biological applications. However, the use of PBN against superoxide-
hydroperoxyl and hydroxyl radicals has shown limitation. Therefore, various PBN analogs 
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bearing substituents on the phenyl ring were developed, mainly by Janzen and co-
workers.[32-35] However, these compounds presented similar limitations that are rapid 
disappearance of hydroxyl and superoxide radicals in aqueous solution, and very similar EPR 
spectra with close hyperfine splitting constants (hfsc) leading to possible misinterpretation. A 
phosphorylated derivative of DMPO, denoted DEPMPO and represented in Figure 1.3, 
showed interesting spin-trapping properties with half-lives values about fifteen times higher 
than that of DMPO in aqueous solutions.[36-38] This improvement of the hydroperoxyl spin-
adduct stability was found to be induced by the presence of the diethylphosphoryl group 
which tends to stabilize the aminoxyl obtained during the trapping. Therefore, the use of a 
phosphoryl group was also extended to linear PBN and 4-PyOBN nitrones. Structures of the 
corresponding N-benzylidene-1-diethoxyphosphoryl-1-methylamine N-oxide (PPN) and 1-
diethoxyphosphoryl-1-methylamine N-oxide (4-PyOPN) are represented in Figure 1.3.[39] 
Replacement of the methyl group by a diethylphosphoryl group led to a significant increase of 
the spin-adduct half-lives. 
 
Figure 1.3. Structure of 4-PyOBN and ?-phosphorylated nitrones. 
Several PPN-type nitrones, by varying substitutions on the aryl group, were synthesized 
(Figure 1.4).[40] Except 4-DOPPN, all PPN-type nitrones were able to trap carbon-centered 
radicals and formed intense and persistent spin adducts in aqueous and organic media. PPN 
and 4-PyOPN were the most potent of this series in trapping superoxide radical in aqueous 
environment, with acceptable decay kinetics as well. One of the advantages of the PPN-type 
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series is that their various spin-adducts are easily identified by their EPR spectra, because of 
the existence of a strong hyperfine coupling with the phosphorus nucleus. 
?ster derivatives. Tuccio and co-workers studied the spin trapping properties of N-2-(2-
ethoxycarbonyl-propyl)-?-phenylnitrone (EPPN)[41] bearing an ethoxycarbonyl group in ?-
position.[42], [43] EPPN showed higher lipophilicity than PPN with octanol-phosphate buffer 
partition coefficient (Kp) of  29.8 and 10.2, respectively, suggesting that EPPN could cross 
biomembranes. EPPN was also found to be a very efficient trap for carbon-centered radicals 
but unsuitable for hydroxyl trapping in aqueous conditions. The superoxide spin adduct of 
EPPN was found to be more stable than those of PBN, DMPO, 4-PyOBN and PPN, yielding 
to a persistent spin adduct without any artifactual signals.[43] But the short-lived superoxide 
spin adduct of EPPN at physiological pH has limited its used in biological media. Finally, it 
was demonstrated that the presence of an electron-withdrawing group at the ?-position of the 
nitrone function, in the case of PPN, 4-PyOPN and EPPN, greatly enhances the superoxide 
adduct stability. Stolze and co-workers have developed EPPN analogs either by replacing the 
ethoxy group by a propoxy, iso-propoxy, n-butoxy, sec-butoxy and tert-butoxy moiety or the 
phenyl ring by a pyridyl ring (Figure 1.4).[44] As observed for the parent EPPN, these new 
compounds were efficient for the detection of carbon-centered radical but no significant 
improvement of the superoxide adduct stability could be obtained for these lipophilic EPPN 
derivatives.  
Two ester nitrone derivatives with improved spin adduct stability were next designed. 
EPPyON derives from 4-PyOBN by addition of an ethoxycarbonyl group in ?-position, the 
oxidopyridinium group exhibiting stabilization of the superoxide spin adduct, whereas 
DEEPN, bears two electron-withdrawing groups in ?-position of the nitrone function (Figure 
1.4).[42] DEEPN (Kp = 4.8) is less lipophilic than PBN, PPN and EPPN but more lipophilic 
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than DEPMPO (Kp = 0.16). On the contrary, EPPyON is highly hydrophilic with a partition 
coefficient of Kp = 0.33. The two nitrones were found to efficiently trap various carbon- and 
oxygen-centered radicals in aqueous media but were unsuitable for detecting hydroxyl radical. 
The superoxide spin adducts of these two nitrones decay approximately at the same rate at 
neutral pH but DEEPN-O2H spectrum is simpler, making DEEPN an efficient spin trap for 
superoxide detection in the PBN series.  
Consequently, these results led to combine in the same molecule an oxidopyridinium and two 
ethoxycarbonyl groups yielding the nitrone DEEPyON.[45] Spin trapping abilities were 
studied as well as the kinetic aspects of the superoxide detection that is the trapping reaction 
rate constants and for the spin adduct decay at pH 7.2. Results were compared to the 
monoester nitrone EPPyON and to its corresponding cyclic derivatives bearing two ester 
groups denoted as DEPO. Unfortunately, it was shown that the presence of a second ester 
group gave weaker superoxide trapping capacities in the oxidopyridinium series. On the 
contrary in the cyclic series an opposite effect was observed with DEPO being three times 
more potent than its corresponding analog with only one ester group (EMPO). However, 
DEPO-O2H decayed much faster than EMPO-O2H at nitrone concentration up to 0.005 mol.L
-
1, making EMPO preferred in detecting superoxide radical. 
 
Figure 1.4. EPPN (R = CO2Et) and the EPPN series (with R = propoxy, iso-propoxy, n-
butoxy, sec-butoxy or tert-butoxy) as well as other ester derivatives including cyclic nitrones. 
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N-tert-butyl substituted derivatives. In our group, a series of mono-, di- and tri-N-tert-butyl-
substituted PBN derivatives was developed in order to study the effects of the substituents in 
β-position of the nitronyl function (Figure 1.5).[46] An increased positivity on the nitronyl 
carbon was observed and was found to correlate well with experimental NMR chemical shifts. 
A moderate nucleophilic nature was observed for superoxide addition to nitrone as well as for 
phenyl radical addition to nitrone using UV-vis. stopped-flow kinetic and spin-trapping 
kinetics, respectively. Moreover, the antioxidant properties against H2O2-induced cell death 
were found to be affected by the nature of the substituents, with a good correlation with the 
oxidation potentials as determined by cyclic voltammetry. This work is presented in the 
second chapter of this thesis report.  
 
Figure 1.5. mono-, di- and tri-N-tert-butyl-substituted PBN derivatives. 
 
Adamantan substituted nitrones. The tert-butyl group of PBN was also modified with a 
cyclic moiety derived from adamantane,[47, 48] which has itself being investigated as 
bioactive compound. The rational was to increase the lipophilicity of the nitrone and to ensure 
enhanced spin adduct stability. Hydroxyl adducts exhibited significantly higher stability than 
those of PBN, very likely due to rigid adamantane ring. Among the adamantly derivatives 
synthesized, the three following compounds (Figure 1.6) proved soluble enough in water for 
spin trapping in aqueous media.[48] 
 
Figure 1.6. Structures of adamantly PBN-type nitrone derivatives. 
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The hydroxyl adducts stability of PyAN and POAN was the highest of the series and 
consequently, these two compounds were further study on UV-B-damaged isolated thylakoid 
membranes. The primary target of UV-B is photosystem (PSII) which is one essential 
pigment-protein complexes conducting photosynthetic transport. The two adamantyl nitrones 
were less toxic than their corresponding N-tert-butyl nitrones (IC50 of ~10 mM for PyAN and 
POAN compared to 6.7 and 1.9 for PyBN and 4-PyOBN, respectively). Moreover, they 
proved suitable for detecting hydroxyl radical produced in thylakoid membrane under UV-B 
stress, with enhanced spin adduct stability.[47] 
α-aryl substitutions of PBN. A phosphorylated nitrone derivative bearing a hydroxyl in para 
position of the phenyl ring (4-HOPPN) was found to trap various carbon-, oxygen- and sulfur-
centered radicals and to stabilize superoxide spin adduct.[49] The optimized geometry 
observed for 4-HOPPN superoxide spin adduct confirmed that the introduction of the 
phosphoryl group efficiently stabilize the spin adduct compare to PBN superoxide spin 
adduct. Moreover, stronger intra-molecular interactions, including Hydrogen bonding and the 
nonbonding attractive interactions as well as the bulky steric protection in 4-HOPPN-OOH 
were suggested to be responsible for stabilizing the superoxide spin-adduct. In the series of 
ortho-, meta- and para-substituted PBN developed by Janzen and co-workers in the 90s, 
NMR and EPR data of the meta- and para-substituted derivatives were found to correlate with 
the Hammett constants which indicates the polar effect of substituents.[19] Our group has 
recently worked on the reactivity of six para-substituted PBN derivatives toward superoxide 
radical anion and hydroperoxyl radical, structures are represented in Figure 1.7.[50] 
Competitive spin trapping using stopped-flow kinetics and EPR spectroscopy were employed 
to determine the rate of O2
•- and HO2• radical addition. Computational methods were used to 
predict the nitronyl atom charge densities and the free energies of superoxide and 
hydroperoxide radical addition to nitrones. The combined experimental and theoretical data 
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suggest that the addition of O2
•- is weakly electrophilic and not affected by the substituents 
properties whereas HO2
• addition  is  predominantly  electrophilic  and  follows  Hammett’s 
equation. The relative rate of Ph• trapping showed no correlation with the Hammett values, 
indicating the absence of a polar effect and supporting the non nucleophilic nature of phenyl 
radical. This demonstrated that the reactivity of the nitrone function can be modulated by the 
nature of the substituents but this is quite dependent to the radical trapped. Moreover, a good 
correlation was observed between the electrochemical potentials and the Hammett sigma para 
constant (σp) with compounds bearing an electron-donating group being more easily oxidized 
than those bearing an electron-withdrawing group. The polar effect can be explained by the 
stabilization of the intermediate nitroxide formed through resonance structures. This work is 
presented in the second chapter of this thesis report. 
 
Figure 1.7. Examples of para-substituted PBN derivatives including S-PBN and NXY-059. 
 
Sulfophenyl substituted PBN. In order to improve the hydrophilicity of PBN, sulfonic acid 
substituents were grafted onto the phenyl ring. The ortho monosubstituded derivative is called 
S-PBN and the ortho, para disubstituted derivative is called NXY-059 (Figure 1.7). The 
ability of PBN, S-PBN and NYX-059 to form radical adducts and prevent salycilate oxidation 
were studied in aqueous media.[51] The three compounds were found to efficiently trap 
oxygen- and carbon-centered radicals and PBN was the most potent to prevent salycilate 
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oxidation. Yang and co-workers studied the neuroprotective effect of PBN and S-PBN in a 
focal cerebral ischemia model and a significant attenuation of about 35% infarct volume was 
noted.[52] This was further confirmed on an embolic model of focal cerebral ischemia[53] 
and despite differences in their pharmacokinetics and absorption through the blood–brain 
barrier, the two spin traps appeared to have similar properties. S-PBN also exhibited 
neuroprotective properties in ischemia/reperfusion nerve injury.[54] However, PBN was 
found most potent than S-PBN as neuroprotectant in cortical areas, probably due to the poor 
brain penetration by S-PBN.[55] With two sulfonic acid groups, NXY-059 is more water-
soluble but its superiority compared to PBN as a neuroprotectant against stroke was 
demonstrated.[56] NXY-059 was the first compound to reach phase III clinical trials in the 
USA conducted by its licensee AstraZeneca.[57, 58] Unfortunately pooled analysis concluded 
that NXY-059 was not effective,[59] which led to the termination of NXY-059 as therapeutics 
for acute ischemic stroke. The success of NXY-059 has been mainly limited by its poor 
bioavailability, limited stability which required administration of high doses. In addition 
several critiques about the preclinical studies have been raised and it appears that more 
rigorous and strenuous testing at the preclinical stage is needed when evaluating 
neuroprotective agents.[60] 
Cyclic analogs of PBN. A high interest in developing treatment for stroke, septic shock and 
related diseases led Hoechst Marion Roussel Int. to develop 3,4-dihydro-3,3-dimethyl- 
isoquinoline N-oxide, a cyclized version of PBN also called MDL 101.02.[61] This compound 
which was supposed to have more potent radical trap due to the constrained and potentially 
more coplanar orientation of the nitrone and aromatic ring was in fact less planar than PBN, 
according to subsequent molecular modeling studies. However, MDL 101.002 was found to 
be more potent than PBN in several tests of antioxidant and radical trapping activity. A wide 
range of isoquinoline analogs were next synthesized such as aryl-substituted nitrones as well 
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as related spiro compounds (Figure 1.8) and they were found to be at least 10-fold better than 
PBN in reducing liposomes oxidation. Other chemical modifications were conducted with the 
fused phenyl ring being replaced by a more extended aromatic system or with electron rich 
heterocycles as well as five, six or seven atom nitrone-containing rings as shown in Figure 
1.8.[62, 63] 
 
Figure 1.8. General structures of cyclic PBN derivatives including the hydroxylated 
metabolites and two derivatives. 
 
When a second antioxidant functionality was added such as (o,o’-dimethylphenol) which is an 
antioxidant based on α-tocopherol, the activity was increased. The lipophilicity (log k’W) was 
measured by a chromatographic technique and a general trend was noted with the more 
lipophilic compounds being the more active in vitro. An interesting hydroxylated metabolite 
of MDL 101.002 was isolated and identified by the same group.[64] Despite its less potent 
antioxidant activity than MDL 101.002 in an in vitro lipid peroxidation assay, this metabolite 
was found to greatly reduce acute toxicity and exhibited sedative properties. Therefore, 
additional analogs were synthesized to increase the lipophilicity of this metabolite. Among 
them, oxidation and acetylation of the hydroxyl function can be quoted (Figure 1.8), as well 
as the replacement of the gem-dimethyl moiety with a spirocyclo alkyl group in both alcohol 
and ketone series. These compounds were found to be more lipophilic and more active than 
the hydroxyl metabolite in the in vitro lipid peroxidation assay, while only the ketone 
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derivatives were more potent in the in vitro neuronal peroxidation assays. This beneficial 
activity results from the ketone formation which simultaneously increases lipophilicity and 
removes the stereocenter. In addition, the introduction of an electron-withdrawing group 
conjugated with the nitrone group renders it more reactive toward radicals. However as 
regards to the side effects, the improvement brought by the ketones derivatives compared to 
MDL 101.002 remained limited.  
The therapeutic potential of a series of 2-benzazepine nitrones developed by Soto-Otero and 
co-workers against age-related neurodegenerative disorders was studied.[65, 66] Among the 
several analogs synthesized, two derivatives bearing respectively a C-3 spiro cyclopentyl and 
a tetrahydropyranyl moieties (Figure 1.9), showed promising protection of dopaminergic 
neurons intoxicated with 6-hydroxydopamine, a toxin implicated in Parkinson’s disease. One 
of these compounds was also found potent in a model of Alzheimer neurodegeneration. These 
observations may contribute to improve therapeutic potential of 2-benzazepine nitrones in 
age-related neurodegenerative diseases. 
 
Figure 1.9. Potential neuroprotective agents in age-related diseases. 
 
2. Modification of the nitronyl function  
Heteroaryl nitrones. A survey of the literature on heteroaryl nitrones from 1980 to 1999 has 
been reviewed by Golstein and Lestage, in which pyridyl, thienyl, furyl and immidazolyl 
substituted nitrones were described.[67] Results have demonstrated that the presence of a 
hetero-aromatic substituent on the nitrone double bond increased efficiently the stability of 
the spin-adduct and the ability to trap radicals. Moreover, lipophilicity and solubility are 
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modulated by the presence of a heterocycle and therefore so is crossing of biological 
membranes. Several groups have next designed a number of heteroaryl nitrones and their 
protective effects against various damages were studied. Nepveu and co-workers designed 
potent compounds against microvascular damages induced by ischemia/reperfusion[68] and a 
majority of these compounds were more efficient to trap •CH3 than •OH radical. No 
correlation was observed between the protective effect and their partition coefficient or their 
capacity to trap •CH3 and •OH radicals. Three compounds derived from piperol, O-benzyl 
vanillin and furfural (Figure 1.10) were the most potent of the series. Dias et al. synthesized 
other derivatives including N-methyl nitrone derivatives, which potency in preventing 
microvascular damage induced by ischemia/reperfusion.[69] It has to be underlined that a 
correlation between the lipophilicity and and their biological action was noted. 
 
Figure 1.10. Nitrones derived from piperonal, O-benzyl vanillin and furfural. 
 
Porcal and co-workers have synthesized thiadiazole and furanoxyl nitrone derivatives 
combining in their structures a nitronyl group with neuroprotection properties, an antioxidant 
fragment and an heterocyclic group able to stabilize the spin adduct (Figure 1.11).[70] These 
compounds proved excellent spin-trapping capacity, scavenging oxygen, carbon, sulfur and 
nitrogen-center free radicals.[71] The neuroprotective activity was demonstrated on a human 
neuronal-like cellular system exposed to H2O2 without any cytotoxicity at 10?M. N-alkyl 
substitutions such as tert-butyl, cyclohexyl or benzyl group showed to affect both the spin-
adduct stability and the biological activity with the N-cyclohexyl derivative exhibiting better 
cell viability than its N-tert-butyl derivative, while this latter exhibited better radical 
scavenging activity and the benzyl derivative was the less potent compound. These results 
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suggest that heteroaryl nitrones have therapeutic potential as neuroprotective agents in 
preventing cell death against oxidative stress and damage. 
 
Figure 1.11. General structures of thiadiazolylnitrones,  furoxanylnitrones,??-aryl-N-alkyl 
and indoline nitrones. 
The 4-furoxanyl nitrone denoted FxBN[71] showed appropriate solubility in aqueous 
conditions, which is an important physical chemical property for biological application. FxBN 
formed hydroxyl and superoxide spin adduct with long half-life of >2h and ~0.5 h, 
respectively, which suggests it could be a better trap than PBN and DMPO for oxygen-
trapping in biological conditions.  
Samadi and co-worker developed a series of ?-aryl and N-alkyl substituted heteroaryl nitrones 
as potential agents for stroke treatment in cerebral ischemia (Figure 1.11). In a first report, 
various ?-aryl-N-alkyl nitrones were synthesized in order to evaluate the effect of different 
electron-donating or electron-withdrawing substituents in the aromatic ring.[72] The in vitro 
antioxidant activity was determined using two different tests. The stable free radical 2,2-
diphenyl-1-picylhydrazyl (DPPH) was used as reagent to investigate the scavenger properties 
and showed that for phenol derivatives, the para position was preferred over the meta 
position, as well as the absence of the bromine atom at the ortho position. The oxygen radical 
absorbance capacity (ORAC) using a fluorescent probe was used to measure the peroxyl free 
radical scavenging ability of nitrones in the second in vitro assay. A significant antioxidant 
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activity was demonstrated for most of the nitrones and the substituted indole was the most 
potent, followed by the two phenol benzene-type nitrones. Conversely to the first in vitro 
assay, the meta position of the hydroxyl group as well as the presence of a bromine in ortho 
position were found to increase the antioxidant activity. PBN was poorly active in the first 
assay and inactive in the second one. Furthermore, the scavenging of hydroxyl radical was 
investigated and all the nitrones were able to efficiently trap •OH free radical. Theoretical and 
computational approaches were used to predict the antioxidant capacity and were found in 
agreement with the DPPH assay with the phenol derivatives being more efficient in electron 
transfer processes. The calculated energy values for hydroxyl and peroxyl trapping predicted 
that the most favorable adduct-spin will take place between the indole derivative and 
compounds containing a ortho-bromo, a meta-hydroxyl and a para-methoxy function on the 
aryl group. Finally, the in vitro pharmacological analysis was carried out, in human 
neuroblastoma cells previously stressed, in order to determine the neuroprotective capacity of 
these nitrones but protection was in general low.  
A series of α-aryl and heteroaryl-N-alkyl nitrones were developed as potential agents for 
stroke treatment. The α-aryl-N-alkyl nitrone derivatives comprised a strong electron 
withdrawing group or a highly hindered phenol or nitrooxy-alkoxy chain at position C-4.[73] 
The heterocyclic groups, such as quinoline or furan, were substituted with halogen atoms in 
appropriate position, as showed in Figure 1.12. Theoretical calculations were first carried out 
to predict their ability to cross the blood-brain-barrier (BBB) and suggested that, except 
nitrones bearing a 3-(nitrooxy)-alkoxy-benzilidene substituents, they should present a good 
brain penetration profile. The neuroprotection afforded by the compounds was estimated 
following Goldstein et al. approach which is based on the calculation of orbital energies and 
lipophilicity,[74] suggesting that nitrones bearing a para-hydroxyl group or quinolinyl group 
would exhibit good level of neuroprotection. On the contrary, the presence of a 3-(nitrooxy)-
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alkoxy-benzilidene group would lead to a poor level of neuroprotection. Data showed that 
both the presence of an electron-withdrawing group (CF3) in the benzene ring or the quinoline 
heterocyclic ring system conjugated with the nitrone moiety are key structural motif for 
neuroprotection. However, the presence of a highly hindered phenol moiety or a bromofuran 
ring was associated with strong toxicity. Therefore, it demonstrates that theoretical prediction 
were in good agreement for a majority of the compounds but not for all. It was also observed 
that N-benzyl nitrones presented higher neuroprotection than their corresponding N-tert-butyl 
nitrones. Among the whole range of nitrones synthesized, the quinolinyl nitrones showed 
potent combined antioxidant and neuroprotective properties and could therefore be considered 
as lead compounds.  
 
Figure 1.12. Exemples of a-aryl, heteroaryl and triazole-N-alkyl nitrone derivatives. 
More recently, Sambasiva Rao et al. developed a series of 1,2,3-triazole substituted N-phenyl 
nitrones and studied their anti-inflammatory and anti-cancer activity against various cancer 
cells lines.[75] Among the series, only the derivative bearing a six-carbon fluorinated chain 
exhibited both anti-inflammatory and anti-cancer activity. Most of the others exhibited either 
good anti-inflammatory or good anti-cancer activity. 4-fluorophenyl or 4-chlorophenyl 
substitution on the triazole moiety as well as phenyl and tert-butyl N-alkyl nitrones promoted 
the highest cytotoxicity which, however, remained significantly lower than doxorubicin. 
Imidazolyl nitrones. A series of imidazolyl nitrones was developed by Servier and exhibited 
good water-solubility with improved spin-trapping properties than the parent PBN.[74] 
Imidazolyl nitrones either with aromatic or heteroaromatic cycle substitutions proved higher 
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efficiency than PBN in an in vitro lipid peroxidation test on cortical membranes. Their 
capacity to oppose lethality induced by intracerebroventricular administration of tert-butyl 
hydroperoxide (t-BHP) in mice was also demonstrated with better protection compared to 
PBN. However, this was accompanied by hypothermia and only the phenylimidazolyl nitrone 
(Figure 1.13) showed significant protection (80% survival) without any hypothermia 
observed. The neuroprotection afforded by imidazolyl nitrones was found to correlate with the 
partition coefficient with the more lipophilic compounds being the more active. Moreover, it 
was shown that HOMO energy level of imidazolyl nitrones also influenced the biological 
behavior with higher protection when the HOMO energy is higher.  
 
Figure 1.13. Structure of triazole of two imidazolyl nitrones. 
The capacity of ten imidazolyl nitrones to directly scavenge free radicals was also studied in 
vitro by Reybier and co-workers and showed a high capacity to trap and stabilize carbon-
centered radicals.[76] Among the derivatives, S34176 bearing a trifluoro group in para 
position of the phenylimidazolyl nitrone (Figure 1.13) was selected for its in vivo activities. 
Lockhart and co-workers studied the neuroprotective effect of this compound in different in 
vivo paradigms of neuronal degeneration.[77] When S34176 was administrated 30 min before 
global ischemia (75mg/kg i.p.), the neuronal protection was 50% better compared to the 
control. Similar injection 5 min after ischemia showed same results. However, when S34176 
was administered 3 h post-ischemia, a limited efficacy was observed and this derivative was 
also ineffective in preventing focal permanent-occlusion ischemia. Unfortunately, the short 
active window of S34176 demonstrated that this compound alone have a limited therapeutic 
benefit in acute phase of cerebral ischemia.  
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Azulenyl and stilbazulenyl nitrones. Since the beginning of the 90s, the Becker’s group in a 
collaborative work with UpJohn Company has been interested in azulenyl nitrones derivatives 
named AZN (Figure 1.14). As already observed for cyclic analogs and imidazolyl nitrones, 
the aromatic rings confer higher rigidity and stability to the spin adducts. These compounds 
are prepared from guaiazulene, a natural product which is itself known to exhibit antioxidant 
and anti-inflammatory properties[78] and which has been used in a number of medical 
applications.[79, 80] Another important feature is that the guaiazulene ring system confers an 
oxidation potential exceptionally low in addition of being lipophilic. Indeed, cyclic 
voltammetry studies showed that the oxidation potential of AZN was 0.84V vs. SCE while 
that of PBN is 1.47 V. This potential is close to that of essential antioxidants such as 
glutathione (0.69 V vs. SCE) and ?-carotene (0.76 V vs. SCE).[81] Thus, compared to 
conventional nitrones, azulene-based spin traps exhibit improved antioxidant properties and 
may more readily penetrate the blood–brain barrier.  
 
Figure 1.14. Structures of AZN, w-AZN and STAZN. 
AZN nitrone also allows a colorimetric approach to the detection, isolation and analysis of 
free radical adducts in the case of rapid nitroxide decay. Indeed, AZN was found to react with 
peroxyl radicals to form a nitroxide that decomposes into aldehyde and secondary nitroxide 
by-products which exhibit different color and therefore can be easily distinguished.[82] 
Biological results have demonstrated that AZN may be promising as a clinical 
neuroprotectant in ischemic brain injury.[83] Both AZN and its water-soluble derivative w-
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AZA produced significant in vivo neuroprotection activity in a mouse Parkinson’s  disease 
model using MPTP as a neurotoxin.[84, 85]  
A second-generation of azulenyl nitrones called stilbazulenyl nitrones (STAZN) were 
synthesized in five steps from the natural guaiazulene (Figure 1.14).[86] STAZN possesses an 
oxidative potential of 0.33 V vs. SCE which is about half lower than that of AZN and 
therefore exceptionally lower compared to PBN. Antioxidant assays demonstrated that 
STAZN possesses remarkable potency as chain-breaking antioxidant and displays a far 
superior antioxidant profile comparing to PBN and AZN which were studied at concentration 
double or more than STAZN. Moreover STAZN appears to be more potent than the first-
generation nitrone AZN for neuroprotection in vivo.[87] Other studies demonstrated that 
STAZN is also a highly potent cardioprotective agent in acute coronary ischemia, suggesting 
the potential for clinical benefit in the setting of acute coronary syndromes.[88] 
STAZN was also studied in heterogeneous media i.e. micelles and liposomes. The rate 
constant for reaction with peroxyl radicals and a number of radicals trapped were studied and 
compared to three phenolic antioxidants and showed that the inhibition rate constant for 
STAZN depends on the reaction medium and the type of initiator.[89] More recently, in vitro 
assays were carried out to evaluate the efficacy and safety of STAZN as a lead compound to 
treat ischemic stroke.[90] CeeTow analysis was used to determine the acute toxicity profile of 
the STAZN and results have shown an excellent safety profile. Moreover, a lack of mutagenic 
activity was observed, indicating that STAZN may have significant potential as a novel 
neuroprotective agent and should continue to be developed as a lead compound to treat stroke. 
Hartley and co-workers have designed a compound combining in its structure a nitrone spin-
trap and a phenol antioxidant with a cyclopropane radical clocklike unit (Figure 1.15). The 
nitrone and the phenol group acts as radical sensors with different selectivity. Very reactive 
electron-rich radicals are expected to react with nitrone whereas electron-poor species would 
Chapter I 
 
 
28 
 
react with the phenol moiety. The cyclopropane should open rapidly to give an unstable 
primary radical which will cyclize onto nitrone to generate a nitroxyl actuator.[91]  
 
Figure 1.15. Dual detector probe detects and distinguishes between hydroxyl radicals, methyl 
radicals and iron (III) ions. 
 
3. Towards the targeting of nitrone spin-traps 
Although some of the strategies developed towards the synthesis of nitrones with improved 
antioxidant properties proved to be promising as described above, it appears that one of the 
limitation in  having  a  “super”  nitrone  spin-traps results from insufficient control of 
biodistribution, membrane crossing and specific targeting. Therefore, several groups have 
designed antioxidants or nitrones derivatives by grafting them onto suitable carriers able to 
target specific production site of ROS such as the mitochondria or phospholipidic membranes. 
Mitochondria-targeting. For example, one of the most promising strategies consists to 
directly link the antioxidant onto a mitochondria-targeted compounds as mitochondria is the 
main source and the first target of reactive oxygen species. Lipophilic phosphonium cations 
were first used to investigate mitochondrial biology by Vladimir Skulachev and colleagues in 
the late 1960s.[92] Despite their negative charge, lipophilic cations are relatively lipid-soluble 
and can pass easily through all biological membranes, including the blood-brain-barrier and 
into muscle cells and thus reach tissues that are most affected by mitochondrial oxidative 
damage. Therefore, these compounds are able to cross the mitochondria inner membrane and 
accumulate within the mitochondria matrix. For this reason, they have proven to be among the 
most useful probes for the investigation of mitochondria function.[93, 94] Various 
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mitochondria-targeted antioxidants were synthesized by grafting the triphenylphosphonium 
cations (TPP) to  antioxidants  such  as  α-tocopherol (MitoVitE)[95] and PBN spin-trap 
(MitoPBN)[96]  (Figure 1.16). It has been reported that MitoPBN reaches 2.2-4.0 mM 
concentration within the mitochondria and blocks the oxygen-induced activation of 
uncoupling proteins. This concept has been extended to cyclic nitrone[97, 98] and to acyclic 
nitroxide.[99] However, the toxicity of triphenyl-phosphonium derivatives at low 
concentration has limited their use as therapeutic agents. N-aryl pyridinium nitrone (Figure 
1.16) have also been used to detect superoxide production from the mitochondria.[100] 
Carnitine, which is used in the transport of fatty acids into mitochondria, was also used as 
potential method of targeting the nitronyl group to mitochondria and the conjugate CarnDOD-
7C was prepared (Figure 1.16).[101] 
Biological membrane-targeting. Another family of spin traps, tailored to intercept radicals 
within biological membranes was developed such as the DOD-8C nitrone (Figure 1.16).[102] 
In lipid membranes, its hydrophilic carboxylate group orientates towards the aqueous phase, 
whereas the nitrone moiety sunk into the membrane. The radical penetration of lipid bilayers 
was determined using lipophilic spin traps with a combination of NMR and ESR techniques. 
Three families of homologous spin-traps derives from DMPO, PBN and adamantyl-PBN were 
synthesized by varying the chain length of the substituent and therefore the overall 
lipophilicity.[103] The intercalation depth of these spin-traps within the liposomal bilayer was 
then determined, in order to predict the susceptibility of lipid moieties to radicals attack. This 
showed that the more lipophilic the spin adduct, the deeper it is found in the bilayer. 
However, the depth of penetration also depends on the steric bulk of the intercalant.[104] 
Lipophilic nitrones with two long alkyl chains have also been developed[105, 106] as well as 
a lipophilic β-cyclodextrin cyclic nitrone conjugate[107] or cholesteryl-based nitrones.[108, 
109] 
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Figure 1.16. Examples of lipophilic cationic and neutral nitrones. 
Amphiphilic-nitrone derivatives.  
With the expectation that amphiphilic compounds possessing both a hydrophilic polar head 
and a lipophilic group would exhibit improved bioavailability and membrane crossing ability, 
our work over the past 15 years has been devoted to the design and the synthesis of 
amphiphilic antioxidants with a particular attention to nitrones derivatives. The use of 
antioxidants is limited by their low bioavailability and conjugation to an amphiphilic carrier is 
expected to improve the bioactivity. Tuning of the hydrophilic/lipophilic balance would 
ensure a better ability to cross membranes and consequently would improve the protective 
activity of nitrone-type synthetic antioxidants. The lipophilic group is typically a large 
hydrocarbon or fluorocarbon moiety and confers to the molecule a hydrophobic character; 
while the hydrophilic polar functional group can be a charged group such as anionic or 
cationic groups or an uncharged group. As a result, an amphiphilic compounds which has 
lipophilic and hydrophilic groups may dissolve in water and to some extent in non-polar 
organic solvents.  
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Our laboratory has focused on the design of amphiphilic nitrone compounds. Two original 
series of amphiphilic PBN derivatives were developed. In the first series, a polar head group 
was grafted onto the aromatic ring of PBN and a hydrophobic moiety, either hydrogenated or 
perfluorinated, was linked to the N-tert-butyl group through a thioether, a carbamate or an 
amide bond.[110] The nature and the length of the hydrophobic chain as well as the nature of 
the polar head were varied,[105, 111, 112] and some examples are represented in Figure 1.17. 
Preliminary biological evaluations showed that amphiphilic derivatives were more potent than 
PBN, demonstrating that amphiphilicity is a key feature in determining bioactivity and 
protection against in vitro and in vivo oxidative toxicity.[110, 111, 113, 114] Among the 
series, LPBNAH (Figure 1.17) exhibited very high antioxidant activity as well as anti-ageing 
effect.[112, 115, 116] A structural isomer, for which the position of the polar head and 
hydrophobic chain on the PBN moiety is reversed were next synthesized (Figure 1.17) and 
showed even better potency in preventing oxidative-stress mediated damages.[117] However, 
this first series was only developed for the PBN moiety. In order to extend the amphiphilic 
strategy to other antioxidants, we, therefore, developed a second series of amphiphilic 
carriers.  
 
Figure 1.17. Examples of the first series of amphiphilic PBN derivatives. 
 
In the second series, an amino acid was used as the core of the carrier upon which 
hydrophobic and hydrophilic parts are linked, respectively by the carboxyl and amino groups 
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of the amino acid. The choice of an amino acid as a central scaffold was evident both for its 
absence of toxicity and for the various functionalization possibilities it allows. Among the 
twenty amino acids available, lysine (bearing an amino group) and aspartic acid (bearing a 
carboxylic acid group) were chosen because they can be easily functionalized on their side 
chains, through an amide bond. The carrier was made of : i) a glycosidic polar head derived 
from lactobionic acid which provides good water solubility to the molecule, ii) a 
perfluorinated chain that supplies hydrophobicity without inducing cytolytic effect[118] and 
therefore enabling membrane crossing ability, and iii) an amino acid as scaffold, bridging the 
polar and apolar groups, and upon which the antioxidant moiety can be grafted through an 
amine bond. The choice of the antioxidants was supported by their singular intrinsic 
properties. In a first study, the biological activity of three antioxidants such as lipoic acid, 
indole-3-propionic acid and Trolox® as well as PBN were studied (Figure 1.18).[119] Using 
in vitro primary cortical mixed cell cultures and in vivo rotifers cultures we confirmed that the 
amphiphilic character of the antioxidant drug improve the protection by at least two times. 
Only for indole-3-propionic acid, the protection was lowered after conjugation to the 
amphiphilic carrier indicating that the free acid group may be involve in the antioxidant 
mechanisms.  
 
Figure 1.18. Examples of the second series of amphiphilic antioxidant derivatives including 
the PBN derivative called FAPBN and the DMPO derivative called FAMPO. 
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More recently, the cyclic nitrone DMPO was grafted onto the same amphiphilic carrier 
(FAMPO) and its protection against different stress inducers was compared to the PBN 
derivative (FAPBN) and to the non-amphiphilic parent compounds.[120] Cytoprotection was 
studied on bovine aortic endothelial cells (BAEC) against hydrogen peroxide (H2O2), 3-
morpholinosynonimine hydrochloride (SIN-1) and 4-hydroxynonenal (HNE) induced cell-
death. FAPBN was found to be the most efficient against H2O2 whereas FAMPO was better 
protective against ONOO- and none of them were effective against HNE. This indicates that 
all amphiphilic nitrones were more potent than their corresponding parent derivatives. 
However, the difference in the cytoprotective properties of FAPBN and FAMPO may indicate 
different intrinsic antioxidant properties and localization in the cell. The continuation of this 
work will be presented in the third chapter of this thesis report. I will describe a series of 
derivatives in which two lysine amino acids have been conjugated allowing the presence of 
two antioxidant groups on the same amphiphilic. Along the series, we will tune the 
hydrophilic/lipophilic balance of the derivatives from lipophilic ones (without a polar head) to 
amphiphilic ones (with a lactobionamide polar head group). The second part of the chapter 
will present the latest series developed in which the polar head group is a specific ligand that 
targets melanosomes. Physical-chemical and antioxidant properties of these new amphiphilic 
nitrone derivatives will be presented as well.  
 
Conclusion 
Nitrone spin traps have been recognized as efficient protecting agent against harmful 
oxidative stress in in vitro and in vivo models and therefore they can both be used as 
analytical and biological tools. The connectivity as well as the nature and the position of 
substituents on a nitrone molecule may significantly affect the chemical and biological 
properties of the nitronyl group. Over the past years, research has been notably focused on the 
development of analogs of both PBN and DMPO in order to improve their biological and 
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spin-trapping properties. Among the PBN derivatives described in this chapter, simple 
chemical structural modifications were firstly carried out either on the phenyl ring or on the 
N-tert-butyl group of PBN. Various analogs were designed to improve the spin-adduct 
stability, we can cite the addition of a phosphorylated substituent on the N-tert-butyl group of 
the nitronyl which led to increased stability of the spin adducts formed. Furthermore, cyclic 
PBN analogs as well as heteroaryl or azulenyl nitrone derivatives were found to increase the 
spin-adduct stability by the presence of an aromatic ring which confers higher rigidity to the 
system. From the therapeutic side, of particular interest is the sulfophenyl series which went 
up to phase III clinical trials although their spin-trapping activity was lower than PBN. This 
clearly confirms previous findings that the biological protection afforded by PBN-type nitrone 
is not mediated by the spin-trapping action. In some series, a second antioxidant moiety was 
added in the nitrone structure such as a guaiazulene or phenolic groups. Through these various 
chemical modification, the intrinsic properties of nitrones has been improved in some cases 
but at the moment no nitrone derivative used as a drug is on the market.  
Another strategy to improve the bioactivity of nitrone has been focused on improving its 
bioavailability. Conjugation to a lipophilic cations has shown to specifically target the 
mitochondria allowing detection of free radical on site. Another approach relies on the use of 
amphiphilic carriers which are believed to improve the ability to cross cell membranes. By 
modulating the hydrophilic/lipophilic balance of the cargos, several amphiphilic derivatives 
were developed in our group and showed high potency in preventing oxidative stress 
mediated damages in in vitro and in vivo models. 
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I. Introduction 
 
The addition of free radicals to nitrones yields a persistent aminoxyl-based spin-adduct that 
can be detected and characterized by electron paramagnetic resonance (EPR) spectroscopy. 
Spin trapping by EPR spectroscopy is a popular method for the detection of free radicals in 
chemical and biological systems.[1] The  α-phenyl-N-tert-butylnitrone (PBN) and its 
derivatives are widely employed as spin-traps in in-vitro, in-vivo and ex-vivo systems.[2, 3] 
Aside from their application as spin-traps, nitrones have also exhibited a variety of protective 
properties in animal models against oxidative stress mediated injury.[4, 5] However, despite 
the promising pharmacological properties of PBN, the molecular mechanism of its action is 
not well understood.  Of the many PBN derivatives that have been synthesized over the years, 
disodium-[(tert-butylimino)-methyl]benzene-1,3-disulfonate N-oxide (NXY-059) has gained 
the most attention since it is the first neuroprotective agent that had reached the phase 3 
clinical trial in the USA.[6] Although it has been suggested that the radical trapping properties 
of NXY-059 is the basis of its neuroprotective action, experimental evidences suggest other 
possible mechanisms being involved.  
One of the promising strategies in the design of novel nitrone-based spin-traps is to 
selectively target these compounds in relevant sites of radical production, mainly the 
mitochondrial electron transport chain, the cytosol, and the membrane bound NAD(P)H 
oxidase.[7-9] Selective targeting is usually achieved by conjugating the nitronyl group to 
specific target ligands, and therefore, the choice of linker groups for optimal spin tapping 
properties is highly desirable. In addition to the type of ligands that are tethered to nitrones, it 
has been demonstrated that the nature of the linker group also affects its bioactivity.[10]  
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Figure 2.1.1. General structure and some examples of substituted linear nitrones. 
 
Only a relatively limited number of N-tert-butyl substituted nitrones have been synthesized 
over the past years where functionalization of the aromatic ring being the most facile. Several 
N-tert-butyl substituted PBNs have been synthesized such as N-benzylidene-1-
diethoxyphosphoryl-1-methylethylamine N-oxide (PPN), [11] N-benzylidene-1,1-
bis(ethoxycarbonyl)ethylamine N-oxide (DEEPN),[12] or the amide amphiphilic nitrones 
developed by our group (LPBNAH),[9] (Figure 2.1.1), but the effect of the substituents on the 
electronic properties of the nitrones and their reactivity to radicals such as O2
•– are not known. 
The substituent effect on the reactivity of DMPO-type cyclic nitrones has been extensively 
studied through experimental and computational approaches[13-15] demonstrating the 
nucleophilic nature of O2
•– addition to C-5-substituted DMPO nitrones.[13]. Therefore, 
derivatization of the tert-butyl group of the PBN may exhibit electronic properties that 
enhance O2
•– addition to nitrones and offers opportunities for multi-functionalization of the 
spin-trap for subcellular target specificity and controlled delivery in in-vitro and in-vivo 
systems. 
Our previous computational and kinetic studies showed that para-substitution by electron 
withdrawing substituents in PBN gave no significant polar effects on their reactivity towards  
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O2
•–, while with HO2•, a more pronounced increase in the kinetic of addition was observed 
indicating the electrophilic nature of this reaction. Our current goal is to explore the reactivity 
of various N-tert-butyl substituted phenyl nitrones so as to identify the most optimal linker 
groups. Through optimization of the linkers, we would be able to design selective targeted 
nitrone-based spin-traps with improved reactivity towards free radicals.  
In this work, five new N-tert-butyl substituted PBNs were synthesized along with a series of 
mono-, di- and tri-hydroxymethyl N-tert-butyl substituted PBN derivatives. The water 
solubility, lipophilicity and electrochemical properties were determined. A UV-Vis stopped-
flow competitive technique was employed to determine the relative rate constants of reaction 
with O2
•–. The relative rate constants of phenyl adduct formation were experimentally 
determined by EPR competition kinetic technique. Using a computational approach, the effect 
of the N-tert-butyl substituents on the nitronyl-atom charge density and electron density 
localization as well as on the free energies of nitrone reactivity with O2
•–and HO2• were 
calculated. Finally, the cytroprotective property of selected compounds against oxidant-
induced cell death was investigated.  
 
II. Results and Discussion. 
Synthesis of tert-substituted nitrones. All the mono-, di- and trisubstituted nitrones with the 
substituents in β-position (See Figure 2.1.1 for details) were synthesized by a one pot 
reduction/condensation of nitro derivatives onto the commercially available benzaldehyde as 
shown in Scheme 1. The PBN-CH2OH[16] was synthesized from 2-methyl-2-nitro-1-propanol 
and benzaldehyde in the presence of zinc powder and AcOH in ethanol according to our 
recently described procedure.[17] After purification by flash chromatography and two 
successive crystallizations from EtOAc/n-hexane, nitrone 1 was obtained in 65% yield which 
is slightly higher than the procedure used by Janzen and Zawalsky (55%).[16] Acetylation of 
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nitrone 1 by a mixture of Ac2O/pyridine 1:1 v/v led to compound 2 (also called PBN-
CH2OAc) in 98% yield, after purification by flash chromatography. The synthesis of 
compound 3 was carried out in one step. First, 2-methyl-2-nitro-1-propanol was activated 
using 1,1'-carbonyldiimidazole (CDI) in the presence of 4-dimethylaminopyridine (DMAP) in 
THF then methylamine was added to the reaction mixture to give after purification compound 
3 in 98% yield. In parallel, 2-methyl-2-nitro propanamine 4 was obtained from 2-methyl-2-
nitro-1-propanol in three steps[9] and was then acetylated to give the nitro compound 5 in 
94% yield. The one pot reduction/condensation of compounds 3 and 5 to benzaldehyde after 
purification by flash chromatography and two successive crystallization from EtOAc/n-
hexane led to nitrones 6 (also called PBN-CH2OCONHMe) and 7 (also called PBN-
CH2NHAc) in 70% and 68% yield, respectively. 
 
Scheme 2.1.1. Synthesis of mono-, di- and tri-β-substituted nitrones. Reagents and 
conditions: (a) Benzaldehyde, zinc powder, AcOH, 4 Å molecular sieves; ethanol, 15→ 60°C, 
10 h; (b) Ac2O/pyr (1:1 v/v), rt, 12h; (c) CDI, DMAP, THF, 2h, rt, then CH3NH2, 18h, rt. 
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Following the same synthetic procedure, the PBN-(CH2OH)2 8 was also synthesized from 2-
methyl-2-nitro-1,3-propadinol in 65% yield, which corresponds to a significant improvement 
compared to the procedure used by Janzen and Zawalsky with15%.[16] The PBN-(CH2OH)3 
9 was obtained following our recent procedure from 2-hydroxymethyl-2-nitro-1,3-
propanediol.[17] Finally, PBN-(CH2OAc)2 10 and PBN-(CH2OAc)3 11 were obtained by 
acetylation of nitrone 8 and 9, respectively. 
Water solubility & partition coefficient. Nitrones 1, 7 and 8 are soluble in water up to a 
concentration of ~ 200 g/L, after which the solution becomes viscous but remained 
transparent. This is significantly higher than PBN whose solubility limit was found to be ~ 21 
g/L. When comparing the amide and carbamate derivatives, 7 and 6, a significant difference 
was noted with 6 exhibiting a water-solubility limit of ~ 11 g/L. Carbamates are indeed 
known to be hardly soluble in water.[18] We also demonstrated that the solubility of 
hydroxylated compounds was not linearly correlated with the number of hydroxyl groups. 
Whereas, the mono- and di-substituted hydroxyl compounds are highly soluble in water (>200 
g/L), the tri-substituted one reaches its solubility limit at ~ 21 g/L likely due intra-molecular 
hydrogen bonding between the three hydroxyl groups as previously observed.[17] Due to the 
oily form of the three ester derivatives their solubility was not determined. 
The relative lipophilicity (log k’w) of the nitrones was measured by HPLC and values are 
reported in Table 1. This confirms the higher lipophilic character of the three ester compounds 
compared to PBN with log k’w values of 1.89, 1.95 and 2.17 for compounds 2, 10 and 11, 
respectively, whereas 1.64 was found for PBN. Although compounds 6 and 7 exhibit different 
water-solubility, they were both found to have similar lipophilicity, slightly lower than that of 
PBN. Finally, the hydroxylated derivatives 1, 8 and 9 were found to be the least lipophilic 
derivatives where the lipophilicity correlates with the number of hydroxyl groups, that is, the 
lower the number of hydroxyl groups, the higher the lipophilicity. Calculated partition 
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coefficients (ClogP) were also determined using Marvin software. Except for the three ester 
derivatives, a good correlation between log k’w and ClogP was obtained (Figure 2.1.2).  
 
Figure 2.1.2. Correlation between log k’w and ClogP. Hydroxylated compounds 1, 8 and 9 
are marked as (?). 
 
Table 2.1.1. Physical-chemical and electrochemical properties of PBN derivatives.  
Compounds 
Water  
solubility 
(g/L) 
Lipophilicity Ep(c) (V) 
 
Ep(a)
 
(V) 
log k’wb Clog Pc In 
H2O
d 
In CH3CN
e 
In CH3CN
e 
2nd Peak 1st Peak 
PBN-CH2OH 1 >200 1.35 1.61 -1.70 -2.12 -1.92 1.57 
PBN-CH2OAc 2 nd
a 1.89 2.05 -1.69  -2.40 -2.03 1.67 
PBN-CH2OCONHMe 6 10.8 1.41 1.94 -1.71 -2.14 -1.96 1.77 
PBN-CH2NHAc 7 >200 1.37 1.32 -1.70  -2.15 -1.97 1.44 
PBN-(CH2OH)2 8 >200 0.95 0.57 -1.74  -2.29 -2.12 1.55 
PBN-(CH2OH)3 9 21.4 0.85 -0.48 -1.67  -2.27 -2.08 1.58 
PBN-(CH2OAc)2 10 nd
a 1.95 1.45 -1.72 -2.31  -1.93 1.76 
PBN-(CH2OAc)3 11 nd
a 2.17 0.84 -1.75 -2.28  -1.89 1.83 
PBN  21.4 1.64  2.66 -1.70  -2.23 -2.10 1.60 
aNot determined. bPartition coefficient values obtained by HPLC. cCalculated octanol/water partition coefficient 
values obtained using Marvin software (http://www.chemaxon.com/marvin/help/index.html). dContaining 50 
mM of NaCl. eContaining 50 mM of TBAP.  
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Spin trapping. To evaluate the spin trapping ability of the PBN substituted derivatives, we 
investigated the formation of various oxygen-centered radical spin-adducts i.e. HO•, O2•–, and 
MeO• adducts. The hyperfine coupling constants (hfcc’s) of the mono substituted derivatives 
1, 2, 6-7 and those of the di- and tri-hydroxylated derivatives 8-9 are reported in Table 2.1.2. 
In most cases, the nitrones tested gave rise to a standard six-line EPR spectrum whose values 
are in agreement with the literature.[19] Two different conditions were used to generate the 
superoxide adducts that is pyridine/H2O2 and DMSO/KO2. In the pyridine/H2O2 system, one 
predominant radical adduct was detected in most cases with hfcc values in agreement with a 
O2
•– adduct. In the KO2 system, the hyperfine coupling constants suggest O2•– adduct 
formation with higher values than in pyridine/H2O2 system which is likely due to solvent 
effect as previously observed for para-substitued nitrones.[20] For the hydroxylated 
derivatives, the presence of a second nitroxide having a six-line pattern spectrum was also 
observed. This second species corresponds to an oxazolidine-N-oxyl compound coming from 
a cyclization reaction between one hydroxyl group and the nitronyl carbon.[17]  
 
Under Fenton condition, the ratio of the cyclic species increased with the number of hydroxyl 
groups: ~ 1/3 for compound 1 (aN = 15.9, aH = 20.1), ~ 2/3 for compound 8 (aN = 15.6, aH = 
19.9) while for compound 9 bearing three hydroxyl groups (aN = 15.3, aH = 19.7), the cyclic 
species was predominant (>90%). This suggests that cyclization may be favored with an 
increasing number of hydroxyl groups and a thorough investigation on this is currently in 
progress in our labs. The formation of five-membered cyclic nitroxides was also evident in 
KO2 system for the hydroxylated derivatives, however, in this case, the ratio of the cyclic 
nitroxide decreased with the number of hydroxyl groups. Cyclisation was observed during 
methoxy radical trapping for the monohydroxylated compound but not for the di-and tri-
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hydroxylated derivatives. Regardless of the radical generating system used, no evidence of 
cyclization was found for the carbamate- and ester-based compounds, while for the amide 
derivative, cyclisation was only evident in the KO2 system. This suggests that cyclization 
involving a nitrogen atom may also occur in basic condition. 
We also investigated the trapping of a carbon-centered radical. The phenyl radical spin-
adducts was obtained by photolysis of a phenyliodide solution in benzene in the presence of 
the nitrones. Although, all the nitrones tested trapped Ph• giving rise to a standard six-line 
EPR spectrum, it should be noted that a weak signal was obtained with the trihydroxylated 
compound 9. In all cases, aN and aH values determined are in agreement with an aryl radical 
adduct of a PBN-type nitrone. 
 
Cyclic Voltammetry. The oxidative and reductive character of these nitrones was 
investigated using cyclic voltammetry and values are reported in Table 1. We first carried out 
cyclic voltammetry in 50 mM NaCl aqueous solution. As already observed for other nitrones, 
the oxidation of the nitronyl group was not detected.[21, 22] On the contrary, we observed 
that all the nitrones exhibited an irreversible one-step reduction, as shown in Figure 2.1.3.  
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Figure 2.1.3. Cyclic voltammograms of PBN and compounds 2, 6 and 7 (A); PBN and 
compounds 2, 10 and 11 (B); PBN and compounds 1, 8 and 9 (C). Reduction in water 
containing 50 mM of NaCl with a sweep rate of 0.1 V.s-1. 
 
The cathodic peak potential of the β-substituted derivatives is observed between -1.67 V and -
1.75 V vs. Ag/AgCl, and that of the PBN being at -1.70 V. This is consistent with the findings 
by Zuman and Exner[23] who reported the weak influence of N-alkyl substituents on the 
reduction potential of α-phenyl-N-alkylnitrones, which was further confirmed by McIntire et 
al.[21] We next studied the electrochemical properties of the nitrones in acetonitrile 
containing tetra-butylammonium perchlorate (TBAP) as electrolyte. Previous works showed 
that PBN undergoes an irreversible one-electron oxidation and a one-step, two-electron 
reduction.[21, 24, 25] Compared to the aqueous conditions, oxidation of nitrones was clearly 
observed in acetonitrile as shown in Figure 2.1.4 and Figure 2.1.5 with values ranging from 
1.44 V to 1.83 V. For the monosubstituted derivatives, the highest observed oxidation 
potential was for the carbamate derivative 6 followed by the ester 2 and then by the 
hydroxylated 1 which suggest a strong inductive effect of the carbamate bond, making nitrone 
6 harder to oxidize than nitrones 2 and 1. This shows that the presence of β-substituents 
affects the oxidation of the nitronyl function. The amide compound 7 with the lowest anodic 
peak potential in the series is, therefore, the easiest to oxidize demonstrating that the oxidation 
of the nitronyl group is more difficult in the presence of electron-withdrawing substituents, in 
agreement with the literature.[21, 25] With regard to the number of substituents, the oxidation 
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potential of the ester derivatives 2, 10 and 11 increases with the number of substituents 
suggesting that the electronic effects are additive. No significant trend was observed for the 
mono-, di- and tri-hydroxylated derivatives whose potential was close to that of PBN, in 
agreement with the literature.[21] 
       
Figure 2.1.4. Cyclic voltammograms of PBN and compounds 2, 6 and 7 in acetonitrile 
containing 50 mM of TBAP with a sweep rate of 0.1 V.s-1; (A) oxidation and (B) reduction. 
 
        
Figure 2.1.5. Cyclic voltammograms of PBN and compounds 2, 10 and 11(A); PBN and 
compounds 1, 8 and 9 (B). Oxidation in acetonitrile containing 50 mM of TBAP with a sweep 
rate of 0.1 mV.s-1. 
The reduction of nitrones in a non-aqueous medium was then investigated and exhibited two 
reduction potentials for all the β-substituted derivatives, whereas for PBN, only one reduction 
peak was observed (Figure 2.1.4 and Figure 2.1.6). 
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Figure 2.1.6. Cyclic voltammograms of PBN and compounds 2, 10 and 11 (A); PBN and 
compounds 1, 8 and 9 (B). Reduction in acetonitrile containing 50 mM of TBAP with a sweep 
rate of 0.1 V.s-1. 
 
The presence of two reduction potentials had been  observed  for  β-phosphorylated nitrone 
spin-traps.[24] For the monosubstituted derivatives, only a modest ease of reduction was 
observed compared to PBN with only ~ 0.1-0.2 V shift in potential. The reduction of the ester 
derivatives becomes slightly easier with increasing number of substituent suggesting an 
additive effect as also observed for the oxidation which is contrary to the hydroxylated 
derivatives where no correlation was found. We further studied the influence of the sweep rate 
of PBN and compounds 2 and 7 on the anodic and cathodic peak current densities. The plot of 
current intensity versus square root of the sweep rate showed a linear decrease for the 
reduction and a linear increase for the oxidation, as shown in Figures 2.1.7 and 2.1.8, 
demonstrating that the electrochemical process is diffusion-controlled.[26, 27] The diffusion 
coefficients of the three nitrones were found in the same range for both oxidation and 
reduction. The reduction of nitrones 2 and 7 exhibited two separate reduction potentials where 
the current intensity and the square scan speed were linear for both peaks. 
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Figure 2.1.7. Sweep rate variations on PBN oxidation (A) and reduction (B) in acetonitrile 
containing 50 mM of TBAP at sweep rate ranging from 0.1 V.s-1 to 1 V.s-1 with corresponding 
linear regression curve. 
 
 
Figure 2.1.8. Linear regressions corresponding to sweep rate variations on PBN, PBN-
CH2OAc and PBN-CH2NHAc oxidation (A) and reduction (B) in acetonitrile containing 50 
mM of TBAP at sweep rate ranging from 0.1 V.s-1 to 1 V.s-1. 
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Nitronyl atoms charge density correlation with NMR chemical shift. Examination of the 
optimized structures at the B3LYP/6-31G* level of theory shows C=N and N-O bond 
distances that are in the range of 1.312-1.317 Å and 1.276-1.292 Å, respectively, which are 
consistent with the X-ray crystallographic C=N and N-O bond lengths observed for N-tert-
butyl- -(2-pyridyl)nitrone of 1.307 Å and 1.294 Å, respectively.[28] The natural population 
analysis (NPA) charges on the nitronyl-carbon, nitronyl-nitrogen, and nitronyl-oxygen atoms 
were determined at the PCM/B3LYP/6-31+G** level for compounds 1-3 and 5-11 as well as 
for the other N-tert-butyl substituted derivatives (Table 2.1.3).  
Table 2.1.3. Natural population analysis (NPA) charge densities of the nitronyl- atoms of 
PBN derivatives at the PCM/B3LYP/6-31+G**//B3LYP/6-31G* level of theory. In bold are 
the data for the molecules synthesized. 
Nitrones monosubstitution disubstitution trisubstitution 
C N O C N O C N O 
PBN -CH3 0.009 0.073 -0.606 n/a n/a n/a n/a n/a n/a 
α-s
ub
st
it
ut
io
n 
-COOH 0.029 0.067 -0.607 0.041 0.059 -0.606 0.050 0.056 -0.590 
-C(=O)OMe 0.005 0.077 -0.577 0.037 0.063 -0.601 0.040 0.061 -0.576 
-C(=O)NH2 0.043 0.055 -0.617 0.074 0.037 -0.631 0.068 0.039 -0.613 
-OMe 0.014 0.047 -0.595 0.020 0.030 -0.601 0.023 0.016 -0.595 
-OC(=O)Me 0.028 0.050 -0.596 0.034 0.028 -0.592 0.040 0.012 -0.577 
-OC(=O)NHMe 0.016 0.049 -0.601 0.049 0.017 -0.617 0.049 0.018 -0.584 
-NHC(=O)Me 0.023 0.057 -0.609 0.005 0.055 -0.583 0.004 0.046 -0.564 
-SMe 0.017 0.057 -0.596 0.012 0.048 -0.584 0.014 0.035 -0.567 
-P(=O)(OMe)2 0.021 0.048 -0.586 0.031 0.047 -0.575 0.051 0.028 -0.582 
β-s
ub
st
it
ut
io
n 
-CH2OH 0.015 0.070 -0.608 0.015 0.074 -0.605 0.023 0.062 -0.613 
-CH2OC(=O)Me 0.023 0.065 -0.608 0.025 0.062 -0.605 0.037 0.053 -0.608 
-CH2NHC(=O)Me 0.028 0.063 -0.619 0.035 0.059 -0.620 0.052 0.049 -0.624 
-CH2OC(=O)NHMe 0.023 0.066 -0.608 0.041 0.150 -0.241 0.027 0.056 -0.596 
-CH2C(=O)NH2 0.036 0.054 -0.621 0.061 0.042 -0.633 0.038 0.050 -0.609 
-CH2C(=O)OMe 0.023 0.067 -0.610 0.034 0.061 -0.611 0.034 0.063 -0.604 
-CH2OMe 0.016 0.070 -0.607 0.020 0.067 -0.609 0.022 0.066 -0.610 
-CH2P(=O)(OMe)2 0.030 0.054 -0.609 0.024 0.055 -0.601 0.008 0.068 -0.566 
-CH2SMe 0.016 0.070 -0.604 0.018 0.071 -0.597 0.022 0.067 -0.594 
In general, increasing the number of substitution results in more positive charge densities on 
the nitronyl-C with the exception of few compounds such as PBN-NHC(=O)Me and PBN-
CH2P(=O)(OMe)2, whereas for the nitronyl-N, an opposite but less pronounced trend was 
observed. As for the nitronyl-O, no significant effect of the substitution was observed 
throughout the series of N-tert-butyl substituted derivatives. This observation is consistent 
with increased distribution of the mesomeric B to the resonance hybrid form in the presence 
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of multiple substituents, where there is an increased electron density on the nitronyl-N and a 
decreased electron density on the nitronyl-C. This is further supported by natural bond orbital 
(NBO) analysis showing that there is a decrease in the percent (0.25%-2.97%) of electron 
localization on the nitronyl-C with increasing substitution (from mono to tri) except for PBN–
NHC(O)Me and PBN-CH2P(=O)(OMe)2  where there is an increase in electron distribution 
(Table 2.1.4). 
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36.93 
63.07 (50.24) 
49.76 
36.77 
63.23 (50.39  
49.61 
36.79 
63.21 (50.26) 
49.74 
π 
39.52 
60.48 
 
39.08 
60.92 
 
38.21 
61.79 
 
-P
(=
O
)(O
M
e)2   σ 
36.90 
63.10 (50.38) 
49.62 
36.59 
63.41 (50.44) 
49.56 
36.38 
63.62 (50.49) 
49.51 
π 
38.30 
61.70 
 
37.84 
62.16 
 
36.09 
63.91 
 
 
β-substitution 
-C
H
2 O
H
  σ 
37.01 
62.99 (50.22) 
49.78 
36.99 
63.01 (50.22) 
49.78 
36.76 
63.24 (50.33) 
49.67 
π 
39.88 
60.12 
 
40.12 
59.88 
 
37.95 
62.05 
 
-C
H
2 OC(=O)Me  σ
 
36.96 
63.04 (50.29) 
49.71 
36.85 
63.15 (50.29) 
49.71 
36.73 
63.27 (50.49) 
49.51 
π 
39.43 
60.57 
 
38.38 
61.62 
 
37.34 
62.66 
 
-C
H
2 NHC(=O)Me  σ
 
37.06 
62.94 (50.08) 
49.92 
36.98 
63.02 (50.16) 
49.84 
36.96 
63.04 (50.16) 
49.84 
π 
39.41 
60.59 
 
38.68 
61.32 
 
38.08 
61.92 
 
-C
H
2 OC(=O)NHMe  σ
 
36.96 
63.04 (50.29) 
49.71 
36.86 
63.14 (50.39) 
49.61 
36.82 
63.18 (50.46) 
49.54 
π 
39.46 
60.54 
 
38.43 
61.57 
 
37.82 
62.18 
 
-C
H
2 C
(=
O
)N
H
2   σ
 
37.07 
62.93 (50.15) 
49.85 
37.12 
62.88 (49.93) 
50.07 
37.00 
63.00 (50.26) 
49.74 
π 
38.82 
61.18 
 
37.68 
62.32 
 
38.14 
61.86 
 
-C
H
2 C(=O)OMe  σ
 
36.97 
63.03 (50.22) 
49.78 
36.94 
63.06 (50.24) 
49.76 
36.75 
63.25 (50.19) 
49.81 
π 
39.29 
60.71 
 
38.79 
61.21 
 
38.70 
61.30 
 
-C
H
2 OMe  σ
 
37.01 
62.99 (50.23)  
49.77 
36.93 
63.07 (50.31) 
49.69 
36.81 
63.19 (50.34) 
49.66 
π 
39.92 
60.08 
 
39.54 
60.46 
 
38.65 
61.35 
 
-C
H
2 P
(=
O
)(O
M
e)2   σ 
36.97 
63.03 (50.27) 
49.73 
37.03 
62.97 (50.16) 
49.84 
37.06 
62.94 (49.71) 
50.29 
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The effect of the nature of substituent on the charge density of the nitrone moiety was also 
studied using 1H and 13C NMR spectroscopy. Similar to carbonyl compounds, nitrones are 
susceptible to nucleophilic addition reaction, and therefore, the electronic nature of the 
nitronyl-C can affect its reactivity towards nucleophilic radicals such as O2
•–. Figure 2.1.10.A 
shows good correlation between the 13C NMR chemical shift in CDCl3 of the nitronyl-C and 
the calculated nitronyl-C charge density where there is a downfield shift with increasing 
positive charge of the nitronyl-C. This confirms the presence of a polar effect from the 
substituent in β  position  on  the  nitronyl  charge  density  and  suggests  a  stabilization  of  the 
mesomeric B form due to the electron withdrawing effect of the substituents. Only the mono- 
and dihydroxylated derivatives 1 and 8 looked out of the range, likely due to the formation of 
intra-molecular hydrogen bonding between the hydroxyl group and the nitronyl-O,[17] which 
may induce a downfield shift. An opposite trend was observed for the 1H NMR chemical shift 
in CDCl3 of the nitronyl-H where an upfield shift of the β-hydrogen was observed with 
increased positivity of the nitronyl-C further confirming the polar effect from the N-tert-butyl 
substituents. (Figure 2.1.9).  
 
Figure 2.1.9. Correlation of the nitronyl-carbon charge densities with the nitronyl-H chemical 
shifts of nitrones 1, 2, 6-8, 10 and 11 (R2 = 0.656) excluding nitrone 9. 
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UV-Vis stopped-flow kinetics. We then applied the UV-Vis stopped-flow technique for the 
determination of the rate constant of O2
•- reaction to nitrones. Phenol red was used as a probe 
to measure O2
•- production, and the rate of formation of this new species at 575 nm is directly 
proportional to the kinetics of O2
•- decay.[13, 20] The kinetic values obtained using the 
stopped-flow technique were shown to correlate well with the trends in rate constants 
obtained using the EPR technique. The slope of the linear line generated from the UV-Vis 
absorption plot was used to calculate the rate of nitrone-spin trapping by using equation 1, 
where N is the PBN derivative, V and v are the initial rates of O2
•- addition to phenol red (PR) 
in the absence and presence of PBN derivatives, respectively.  
V/v -1  = ksN[N] / kPR[PR]     (1) 
Table 2.1.5. Relative Rate Constants for O2
•- and Ph• Adduct Formation 
Nitrones UV-Vis.a EPRb 
ksN/kPR (10
-3) ksN/ksPBN 
 
kpN/kTN 
(± 0.05) 
kpN/kpPBN 
 
PBN-CH2OH (1) 16.7 ± 0.6 12.8 0.09 0.68 
PBN-CH2OAc (2) 73.6 ± 0.7 56.6 0.18 1.37 
PBN-CH2OCONHMe (6) 19.1 ± 0.3 14.7 0.22 1.66 
PBN-CH2NHAc (7) 13.8 ± 0.2 10.6 0.27 2.01 
PBN-(CH2OH)2 (8) 11.7 ± 0.4 9.0 0.11 0.80 
PBN-(CH2OH)3 (9) 14.2 ± 0.1 10.9 nd
c,d ndc,d 
PBN-(CH2OAc)2 (10) nd
c ndc 0.37 2.79 
PBN-(CH2OAc)3 (11) nd
c ndc 0.26 1.94 
PBN 1.3 ± 0.0 - 0.13 - 
DMPO 17.6 ± 0.5 13.5 ndc ndc 
TN ndc ndc - 7.58 
aRatio of the second order rate constants for the superoxide radical reaction with various nitrones (ksN) and by 
PBN (ksPBN) in DMF/KO2. 
bRatio of the second order rate constants for the phenyl radical trapping by various 
nitrones (kpN) and by PBN (kpPBN) in benzene. 
cNot determined. dThe EPR signal of the adduct 9-Ph was too 
weak to allow a reliable determination of the ratio.  
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Figure 2.1.10. Correlation of the nitronyl-carbon charge densities with: (A) Nitronyl-C 
chemical shifts of nitrones 2, 6, 7, 10, 11 and PBN (R2 = 0.965) excluding nitrones 1 and 8 
marked as (○) and 9 which is not soluble in CDCl3. (B) Experimental relative rate constant of 
O2
•– addition to nitrones (ksN/kPR) including para-substituted nitrones marked as (?) from 
Durand et al, 2008 (R  = 0.451) and excluding nitrone 2 marked  as  (○).  (C) Experimental 
relative rate constant of phenyl addition to nitrones (kpN/kTN) (R  = 0.504).  
The slopes of the KO2 controls were averaged to give kPR. The relative rate constants (ksN/kPR) 
are shown in Table 3, and for comparison, the rate of formation of DMPO and PBN were 
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included. All of the relative rates were significantly lower than 1, demonstrating that O2
•- 
reacts faster with phenol red than with the nitrone spin-traps. From these values, ksN/ksPBN 
ratio was calculated leading to the following order of increased reactivity to O2
•-: PBN-
(CH2OH)2 < PBN-CH2NHAc < PBN-(CH2OH)3 < PBN-CH2OH < DMPO < PBN-
CH2OCONHMe < PBN-CH2OAc. It is worth mentioning that all substituted nitrones exhibit 
~ 10-50 times higher rates of trapping compared to PBN. As shown in Figure 2.1.10.B, the 
plot of the rate constant of O2
•--nitrone reaction with the nitronyl-C charge density shows 
increased rates of reaction for the more positively charged carbons, however, with a fairly 
poor correlation coefficient. For the sake of comparison, we also plotted the data for para-
substituted nitrones.[20] The correlation for para-substituted nitrones is even weaker, which 
made us to conclude in our previous work that O2
•- addition to nitrone might be weakly 
electrophilic. With more compounds included in this study, the trend may suggest a 
nucleophilic nature of O2
•- addition to this set of nitrones although the correlation is not 
satisfactory. This may also suggest that the reaction of O2
•- to nitrone is not charge-controlled 
but rather orbital-controlled, hence, warrants further investigation.   
Spin trapping kinetics. Since some nitrones in the series were poorly water-soluble or were 
found to be highly reactive towards HO•, the use of a Fenton system was precluded. 
Therefore, we chose to study phenyl radical (Ph•) trapping in benzene where the 
corresponding adducts show high stability. The 1,3,5-tri[(N-(1-diethylphosphono)-1-
methylethyl) N-oxy-aldimine] benzene (TN)[29] was used as competitive scavenger to 
examine the relative rates of trapping by the nitrones 1, 2, 6-11 compared to PBN (Figure 
2.1.11). It is worth noting that the adduct decay must be slow enough to be neglected to obtain 
reliable results with this approach.[30] The Ph• was generated by UV photolysis of a solution 
containing large excess of iodobenzene in the presence of TN and of the nitrone of interest, 
denoted as N. As previously observed,[29] the possibility of multiple-trapping by TN was 
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neglected since the poly-adducts were never observed by EPR in our study. In this method, 
the Ph• spin trapping rate was monitored by measuring the intensity (as the signal area) of the 
EPR signal of the corresponding adducts. The standard kinetic competition model employed 
as described elsewhere [29] yielded equation 2. In this equation, the second-order rate 
constants for Ph• trapping by the nitrone N and TN are denoted as kpN and kTN respectively, 
while r and R represent the trapping rate by TN only in presence of N, and by both TN and N, 
respectively.  
R/r   = 1 + kpN[N] / kTN[TN]     (2) 
By plotting the R/r ratio as a function of the [N]/[N]ratio for each nitrone 1, 2, 6-11, a straight 
line was obtained with a slope equal to kpN/kTN. Five experiments were performed at five 
different [N]/[TN] ratios kept between 1 and 4. The commercially available PBN was then 
employed instead of N in order to determine the kpPBN/kTN ratio. From these results, the 
kpN/kpPBN ratio was calculated and the values obtained for nitrones 1, 2, 6-11 are reported in 
Table 2.1.5. 
 
Figure 2.1.11. EPR signals recorded in benzene by photolysis of 3 mol.L-1 phenyliodide 
solution in the presence of the nitrones 10 and 7 at two different ratios [10]/[TN]: a) [10]/[TN] 
= 0.67 ([10] = 20 mmol.L-1 and [TN] = 30 mmol.L-1); b) [10]/[TN] = 2 ([10] = 40 mmol.L-1 
and [TN] = 20 mmol.L-1). The peaks with cross (×) correspond to the phenyl radical adduct of 
10, while the other lines correspond to the phenyl radical adduct of TN. 
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Though all the nitrones studied were found less efficient than the tri-(phosphorylated nitrone) 
TN, many of the substituted PBN trapped Ph• significantly faster than PBN where only the 
hydroxylated compounds exhibited slower trapping rates than PBN. It should be mentioned 
that the EPR signal of the phenyl radical adduct on 9 was much too weak to permit a reliable 
evaluation of kpN/kTN. This could be due to a much lower trapping efficiency of 9 and/or to a 
more rapid decay of the spin-adduct. Actually, it turned out that the Ph• adducts of the 
hydroxylated nitrones exhibited faster decay than those of other nitrones, and this was more 
particularly evident in the case of 9. This observation suggests that the hydroxyl groups would 
intervene in the nitroxide decay mechanism. The most efficient compounds in the series for 
trapping Ph• are the di- and tri-acetylated nitrones 10, and 11 and the amide derivative 7, 
while the least effective were PBN and the di- and monohydroxylated nitrones 1 and 7. 
Similar to what was observed for the stopped-flow kinetics experiments, the rates of reaction 
correlate with the nitronyl-C charge density where reasonable correlation can be observed 
with Ph• (Figure 2.1.10.C). The increased rate of trapping by β-substituted nitrones with 
increasing positive nitronyl-C charge density suggests a nucleophilic nature of the Ph• 
addition to the nitronyl-carbon atom. It has been shown that electron-withdrawing substituent 
on the aromatic ring of PBN-type compounds increases the reactivity of the nitronyl group for 
nucleophilic addition reactions and nucleophilic radical addition.[31, 32] On the contrary, 
PBN-type nitrones bearing an electron-donating substituent have also been suggested to 
exhibit high reactivity to electrophilic radicals.[33, 34] In this work the polar effect of the N-
tert-butyl substituents is obviously electron-withdrawing with hydroxyl, ester, amide and 
urethane groups, which therefore may favour nucleophilic addition. This is in agreement with 
the findings by Sueishi et al., who suggested the nucleophilic nature of phenyl radical 
addition to nitrones.[31] More recently De Vleeshouwer et al. confirmed the moderate 
nucleophilic character of phenyl radical using natural population analysis.[35] 
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Thermodynamics of adduct formation. Examination of the optimized structures at the 
B3LYP/6-31G(d) level of theory of various spin-adducts show Cnitronyl-N and N-O bond 
distances of 1.280-1.292 Å and 1.472-1.513 Å, respectively, and are consistent with the X-ray 
crystallographic Cnitronyl-N and N-O bonds observed for the phenyl radical adduct of N-tert-
butyl- -(2-pyridyl)nitrone with bond distances of 1.287-1.291 Å and 1.462-1.466 Å, 
respectively.[28] Table 4 shows the energetics of O2
•– and HO2• addition to various mono-, di-, 
and tri-, - and -substituted PBN derivatives. Majority of the nitrones (22 out of 35) 
exhibited decreased reactivity of O2
•– and HO2• as the number of substitution increases from 
mono-to tri-substitution (Table 4). Only in few cases were the favorability of radical addition 
significantly increases with increasing substitution (i.e., from mono- to tri-substitution) such 
as in the addition of O2
•– to –COOH, -NHC(=O)Me, -CH2OC(=O)Me, and -CH2SMe, and 
HO2
•  to –COOH, -NHC(=O)Me, and -CH2C(=O)NH2. Reactivity of O2•– in general are 
endoergic with -NHC(=O)Me mono-, di-and tri-substitution to be the most favorable with 
ΔGrxn, 298K  (kcal/mol) of 12.7, 11.9 and 6.9, respectively. Structure of these O2•–  adducts 
shows intramolecular H-bonding interaction between the amide-H and peroxyl-O (Figure 
2.1.13) resulting in proton abstraction of one of the amide-H’s by the peroxide-O to form the 
hydroperoxyl moiety, similar to that observed for the 5-carbamoyl-5-methyl-1pyrrroline N-
oxide (AMPO)[36] with an endoergic ΔGrxn, 298K of 6.1 kcal/mol, and with diamide-substituted 
DMPO derivatives with ΔGrxn, 298K  = -3.3 kcal/mol  both of which became the basis for the 
fast and favorable reactivity of amide-conjugated nitrones compared to other spin-traps with 
no such strong intramolecular interactions.[13, 14] The reactivity of HO2
• to nitrones that are 
mono-substituted with -CH2OC(=O)Me and di-substituted with -OC(=O)Me gave the most 
exoergic free energies of reaction with  ΔGrxn,298K (kcal/mol) of -4.4 and -3.5, respectively. 
However, the most exoergic ΔGrxn,298K(kcal/mol) value observed among all the tri-substituted 
analogues was only -1.0 for the –OMe tri-substitution. Previously, at the same level of theory, 
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we showed that addition of HO2
• to monoester-substituted, EMPO, and the diester-substituted, 
DEPO,  gave  the  most  exoergic  ΔGrxn,298K of -6.2 kcal/mol compared to other DMPO-
derivatives. This suggests that ester conjugation to nitrones are preferred for HO2
• 
trapping.[37] 
Table 2.1.6. Free energies (ΔGrxn,298K,aq in kcal/mol) of O2•– and HO2• addition to N-tert-butyl-
substituted PBN derivatives at the PCM/B3LYP/6-31+G(d,p)//B3LYP/6-31G(d) level of 
theory in water. 
aAfter several attempts to optimize this adduct, only fragmented  products were obtained. 
The absence of a significant global trend in HO2
•/O2•– reactivity as a function of increasing 
nitronyl-C charge density and/or increasing substitution could be accounted for the competing 
inductive effects of the methyl group in the partially and -substituted PBN as well as the 
competing resonance effect by the phenyl ring with the inductive effect of the and -
substitution. For mono- substituted PBN (with the exception of two outliers, -
P(=O)(OMe)2, -NH(C=O)Me), a fairly poor correlation (R² = 0.473) can be observed between 
Nitrones Free energies of radical addition (kcal/mol) 
O2
•– addition HO2• addition 
mono- di- tri- mono- di- tri- 
PBN -CH3 18.3 n/a n/a -0.9 n/a n/a 
α-s
ub
st
it
ut
io
n 
-COOH 16.8 13.1 7.5 1.7 0.5 0.1 
-C(=O)OMe 16.3 21.9 17.2 1.9 0.5 3.1 
-C(=O)NH2 15.2 14.1 14.8 4.5 4.0 3.4 
-OMe 17.7 19.3 18.3 -3.1 -2.9 -1.0 
-OC(=O)Me 15.8 15.2 a -1.4 -3.5 2.6 
-OC(=O)NHMe 16.7 20.1 21.2 3.6 -2.7 2.0 
-NHC(=O)Me 12.7 11.9 6.9  0.4 0.9 0.6 
-SMe 17.2 22.4 18.3 -2.2 2.0 0.0 
-P(=O)(OMe)2 20.0 28.1 24.5 -0.9 0.4 3.0 
β-s
ub
st
it
ut
io
n 
-CH2OH 16.1 19.5 20.3 0.8 3.0 2.6 
-CH2OC(=O)Me 16.7 24.7 12.3 -4.4 1.5 1.7 
-CH2NHC(=O)Me 18.0 24.6 16.0 3.4 4.9 1.0 
-CH2OC(=O)NHMe 13.9 17.4 22.6 -2.5 1.1 1.3 
-CH2C(=O)NH2 17.1 14.8. 15.1 3.0 5.5 -0.7 
-CH2C(=O)OMe 17.8 20.4 18.3 0.9 5.0 -0.3 
-CH2OMe 19.8 17.5 21.7 0.2 1.0 1.1 
-CH2P(=O)(OMe)2 16.1 23.6 16.8 1.0 0.8 2.4 
-CH2SMe 19.7 18.6 10.3 -0.2 0.9 0.6 
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the charge densities on the nitronyl-C  with  their  respective  free  energies  (ΔGrxn,298 K) of 
addition with O2
•– (Figure 2.1.9).  
 
 
 
Figure 2.1.12. Plots of NPA charge densities of the nitronyl carbon of the monosubstituted 
nitrones  versus  their  free  energies  (ΔGrxn, 298K) of O2•– addition  reactionsμ  (A)  α-substituted 
nitrones (?) (R  = 0.473) excluding -P(=O)(OMe)2 and -NHC(=O)Me derivatives (?). (B) β-
substituted nitrones (?) (R  = 0.169). 
In a similar study involving para-substitution on PBN, we showed that there was no 
correlation  that can be observed  for ΔGrxn,298 K and nitronyl-carbon charge densities in both 
O2
•– and HO2•  addition reactions.[20] Therefore, reactivity of O2•– and HO2•  to mono- -
substituted PBN might be similar in nature (i.e., nucleophilic) to those observed for the O2
•– 
addition to 5-substituted DMPO analogues which are also mono- -substituted ones,[13] but 
the effect is much less pronounced indicating that inductive effect of the substituents is 
weaker for PBN than that of DMPO analogues. For the mono- β-substitution, no correlation 
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were be observed with the charge density and their respective ΔGrxn,298K of reactivity to O2•– 
(Figure 2.1.12) which could be due to the presence of the methylene group that can further 
diminish the inductive effect by the functional substituent groups. 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.13. Optimized O2
•– adduct structures with the least endoergic free energies of 
formation showing the intramolecular H-bond interaction of the amide-H with the peroxyl-O.  
PBN-tri-NHC(=O)Me 
1.66 
1.02 
1.10 
1.52 
PBN-mono-NHC(=O)Me PBN-di-NHC(=O)Me 
1.66 
1.03 
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Cell culture and viability studies. Cytoprotective properties of nitrones against H2O2-
induced cell death was investigated in vitro using bovine aortic endothelial cells (BAEC). 
BAEC were pre-incubated with varying concentrations (10-50 ȝM) of nitrone derivatives 1, 2, 
and 6-8 (i.e., PBN-CH2OH, PBN-CH2OAc, PBN-CH2OCONHMe, PBN-CH2NHAc, and 
PBN-(CH2OH)2) and were challenged for two hours with H2O2 (1 mM). Extent of 
cytoprotection was measured using [3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium-
bromide] (MTT) assay. Our results are presented in Figure 2.1.14 and show that at 10 µM 
nitrones 2 and 7 exhibited the highest cytoprotection against H2O2-induced toxicity. At 50 
µM, the protection afforded by the nitrones was more pronounced for PBN and compounds 1, 
7 and 8 while for compounds 2 the protection remained similar. A significant decrease of cell 
viability for compound 6 was noted which was even lower than the control and may indicate a 
slight toxicity due to the urethane substituent. 
 
Figure 2.1.14. Cytoprotectivity of PBN derivatives at 10 and 50 µM on Bovine Aortic 
Endothelial Cells against 1 mM H2O2 after 2 hours of incubation.  
To examine the relationship between the electrochemical properties and the antioxidant 
activity of our derivatives, we tried to correlate the cytoprotection data versus the 
electrochemical potentials of the nitrones. While no correlation between the reduction 
potential and the cell viability of nitrone-treated BAEC was observed, a good correlation was 
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observed for the oxidation potentials recorded in acetonitrile with the following order of 
increasing protective property: PBN-CH2OCONHMe < PBN-CH2OAc < PBN-CH2OH ~ 
PBN-(CH2OH)2 < PBN < PBN-CH2NHAc. Whereas this correlation is particularly obvious at 
50 µM where increased cytoprotection is inversely correlated with the oxidation potential 
(Figure 2.1.15), at 10 µM no correlation was observed (data not shown). It has to be noted 
that at 10 µM, the protection afforded by the nitrones against 1 mM H2O2 was very limited. 
This indicates that the ability of nitrones to be oxidized at lower potentials offers better 
cytoprotection, further supporting the role of nitrones in attenuating oxidant-mediated toxicity 
by an antioxidant mechanism and not solely through spin trapping properties.  
 
Figure 2.1.15. Correlation of cell viability with oxidation potential of nitrones 1, 2, 6-8 and 
PBN in acetonitrile (R2 = 0.910).  
 
III. Conclusion 
In this work, we have studied the electronic effect of various substituents on the reactivity of 
α-phenyl N-tert-butyl nitrones. A series of N-tert-butyl substituted mono-hydroxyl (CH2OH); 
mono-ester (CH2OAc); mono-amide (CH2NHAc) and mono-urethane (CH2OCONHMe) as 
well as di- and tri-hydroxyl and ester derivatives was prepared in good yield. The substituent 
effect on the redox properties was investigated by cyclic voltammetry and showed that 
electron-withdrawing groups make the nitronyl group more difficult to oxidize. The 
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substituent effect was also demonstrated by computational approach where increased 
positivity on the nitronyl-carbons were observed for multiple α- and β-substituted compounds, 
which correlates well with experimental NMR chemical shifts. A UV-Vis stopped-flow 
kinetic technique was used to demonstrate the nucleophilic nature of superoxide (O2
•–) 
addition to nitrone in agreement with previous findings on cyclic nitrones. The 
thermodynamics of O2
•– adduct formation showed that the reactivity is endoergic in general, 
however  for  α-substituted derivatives, a modest correlation was observed with the nitronyl 
charge density suggesting a weak nucleophilic nature of O2
•– addition. Moreover, the 
nucleophilic nature of phenyl radical (Ph•) addition to nitrone was also observed using EPR 
kinetic method. Finally, a correlation between the cytoprotective property of nitrones against 
H2O2-induced cell death and their oxidation potential was observed indicating the antioxidant 
properties is also affected by the nature of the substituent. This study confirms that the 
electronic effect of the substituents grafted on the N-tert-butyl group is of high importance in 
the design of nitrone with improved trapping and antioxidant properties. Among the nitrones 
tested, the amide derivative PBN-CH2NHAc gave the best properties such as low oxidation 
potential, good trapping properties combined with cytoprotective activity making the amide 
bond an efficient linker for N-tert-butyl functionalization of the α-phenyl N-tert-butyl nitrone.  
 
IV. Experimental Section 
Synthesis. All reagents were from commercial sources and were used as received. All 
solvents were distilled and dried according to standard procedures. TLC analysis was 
performed on aluminum sheets coated with silica gel (40-63 µm). Compound detection was 
achieved either by exposure to UV light (254 nm) and by spraying a 5% sulphuric acid 
solution in ethanol or a 2% ninhydrin solution in ethanol, and then by heating at ~ 150°C. 
Flash chromatography was carried out on silica gel (40-63µm). Size exclusion 
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chromatography was carried out on hydroxypropylated cross-linked dextran. UV/vis spectra 
were recorded on UV/vis spectrometer aquipped with a double-compartment quartz cell of 
10-mm length.. Melting points have not been corrected. The 1H NMR spectra were recorded 
at 250 or 400 MHz and the 13C NMR at 62.86 or 100 MHz. Chemical shifts are given in ppm 
relative to the solvent residual peak as a heteronuclear reference for 1H and 13C. Abbreviations 
used for signal patterns are: bs, broad singulet; s, singlet; d, doublet; dd, doublet of doublet; t, 
triplet; q, quartet; m, multiplet. HR-MS spectra were recorded on a mass spectrometer 
equipped with a TOF analyzer for ESI + experiments. 
α-Phenyl-N-(2-methyl-1-hydoxy-2-propyl)nitrone (1). In an argon atmosphere and under 
stirring, benzaldehyde (0.80 g, 7.54 mmol), 2-methyl-2-nitro-1-propanol (1.8 g, 15.1 10-3 
mol) and AcOH (2.5 mL, 45.08 mmol) were dissolved in EtOH. The mixture was cooled 
down to 0°C then zinc powder (1.92 g, 29.6 mmol) was slowly added in order to keep the 
temperature below 15°C. The mixture was stirred at room temperature for a couple of minutes 
then heated at 60°C in the dark for 10 h in the presence of molecular sieves (4 Å). The 
reaction mixture was filtered off through a pad of Celite, and the solvent was removed under 
vacuum. The crude mixture was purified by flash chromatography (EtOAc/cyclohexane 6:4 
v/v) followed by two successive crystallizations from EtOAc/n-hexane to give compound 1 
(0.94 g, 4.87 mmol, 65%) as a white powder. Rf 0.42 (EtOAc/cyclohexane 8:2 v/v); mp 78.5-
78.9°C; 1H NMR (CDCl3, 400 MHz) δ 8.27 (2H, m), 7.48 (1H, s), 7.43 (3H, m), 4.24-4.27 
(1H, t, J = 6.2 Hz), 3.79-3.80 (2H, d, J = 6.0 Hz), 1.61 (6H, s); 13C NMR (CDCl3, 100 MHz) δ 
132.1, 130.7 (CH), 130.3 (C), 129.2 (CH), 128.5, 72.9 (C), 70.0 (CH2), 23.9 (CH3); UV 
(MeOH) Ȝmax 296 nm; HR-MS (ESI+, m/z) calcd for C11H15NO2 [(M+H)+]: 194.1181, found 
194.1180. The spectra data of compound 1 were in agreement with those reported by Janzen 
et al. except for the melting point that was found to be 75-76°C.[16] 
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α-Phenyl-N-(2-methyl-1-acetate-2-propyl)nitrone (2). Under stirring, compound 1 (0.35 g, 
1.81 mmol) was dissolved in a Ac2O/pyridine (1:1 v/v) mixture at 0°C. After 12h of stirring at 
room temperature, the mixture was poured into cold 1 N HCl and extracted with CH2Cl2 (3×). 
The organic layer was washed with brine, dried over Na2SO4, and concentrated under 
vacuum. The crude mixture was purified by flash chromatography (cyclohexane/EtOAc 6:4 
v/v) to give compound 2 (0.42 g, 1.79 mmol, 98%) as a white oil. Rf 0.38 
(EtOAc/cyclohexane 5:5 v/v); 1H NMR (CDCl3, 400 MHz) δ 8.30 (2H, m), 7.50 (1H, s), 7.43 
(3H, m), 4.43 (2H, s), 2.03 (3H, s), 1.62 (6H, s); 13C NMR (CDCl3, 100 MHz) δ 170.5 (CO), 
130.7 (C), 130.5, 129.0, 128.5 (CH), 72.1 (C), 68.3 (CH2), 23.7, 20.8 (CH3); UV (MeOH) 
Ȝmax 298 nm; HR-MS (ESI+, m/z) calcd for C13H17NO3 [(M+H)+]: 236.1286, found 236.1283. 
2-methyl-2-nitropropyl methylcarbamate (3). In an argon atmosphere and under stirring in 
a sealed tube, 2-methyl-2-nitro-1-propanol (1 g, 8.39 mmol), DCI (2.11 g, 16.78 mmol) and 
DMAP (0.102 g, 0.839 mmol) were dissolved in THF under argon atmosphere. After 2 h of 
stirring at room temperature, methylamine (1.13 g, 16.78 mmol) was added and the stirring 
was continued for 18 h. Then, the mixture was filtered and the solvent was removed under 
vacuum. The crude mixture was purified by flash chromatography (cyclohexane/EtOAc 9:1 
v/v) to give compound 3 (1.45 g, 8.23 mmol, 98%) as a white powder. Rf 0.30 
(cyclohexane/EtOAc 8:2 v/v); mp 48.3-49.3°C; 1H NMR (CDCl3, 250 MHz) δ 4.76 (1H, bs), 
4.39 (2H, s), 2.78 (3H, d, J = 4.90 Hz), 1.59 (6H, s); 13C NMR (CDCl3, 62.86 MHz) δ 156.0 
(CO), 86.7 (C), 68.7 (CH2), 27.6, 23.0 (CH3). HR-MS (ESI+, m/z) calcd for C6H13N2O4 
[(M+H)+]: 177.0875, found 177.0878. 
2-methyl-2-nitro propanamide (5). The synthetic procedure was essentially the same as for 
compound 2. 2-methyl-2-nitro propanamine[38](3.70 g, 31.50 mmol) was used as starting 
material. The crude mixture was purified by flash chromatography (EtOAc/cyclohexane 8:2 
v/v) to give compound 5 (4.7 g, 29.16 mmol, 94%) as a white powder. Rf 0.48 (EtOAc); mp 
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102.6-103.1°C; 1H NMR (CDCl3, 250 MHz) δ 6.15 (1H, bs), 3.71 (2H, d, J = 6.6 Hz), 2.00 
(3H, s), 1.56 (6H, s); 13C NMR (CDCl3, 62.86 MHz) δ 170.7 (CO), 88.8 (C), 46.1 (CH2), 
24.0, 23.2 (CH3). HR-MS (ESI+, m/z) calcd for C6H13N2O3 [(M+H)
+]: 161.0926, found 
161.0927. 
α-Phenyl-N-(2-methyl-1-methylcarbamate-2-propyl)nitrone (6). The synthetic procedure 
was essentially the same as for compound 1. Benzaldehyde (0.30 g, 2.84 mmol) and 
compound 3 (1 g, 5.67 mmol) were used as starting materials. The crude mixture was purified 
by flash chromatography (EtOAc/cyclohexane 5:5 v/v) followed by two successive 
crystallizations from EtOAc/n-hexane to give compound 6 (0.5 g, 2.0 mmol, 70%) as a white 
powder: Rf 0.23 (EtOAc/cyclohexane 7:3 v/v); mp 127.8-128.1°C; 1H NMR (CDCl3, 400 
MHz) δ 8.30 (2H, m), 7.48 (1H, s), 7.42-7.43 (3H, m), 4.66 (1H, m), 4.45 (2H, s), 2.76-2.77 
(3H, d, J = 4.9 Hz), 1.60 (6H, s); 13C NMR (CDCl3, 100  MHz) δ 156.6 (CO), 131.4 (CH), 
130.7 (C), 130.4, 128.9, 128.5 (CH), 72.6 (C), 68.5 (CH2), 27.6, 23.6 (CH3); UV (MeOH) 
Ȝmax 298 nm; HR-MS (ESI+, m/z) calcd for C13H18N2O3 [(M+H)+]: 251.1395, found 
251.1390. 
α-Phenyl-N-(2-methyl-1-acetamide-2-propyl)nitrone (7). The synthetic procedure was 
essentially the same as for compound 1. Benzaldehyde (0.26 g, 2.45 mmol) and compound 5 
(0.8 g, 5.0 mmol) were used as starting materials. The crude mixture was purified by flash 
chromatography (EtOAc) followed by two successive crystallizations from EtOAc/n-hexane 
to give compound 7 (0.39 g, 1.66 mmol, 68%) as a white powder. Rf 0.35 (EtOAc/methanol 
9.5:0.5 v/v); mp 114.1-114.6°C; 1H NMR (CDCl3, 400 MHz) δ 8.27 (2H, m), 7.50 (1H, s), 
7.44 (3H, m), 6.62 (1H, m), 3.68-3.70 (2H, d, J = 6.3 Hz), 1.98 (3H, s), 1.60 (6H, s); 13C 
NMR (CDCl3, 100  MHz) δ 170.5 (CO), 131.7, 130.7 (CH), 130.4 (C), 129.0, 128.6 (CH), 
73.4 (C), 47.3 (CH2), 25.1, 23.3 (CH3); UV (MeOH) Ȝmax 298 nm; HR-MS (ESI+, m/z) calcd 
for C13H18N2O2 [(M+H)
+]: 235.1446, found 235.1442. 
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α-Phenyl-N-(2-methyl-1,3-dihydroxy-2-propyl)nitrone (8). The synthetic procedure was 
essentially the same as for compound 1. Benzaldehyde (0.78 g, 7.40 mmol) and 2-methyl-2-
nitro-1,3-propanediol (2 g, 14.80 mmol) were used as starting materials. The crude mixture 
was purified by flash chromatography (EtOAc) followed by two successive crystallizations 
from EtOAc/n-hexane to give compound 8 (0.99 g, 4.74 mmol, 65%) as a white powder. Rf 
0.21 (EtOAc); mp 84.2-85.6°C; 1H NMR (CDCl3, 400 MHz) δ 8.24 (2H, m), 7.52 (1H, s), 
7.43 (3H, m), 3.91-3.98 (6H, m), 1.50 (3H, s); 13C NMR (CDCl3, 100 MHz) δ 134.7, 131.1 
(CH), 129.9 (C), 129.6, 128.6 (CH), 75.9 (C), 66.8 (CH2), 19.3 (CH3); UV (MeOH) Ȝmax 296 
nm; HR-MS (ESI+, m/z) calcd for C11H15NO3 [(M+H)
+]: 210.1130, found 210.1126. The 
spectra data of compound 8 were in agreement with those reported by Janzen et al.[16] except 
for the melting point that was found to be 52-55°C. 
α-Phenyl-N-(2-methyl-1,3-di-O-acetyl-2-propyl)nitrone (10). The synthetic procedure was 
essentially the same as for compound 2. Compound 8 (0.40 g, 1.79 mmol) was used as 
starting material. The crude mixture was purified by flash chromatography 
(cyclohexane/EtOAc 4:6 v/v) to give compound 10 (0.25 g, 0.85 mmol, 45%) as a white oil. 
Rf 0.27 (EtOAc/cyclohexane 6:4 v/v); 1H NMR (CDCl3, 400 MHz) δ 8.22 (2H, m), 7.41 (1H, 
s), 7.36 (3H, m), 4.50 (2H, d, J = 11.7 Hz), 4.35 (2H, d, J = 11.7 Hz), 1.98 (6H, s), 1.59 (3H, 
s); 13C NMR (CDCl3, 100 MHz) δ 169.2 (CO), 131.9, 129.8 (CH), 129.3 (C), 128.1, 127.5 
(CH), 72.9 (C), 64.3 (CH2), 19.7, 17.8 (CH3); UV (MeOH) Ȝmax 298 nm; HR-MS (ESI+, m/z) 
calcd for C15H19NO5 [(M+H)
+]: 294.1341, found 294.1337. 
α-Phenyl-N-(2-O-acetylmethyl-1,3-di-O-acetyl-2-propyl)nitrone (11). The synthetic 
procedure was essentially the same as for compound 2. α-Phenyl-N-(2-hydroxymethyl-1,3-
dihydroxy-2-propyl)-nitrone[17] (0.40 g, 1.77 mmol) was used as starting material. The crude 
mixture was purified by flash chromatography (cyclohexane/EtOAc 6:4 v/v) to give 
compound 11 (0.43 g, 1.22 mmol, 69%) as a white oil. Rf 0.42 (EtOAc/cyclohexane 5:5 v/v); 
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1H NMR (CDCl3, 400 MHz) δ 8.28 (2H, m), 7.45 (3H, s), 7.34 (1H, m), 4.61 (6H, s), 2.06 
(9H, s); 13C NMR (CDCl3, 100 MHz) δ 169.9 (CO), 133.9, 131.1 (CH), 130.0 (C), 129.3, 
128.6 (CH), 75.5 (C), 61.4 (CH2), 20.6 (CH3); UV (MeOH) Ȝmax 300 nm; HR-MS (ESI+, m/z) 
calcd for C17H21NO7 [(M+H)
+]: 352.1396, found 352.1388.  
Determination of water solubility. For PBN and nitrones 6 and 9, a UV-calibration curve at 
290 nm was established from solutions ranging from 10-3 to 10-2 g/L (R  > 0.995).  A 
saturated solution of nitrone was prepared at 40°C and then let stand at RT overnight. After 
centrifugation (12000 g – 15 minutes) at room temperature, the concentration of the 
supernatant solution was determined using the calibration curve. For nitrones 1, 7 and 8, 
weighted amounts of the nitrone were added into a vial containing water at RT. After each 
addition, the solution was carefully shaken and the complete dissolution was checked by 
visual observation. 
Determination of log k’W values. Compounds were dissolved in MeOH at 1.0 mg/mL and 
were injected onto a C18 reverse phase column (250 mm x 4.6 mm, 5ȝm). The compounds 
were eluted at various MeOH and water ratios (7:3 to 3:7 v/v) using a flow rate of 0.8 
mL/min. The column  temperature was 25°C,  and  the UV detector wavelength was Ȝ = 2λ8 
nm. Linear regression analysis were performed on three data points for compound 9 (from 5:5 
to 3:7; r2 = 0.9996); four points for compound 1 (from 6:4 to 3:7; r2 = 0.9945), compound 8 
(from 6:4 to 3:7; r2 = 0.9973), compound 2 (from 7:3 to 4:6; r2 = 0.9957),  compound 10 
(from 7:3 to 4:6; r2 = 0.9951),  compound 11 (from 7:3 to 4:6; r2 = 0.9976); five points for 
compound 7 (from 7:3 to 3:7; r2 = 0.9936) and compound 6 (from 7:3 to 3:7; r2 = 0.9944). 
The log k’ values were calculated by using the equationμ log k’ = log((t-t0)/t0), where t is the 
retention time of the nitrone and t0 is the elution time of MeOH, which is not retained on the 
column. 
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Determination of ClogP values. The partition coefficient octanol/water (ClogP) was 
determined using MarvinSketch 5.9.0 that is available at www.chemaxon.com/marvin. 
Cyclic Voltammetric Measurement.The electrochemical experiments were carried out using 
a three-electrode cell in a dry argon atmosphere at room temperature. An Ag/AgCl/saturated 
NaCl electrode was used as the reference electrode and a platinum wire as the auxiliary 
electrode. The working electrode (glassy carbon) was polished prior to each experiment using 
a 0.04 µm aqueous alumina slurry on a wetted polishing cloth. 
EPR Measurements. EPR measurements were carried out on a bench EPR spectrometer. The 
general instrument settings used for spectral acquisition were as follows: microwave power, 
10 mW; modulation amplitude, 2 G; received gains, 9 x 101 – 9 x 102; scan time, 60 s and 
sweep width, 99, 147 or 249 G. Spectra were recorded at room temperature and measurements 
were performed using a 50µL quartz cell or capillary tube for UV or non-UV irradiations 
experiments, respectively. The spectrum simulation was carried out using the WINSIM 
program [39] available as free software from Public Electron Paramagnetic Resonance 
Software Tools (http://www.niehs.nih.gov/research/resources/software/tox-pharm/tools/). 
Spin Trapping Studies. Hydroxyl radical adduct. To generate the hydroxyl radical, nitrone 
(20 mM) was dissolved in a Fenton system containing hydrogen peroxide (0.2%), EDTA (2 
mM), and iron-(II) sulfate (1 mM) in Phosphate Buffer Saline solution. Superoxide radical 
adduct. KO2 generating System. The superoxide anion radical was generated using different 
concentrations of nitrones (40mM for compound 2 and 6; 80 mM of compound 10 and 20 
mM in other case) to a solution of DMSO containing 20 % of saturated solution of KO2 in 
DMSO. Pyridine/H2O2 System. A pyridine solution of nitrone (20 mM) containing 230 mM 
H2O2 was used. Methoxy radical adduct. The methoxy radical was generated by adding ~ 1 
mg of solid Pb(OAc)4 to a DMSO solution of nitrone (25 mM) containing 10% v/v of MeOH. 
Phenyl radical adduct. The  phenyl radical was generated by photolysis of a benzene 
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solution of phenyliodide (3mM), using a xenon discharge lamp (250W) giving near UV and 
visible radiations in the presence of nitrone (50 mM). 
General computational methods. For the addition of each radical species (O2
– or  HO2 ) to 
substituted PBN derivatives, density functional theory[40, 41] computational approach was 
employed to determine the optimized geometry, vibrational frequencies, and single-point 
energy of all stationary points.[35, 42-44] The effect of aqueous solvation was also 
investigated using the polarizable continuum model (PCM).[45-49] All calculations were 
performed using Gaussian 03[50] at the Ohio Supercomputer Center. Single-point energies 
were obtained at the B3LYP/6-31+G** level[51] based on the optimized B3LYP/6-31G* 
geometries. Charge and spin densities were obtained from a natural population (NPA)[52] 
analysis and percent electron localization obtained from natural bond orbital (NBO)[53] 
analysis at the single point PCM/B3LYP/6-31+G**//B3LYP/6-31G* level. These calculations 
used six Cartesian d functions. Stationary points for nitrones and its respective adducts have 
zero imaginary vibrational frequency as derived from a vibrational frequency analysis 
(B3LYP/6-31G*). A scaling factor of 0.9806 was used for the zero-point vibrational energy 
(ZPE) corrections for the B3LYP/6-31G* level.[54]  Here, thermal correction to Gibbs free 
energy was added to the total energy, that is, the sum of total electronic (ε0) and thermal free 
(Gcorr)  energies  with  ZPE  correction  (as  outputs  from Gaussian)  were  used  for  ΔG values 
estimation at 6-31G* with the solvent effect added at 6-31+G**. The ΔG of reactions were 
simply the difference of the sums of these values for the reactants and the products. Spin 
contamination for all of the stationary point of the radical structures was negligible, i.e., S2  = 
0.75.  
Stopped-flow kinetics. Procedure followed similar to Villamena et al.[13] A solution of KO2 
saturated DMF was prepared by adding ~ 200 mg of KO2 to 5 mL DMF under nitrogen 
atmosphere. The solution was sonicated and let stand for 5 min. The supernatant (1 mL) was 
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further diluted with 10 mL DMF to reach a maximum absorbance of ~ 3 at 575 nm when 
mixed with 500 µM phenol red in 90% DMF – 10% H2O. This solution was kept on ice and 
under a nitrogen atmosphere and let stand for 10 min before stopped-flow testing. Solutions 
of the nitrones and 500 µM phenol red in 90% DMF – 10% H2O were prepared. A stopped-
flow technique consisted of 150 µL KO2 solution and 150 µL nitrone solution, and the growth 
and decay of absorption was measured using a UV-vis spectrophotometerrapid mix accessory. 
The plot was exported to Sigma Plot 11.0 and the absorption increase was fitted to a linear 
equation (y = ax + b). To ensure a constant concentration of KO2 throughout the experiment, a 
control of KO2 and 500 µM phenol red was performed both before and after nitrone testing. 
Each nitrone was tested with four or more concentrations ranging from 5 – 200mM.  
Spin trapping kinetics. The solvents were of the highest grade of purity commercially 
available and used without further purification. The trinitrone TN was synthesized and 
purified as previously described.[29] Phenyl radical was produced directly in the EPR 
spectrometer cavity by UV photolysis of a 3 mol.L-1 iodobenzene solution in benzene. The 
method of kinetic competition permitted to evaluate the ratio of the second-order rate 
constants for the trapping of Ph• by one of the nitrone N of interest (kpN, corresponding to the 
compounds 1, 2 and 6-11) and TN (kTN), used as competitive inhibitor. Then, the 
commercially available PBN was also tested versus TN in order to determine the ratio of the 
rate constants for the trapping of Ph· by PBN and by TN, i.e. kpPBN/kTN. The concentration of 
the various nitrones was varied from 5 to 20 mmol.L-1 keeping the [N]/[TN] ratio between 1 
and 4. For each nitrone, five experiments were repeated twice at [N]/[TN] values equal to 1, 
1.6, 2, 3.2 and 4. In each case, a series of 30 EPR spectra was then recorded (scan time for a 
single spectrum; 15 s) on a spectrometer operating at X-band with 100 kHz modulation 
frequency. The signal-to-noise ratio was improved using a SVD procedure, as described 
elsewhere.[55] The signal recorded exactly 1.5 min after the beginning of the reaction was 
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then simulated using the winsim software in order to determine the relative areas of the 
adducts N-Ph and TN-Ph. In this approach, the ratio R/r was evaluated as follows: 
r
=
R area of N-Ph signal + area of TN-Ph signal
area of TN-Ph signal  
Cell culture and viability studies. Bovine aortic endothelial cells (BAEC) were cultured in 
T-75 flasks, in Dulbecco's modified eagle medium (DMEM) supplemented with 4.5 g/L 
glucose, 10 % Fetal bovine serum, L- glutamine, 2.5 mg/L endothelial cell growth 
supplement, 1% non-essential amino acids, and 1% pen/strep at 37°C in a humidified 
atmosphere of 5% CO2 and 20% O2. Cells were subcultured after 85-90 % confluence. 
Cytoprotection of β-substituted nitrones against H2O2-induced toxicity was assessed via 
intracellular reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide) to its insoluble formazan form. A confluent BAEC culture was seeded onto 96-well 
plates (~ 1.0 x 104 cells/well) and incubated for 24 hrs. BEAC were pretreated with various 
nitrone concentrations (25 μM, 50 μM, and 100 μM) and incubated for 24 hrs. The cells were 
then incubated in 1 mM hydrogen peroxide for 2 hrs, followed by the addition of 100 µL 
phosphate buffered saline (PBS) and 50 µL of MTT solution (5 mg/mL, 5% ethanol) for 1 hr. 
The cells were then incubated in 200 µL of dimethyl sulfoxide (DMSO) for 2 hrs. Formazan 
formation was measured using a microplate reader at 595 nm absorbance. Data were 
calculated as percent absorbance of untreated cells ± SEM (n=5). 
 
 
83 
 
Chapter II 
Towards the improvement of the intrinsic properties of 
α-Phenyl-N-tert-butyl Nitrone 
 
 
 
 
Chapter II – Part 2 
 
Electrochemical and Spin-Trapping 
Properties of para-substituted 
α-Phenyl-N-tert-butyl Nitrones 
 
 
 
 
 
 
 
This work will be submitted for publication to New Journal of Chemistry: Marie Rosselin, 
Béatrice Tuccio, Frederick A. Villamena and Grégory Durand.
 
 
 
 
 Chapter II - Part 2 
 
84 
 
I. Introduction 
Oxidative stress has been implicated in several pathophysiological disorders such as 
cardiovascular diseases,[56] cancer,[57] stroke and neurodegenerative diseases.[58] The 
ability of nitrones to prevent oxidative stress-mediated damage in in-vitro, in-vivo and ex-vivo 
models has made them promising synthetic antioxidants with considerable potential as 
therapeutics.[5, 59] Within the past twenty years, several nitrone derivatives have been 
developed among which, one can cite MDL cyclic nitrones[60, 61], azulenyl-based 
nitrones[62, 63], imidazolyl nitrones [64, 65], α-aryl-N-alkyl nitrones[66, 67] as well as 
conjugate of tetramethylpyrazine[68] to name only a few.  
Aside from their use as therapeutic antioxidants, nitrones have been used for spin-trapping 
experiments where the nitronyl group reacts with a free-radical to form a stable and 
identifiable aminoxyl radical that is detected by EPR spectroscopy.[69] The spin trapping 
technique was developed in the late 1960s and since then nitrones have been widely used as 
analytical reagents to identify biological relevant free radicals such as oxygen-, carbon- or 
sulfur-centered radicals. Although there are several evidence that support that radical trapping 
and antioxidant properties of nitrones are not dependent each other, the precise mechanism by 
which these compounds act in different biological models has not yet been fully elucidated.[4] 
The nitronyl moiety exhibits electrochemical activity both in aqueous and non-aqueous 
media. Because of the redox behavior of nitrone spin-traps, “inverted spin-trapping” has been 
reported.[24] In this process, the nitronyl group is oxidized to its radical cation, or reduced to 
its radical anion which can then react, respectively, with a nucleophile or an electrophile 
yielding an aminoxyl radical in both cases. It is important to know the redox behavior of 
nitrones in order to determine in which conditions spin-trapping reactions occur. In addition, 
the ease of oxidation of nitrone derivatives has been found to correlate with antioxidant 
properties.[62, 70] Similar to this, correlation of the ease of reduction of indolone-N-oxide 
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and their anti-malarial activity has been established.[71] 
One of strategies in the design of efficient nitrone-based spin-traps is to target the nitronyl 
group in relevant sites of radical production by conjugating it to specific target ligands. The 
choice of linker groups for optimal spin-trapping properties is highly desirable [14, 20] and it 
has been demonstrated that the nature of the linker group also affects its bioactivity.[70] Over 
the past years, we have explored the reactivity of various para- and N-tert-butyl-substituted 
phenyl nitrones [20, 70] so as to identify the most optimal linker groups and design selective 
targeted nitrone-based spin-traps with improved reactivity towards free radicals. 
In this work, we report the redox properties of para-substituted nitrones (Figure 2.2.1) using 
cyclic voltammetry in aqueous and organic media. The relationship between the 
electrochemical behavior of the nitronyl group and the nature of the substituent i.e. electron-
donating vs. electron-withdrawing was studied. The rate constant of phenyl radical trapping 
by these nitrones was next determined using an EPR competition kinetic method.  
 
Figure 2.2.1. Chemical structures of the para-substituted nitrones used in this work. 
 
II. Results and Discussion 
The electrochemical characterization of these nitrones was investigated using cyclic 
voltammetry and values are reported in Table 2.2.1. We first studied the electrochemical 
properties of nitrones in acetonitrile containing tetra-butylammonium perchlorate (TBAP) as 
electrolyte. Aldonitrones are known to undergo a one-electron oxidation in non-aqueous 
media.[21] For all the nitrones tested, one oxidation potential was clearly observed ranging 
from +1.29 V to +1.94 V. Only, for Me2N-PBN (1) three distinct peaks were observed (Figure 
2.2.2).  
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Figure 2.2.2. Oxidation of PBN and compounds 1, 5 and 6 in acetonitrile containing 50 mM 
of TBAP at 0.1 V.s-1. Inset is the correlation of Hammett sigma para constants ( p) with 
oxidation potentials (R2=0.97). 
C-Anilinonitrones were found to undergo a series of oxidation,[25] which suggests that the 
two supplementary oxidation potentials at +0.84 V and +1.67 V originates likely from the 
oxidation of the dimethylaminogroup. A good correlation between the anodic potential and 
the Hammett  sigma para  constants  (σp) of the para-substituents was observed (Inset Figure 
2.2.2), with compounds bearing electron-withdrawing substituents being hardly oxidized 
while those bearing electron-donating substituents were more easily oxidized. Looking at the 
resonance structures shown in Figure 2.2.3, the polar effect from the substituent can therefore 
be explained by the stabilization of the nitroxide formed after oxidation of the nitronyl group 
when there is an electron-donating group (A).  
 
Figure 2.2.3. Oxidation and reduction of PBN and resonance structures in the presence of: 
(A) an electron-donating group (EDG) and (B) an electron-withdrawing group (EWG). 
 
Reduction of nitrones in acetonitrile was also investigated (Figure 2.2.4). Aldonitrones are 
known to undergo a one-step two-electron reduction in non-aqueous media.[21] In our hands, 
for PBN and the  nitrones bearing an electron-donating group i.e. Me2N-PBN (1), MeO-PBN 
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(2) and AcNHCH2-PBN (3), two reductions potentials were observed and whose difference 
from each other was similar for the four compounds (0.19 ± 0.05 V). The presence of two 
peaks may indicate the formation of unstable intermediate one-electron reduction species as 
already suggested by McIntire et al. for pyridyl nitrones.[21] On the contrary, for the three 
nitrones bearing an electron-withdrawing substituent only one reduction peak was observed. 
This may indicate that an EWG, by stabilizing the intermediate radical anion as shown in 
Figure 2.2.3.B, results in an easiest overall reduction. For MeNHCO-PBN (4) and NC-PBN 
(6), a second peak was also observed however with a difference from that of the nitronyl 
group of ~ 0.7 V. It is worth noting that in dry acetonitrile although it was not the most 
common scenario, in some cases only one peak could be observed whose potential was the 
lower of the two peaks. We therefore considered the lowest reduction potential for the 
correlation with the Hammett values and a good correlation was noted (Inset Figure 2.2.4), 
with an increased ease of reduction as the substituent becomes electron-withdrawing, in 
agreement with the stabilizing effect of the nitroxides as shown in Figure 2.2.3.B. This is in 
agreement with the usual trend that electron-donating substituents retard the addition of 
electrons leading to more negative potentials.[25, 72]  
 
Figure 2.2.4. Reduction of PBN and nitrones 1 and 4 in acetonitrile containing 50 mM of 
TBAP at 0.1 V.s-1 Inset is the correlation of Hammett sigma para constants ( p) values with 
reduction potentials  (R2=0.92). 
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Voltammograms were recorded with increasing amount of water (Figure 2.2.5). Addition of 
water from 1% to 30% in volume led to less negative potentials in agreement with the 
findings by Nepveu and colleagues on N-oxide derivatives[71] who suggested that water 
acting as a proton source could protonate the nitroxide radical anion. For the nitrones 
exhibiting two reduction peaks, the shift was similar for the two peaks until a certain amount 
of water (>10%) where they become broader and progressively coalesce. For MeNHCO-PBN 
(4) and NC-PBN (6) the single reduction peak of the nitronyl group followed the same trend 
shifting towards less negative potential values as the water contain increased, while the 
second peak that was not assigned to the nitrone group was not affected. 
 
Figure 2.2.5. Reduction of PBN in acetonitrile containing 50 mM of TBAP at 0.1V.s-1 with 
increasing amount of water. 
We next carried out cyclic voltammetry in 50 mM NaCl aqueous solution and as already 
observed no oxidation of the nitronyl group was observed.[21] On the contrary, we observed 
that all nitrones exhibited an irreversible one-step reduction (Figure 2.2.6). The cathodic peak 
potential of the PBN derivatives was comprised between -1.41 V and -1.92 V vs. Ag/AgCl, 
that of the PBN being -1.74 V. Along the series as already observed in acetonitrile, 
compounds bearing an electron-donating group were more hardly reduced than those having 
an electron-withdrawing substituent, the effect being linearly correlated with the Hammett 
values (Figure 2.2.6). This is in agreement with the resonance structures in Figure 2.2.3.A. 
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Figure 2.2.6. Reduction of PBN and compounds 1-6 in water containing 50 mM of NaCl at 
0.1 V.s-1. Insert is the correlation of Hammett Sigma Para Constants ( p) values with reductive 
potentials (R2=0.87). 
 
In a recent report we studied the electrochemical properties of N-tert-butyl substituted nitrone 
derivatives.[70] We observed that the polar effect was less pronounced on both reduction and 
oxidation potentials when compared to the data reported herein. This indicates the stronger 
polar effect of aromatic substituents compared with N-tert-butyl in agreement with the 
literature.[21, 23] 
 
Table 2.2.1. Physical-chemical and electrochemical properties of PBN derivatives.  
 
Compounds 
 
σpa In CH3CN
b
 In H2O
f
 EPR
i
 
Ep(c) (V)
c 
Ep(a) (V)
c Ep(c) (V) 
kpN/kTN 
(± 0.05) 1st peak 2nd peak 
4-Me2N-PBN 1 -0.83 -2.30 ± 0.04 -2.49 ± 0.03 1.29 ± 0.05e -1.92 0.16 
4-MeO-PBN 2 -0.27 -2.15 -2.41 ± 0.09 1.42 ± 0.10 -1.87 0.25 
4-AcNHCH2-PBN 3 -0.05 -2.02 -2.17 ± 0.01 1.61 ± 0.06 -1.78 0.23 
PBN - 
0 
-2.02 
-2.17 ± 0.01 
(-2.40d) 
1.62 ± 0.06 
(1.47d) 
-1.74 
(-1.88g) 
0.13 
4-MeNHCO-PBN 4 0.36 -1.82 ±0.11 -2.51 ± 0.13 1.79 ± 0.09 -1.65 n.d.j 
4-HOOC-PBN 5 0.45 -2.18  1.82 ± 0.08 n.d.
h 0.22 
4-NC-PBN 6 0.66 -1.68 ±0.03 -2.37 ± 0.04 1.94 ± 0.04 -1.41 0.15 
a Data from Hansch et al.[73] b Containing 50 mM of TBAP. cAverage of three experiments. d Data 
from McIntire et al. in acetonitrile containing 0.10 M of TEAP vs. SCE at Pt with a sweep rate of 150 
mV/s.[21] e Two supplementary peaks were observed at 0.84 ± 0.05 V and 1.67 ± 0.04 V. f Containing 
50 mM of NaCl. g Data from McIntire et al. in water containing 0.10 M of LiClO4 vs. SCE at Pt with a 
sweep rate of 150 mV/s.[21] hNot determined due to insolubility in water. i Ratio of the second-order 
rate constants for the phenyl radical trapping by various nitrones (kpN) in benzene.
 j Not determined. 
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We next studied the spin-trapping properties of the derivatives using the phenyl radical (Ph•) 
adduct formation in benzene in the presence of 1,3,5-tri[(N-(1-diethylphosphono)-1-
methylethyl) N-oxy-aldimine] benzene (TN) as competitive scavenger. [29] The Ph• was 
generated by UV photolysis of a solution containing large excess of iodobenzene in the 
presence of TN and of the nitrone of interest, denoted as N. The Ph• spin trapping rate was 
monitored by measuring the intensity (as the signal area) of the EPR signal of the 
corresponding adducts (Figure 2.2.6). The standard kinetic competition model employed as 
described elsewhere [29] yielded equation 1. In this equation, the second-order rate constants 
for Ph• trapping by the nitrone N and TN are denoted as kpN and kTN respectively, while r and 
R represent the trapping rate by TN only in presence of N, and by both TN and N, 
respectively.  
R/r = 1 + kpN[N] / kTN[TN]         (1) 
By plotting the R/r ratio as a function of the [N]/[TN]ratio for each nitrone, a straight line was 
obtained with a slope equal to kpN/kTN. Five experiments were performed at five different 
[N]/[TN] ratios kept between 1 and 4. 
 
Figure 2.2.7. EPR signals recorded in benzene by photolysis of a 3 mol.L-1 phenyl iodide 
solution in the presence of nitrone 6 and TN at two different concentration ratios [6]/[TN] : a) 
[6]/[TN] = 1.6 ([6] = 32 mmol.L-1 and [TN] = 20 mmol.L-1; b) [6]/[TN] = 3.2 ([6] = 32 
mmol.L-1 and [TN] = 10 mmol.L-1. The peaks topped by a cross (x) correspond to the phenyl 
radical adduct of TN.  
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All the nitrones tested were found to be less efficient than TN with values of kpN/kTN ranging 
from 0.13 to 0.25 (Table 2.2.1). The PBN was the least potent of the series while MeOPBN 
(2) was the most potent in trapping Ph•. The absence of any correlation between the rate of 
trapping and the Hammett values is univocally observed in Figure 2.2.8.  
The nature of radical addition to nitrone has been thoroughly studied over the past decades. It 
has  been  suggested  that  the  positive  ρ  values  are  due  to  the  nucleophilic  character  of  the 
radicals as observed for alkyl,[32, 74] hydroxyl and phenyl radicals.[31] The substituent 
effect was also interpreted in terms of electron-transfer interaction between the free radical 
and the nitrone compound with a negative ρ value for phenyl radical bearing an EWG while 
those bearing an EDG led to a positive slope.[34] It was concluded that the reaction of the 
unsubstituted phenyl radical is an intermediate case. For the sake of comparison we added in 
Figure 2.2.8 the data from Murofushi et al.[34] and from Sueshi et al.[31] which further 
confirm the absence of any marked polar effect.  
 
Figure 2.2.8. Plots of relative rate constant of phenyl radical trapping vs. Hammett sigma 
para constants (σp). (?) This work. (×) Data from Murofushi et al.[34] (+) Data from Sueshi 
et al.[31] 
Some inconstancies on the polar effect on the reactivity of nitrone have already been noted. 
The observed positive  slope  for HO•  trapping  by  PBN derivatives,  and  the  conclusion  that 
HO•  addition  to nitrones is nucleophilic in nature[31] is contrary to the report by De 
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Vleeschouwer et al.[35] which demonstrated the electrophilic character of HO• using natural 
population analysis. This latter group also concluded to a moderate nucleophilic nature for 
•CH3 that is in agreement with the conclusion of Sueishi et al.[32] According to the 
electrophilic scale of De Vleeschouwer et al., phenyl radical exhibits a moderate nucleophilic 
nature while our experimental data and those of other suggest the absence nucleophilic 
properties. This suggests  that  the sign of ρ value is more dependent on the nature of radical 
addition than on the intrinsic characteristic of the radical itself.  
With regards to the rate of trapping by N-tert-butyl substituted nitrone, a reasonable 
correlation was observed with the nitronyl-C charge density suggesting a nucleophilic nature 
of phenyl radical.[70] With more compounds to add in the correlation (Figure 2.2.9) the 
nucleophilic nature of Ph• addition appears less pronounced although a slight polar effect is 
still noticeable. This may also suggest that the reaction of Ph•  to nitrone is rather orbital-
controlled than charge-controlled. 
 
Figure 2.2.9. Correlation of the nitronyl carbon charge densities from Durand et al.[20] with 
experimental relative rate constants of phenyl addition to nitrones (kpN/kpPBN) (y=24.98x + 
1.167; R =0.269) including para-substituted nitrones (marked as▲) from Rosselin et al.[70] 
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III. Conclusion 
In summary, we reported the polar effect of para-substituents on the electrochemical 
properties  of  α-Phenyl-N-tert-butyl nitrones. Both in aqueous and organic solution, 
compounds bearing an electron-withdrawing group were more easily reduced than those 
having an electron-donating group, the effect being linearly correlated with the Hammett 
values of the substituent. An opposite trend was observed for the oxidation. The polar effect 
can be explained by the stabilization of the intermediate nitroxide formed through resonance 
structures. The ease of oxidation of nitrone derivatives has been found to correlate with 
antioxidant properties[62, 70] and therefore the lowest oxidation potential of 4-Me2N-PBN 
and 4-MeO-PBN compared to PBN suggests they may exhibit improved antioxidant 
properties. The relative rate of Phenyl radical trapping showed no correlation with the 
Hammett values indicating the absence of a polar effect in agreement with previous data. This 
further supports the non nucleophilic nature of phenyl radical. Among the nitrones tested, 4-
MeO-PBN exhibited interesting properties such as low oxidation potential, good trapping 
properties making the ether bond an efficient linker for para- functionalization  of  the  α-
phenyl N-tert-butyl nitrone. 
 
IV. Experimental Section 
General methods of cyclic voltammetry and spin-trapping kinetic experiments are described 
in part 1 of this chapter. The only difference in the spin-trapping kinetic experiments is the 
concentration of nitrones 1-6 which was varied from 5 to 35 mmol.L-1. 
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Chapter II 
Towards the improvement of the intrinsic properties of 
α-Phenyl-N-tert-butyl Nitrone 
 
 
 
 
Chapter II – Part 3 
 
α-Phenyl-N-cyclohexyl Nitrones:  
Preparation and Use as Spin-Traps 
 
 
 
 
 
 
 
 
 
Part of this work will be submitted for publication as: Marie Rosselin, Kamal Zéamari, Fanny 
Choteau, Quentin Hericher, Béatrice Tuccio and Grégory Durand. 
   
 
 Chapter II - Part 3 
  
95 
 
I. Introduction 
 
Nitrone-based compounds have been widely used as spin-traps for detecting transient free 
radicals where the nitronyl group reacts with a free radical to form a stable and identifiable 
aminoxyl radical that is detected by electron paramagnetic resonance (EPR) spectroscopy.[69, 
75] Two families of nitrones are mainly employed to do so, the cyclic nitrones derived from 
the 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) and the linear ones derived from the α-phenyl-
N-tert-butyl nitrone (PBN). Aside from their use as spin-traps, the ability of nitrones to 
prevent oxidative stress-mediated damage in in-vitro, in-vivo and ex-vivo models has made 
them promising synthetic antioxidants with considerable potential as therapeutics.[4, 5, 59] 
While the rate constant of free radicals addition to nitrones is rather high, ranging usually 
from 107 to 109 M-1s-1, in some cases, i.e. superoxide radical, the reaction is significantly 
slower rendering the detection difficult. It is therefore of the utmost importance to design 
nitrones that have the highest rate constant of free radical trapping when using them as 
probes. The ease of detection of a free radical is also determined by the stability of the 
aminoxyl spin-adduct. In general, cyclic nitrones lead to more stable spin adducts than linear 
ones and therefore, several analogues of DMPO with improved stability have been 
designed.[75] One can cite the phosphorylated analogue 5-diethoxyphosphoryl-5-methyl-
1pyrroline N-oxide (DEPMPO), [76] the ester 5-ethoxycarbonyl-5-methyl-1pyrroline N-oxide 
(EMPO),[77] the 2-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BocMPO)[78] or an 
amido derivative (AMPO).[13, 36] On the other hand, efforts to synthesize analogs of PBN 
with improved adduct stability have met with limited success when compared to their cyclic 
analogs.[12, 79, 80] In our group, series of para- and N-tert-butylsubstituted PBN derivatives 
have been prepared but although some of our derivatives proved more potent than PBN, their 
rate of trapping remained within the same order of magnitude.[20, 70]  
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Several cyclic variants of PBN have been reported and examined as spin-traps and/or 
therapeutic agents. Thomas and colleagues reported the synthesis of 3,3-dimethyl-3,4-
dihydroisoquinoline N-oxide (MDL 101,002, Figure 1) and several analogs whose presence of 
the cycle made the nitronyl group more reactive toward radical because of restricted rotation 
and higher accessibility.[60, 81] They also reported higher energy HOMO orbital and lower 
energy LUMO orbital for their lead compound compared with PBN making it more reactive 
toward both electrophilic and nucleophilic radicals.[60, 81] Hideg and colleagues also 
reported a series of cyclic variants of PBN derived from adamantane (PyAN, Figure 1) whose 
hydroxyl adduct stability was increased for the most efficient derivative by ~7 times 
compared to that of PBN.[82, 83] An heteroarylnitrone with a N-cyclohexyl group showed 
interesting antioxidant properties although surprisingly it failed to show detectable HO• 
adduct signals while its analog with a N-tert-butyl group did.[84] With the rational that 
increasing the lipophilicity as a result of an expansion of the nitrone-containing ring may 
improve the activity, series of 2-Benzazepine nitrones were developed with the derivatives 
bearing a spirocyclic moiety (SpFigure 1) being significantly more potent than PBN in 
protecting neuronal cells against oxidative stress.[85] A DMPO derivative with a rigid 
spirolactonyl moiety was prepared and showed higher rate constant of superoxide trapping 
compared to several DMPO analogs.[86] 
In connection with our program devoted to the design of targeted nitrone-based spin-traps 
with improved reactivity towards free radicals we report herein the design of bifunctional α-
phenyl-N-cyclohexyl-nitrones (Figure 2.3.1). Our expectation is that the cyclohexyl ring will 
impart lipophilicty to the molecule, high reactivity of the nitronyl group and, stability of the 
spin adduct formed. Further functionalization of the nitrone to accommodate target-specific 
groups may achieve high reactivity to radicals, longer adduct half-life, and enhanced and 
controlled bioavailability in a unified molecular design (Figure 2.3.1). The synthesis of the α-
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phenyl-N-cyclohexyl-nitrone 4 and its OtBu-protected form 3 is reported. The water 
solubility, lipophilicity and electrochemical properties of these two derivatives were 
determined. Their ability to trap oxygen- and carbon-centered radicals were studied using 
EPR experiments. Moreover, EPR competition kinetic experiments are currently under 
progress to determine the relative rate constants of spin-adduct formation. 
 
Figure 2.3.1. Structure of PBN, DMPO, examples of structure of cyclic variants of phenyl- 
and arylnitrones, and general concept of α-Phenyl-N-cyclohexyl nitrone. 
 
II. Results and Discussion 
The synthesis of nitrone 4 is summarized in Scheme 1. Nitrocyclohexane was used as starting 
material and the first step consisted in the grafting of tert-butyl acrylate onto the cyclohexyl 
ring through a Michael reaction. Several experimental conditions were tested and Table 2.3.1 
summarizes the outcome of our screening. In our hands, the use of a 1/35 mixture of 
KOH/MeOH in dry Et2O following the procedure described by Kolter et al. was the most 
efficient condition,[87] leading to compound 1 in 67 % yield after flash chromatography 
purification. When using tBuOK as a base, higher amount of tert-butyl acrylate were needed 
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to ensure a reasonable yield. Moreover degradation of the reaction mixture could occur in 
some cases with no compound 1 formed. Next step consisted in the condensation of the 
nitronyl group onto the bezaldehyde to form the nitronyl group. We investigated two synthetic 
strategies. The first synthetic route relied on the reduction of the nitro group to its 
hydroxylamine form which was further purified and isolated. Reduction was conducted in the 
presence of zinc dust and NH4Cl in a THF/H2O mixture (3:1, v/v) under argon atmosphere 
following our classical procedure.[9] Hydroxylamine 2 was obtained in 75% yield and was 
next condensed to benzaldehyde under argon atmosphere in a dry 3:2 THF/AcOH mixture 
(v/v) in the presence of molecular sieves to give nitrone 3 in 85% yield. The second synthetic 
route consisted in a one-pot reduction-condensation of the nitro derivative 1 onto the 
benzaldehyde in the presence of Zinc dust and AcOH in EtOH.[17] Under these conditions, 
nitrone 3 was isolated after purification in 30% yield and although this second strategy was 
one step shorter, it failed to improve the overall yield. Finally, removal of the tert-butoxy 
protecting group under acidic condition led to nitrone 4 in 92% yield. It is worth noting that 
despite the use of TFA no degradation of the nitronyl group was observed. Before any 
physical-chemical investigation both nitrone 3 and 4 were recrystallized twice in order to 
ensure high purity.  
 
Scheme 2.3.1. Synthesis of α-Phenyl-N-cyclohexyl Nitrone derivatives. 
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Table 2.3.1. Optimization of Michael reaction to furnish compound 1. 
Solvent Base Reactant Reaction Time Temp. Yield 
THF 1.1 eq tBuOK 1.1 eq acrylate Overnight RT 31 
THF 3 eq. tBuOK 1 eq. acrylate Overnight RT 28 
THF 1.5 eq. tBuOK 1.5 eq. acrylate Overnight RT 40 
Et2O KOH/MeOH 1/35 1 eq. acrylate Overnight 0°C to RT 67 
 
The water solubility of nitrones 3, 4 and its sodium salt was determined using a UV 
spectroscopic method[70] and was compared to that of PBN (Table 2.3.2). Nitrone 3 was 
found insoluble in water while nitrone 4 exhibited a water solubility of 2.1 g/L, which is ten 
times lower than that of PBN (21.4 g/L). Water solubility of nitrone 4 was significantly 
improved after conversion under carboxylic salt form (17.1 g/L). The relative lipophilicity 
(log k’w) of the nitrones was measured by HPLC and values are reported in Table 2.3.2. This 
confirms the higher lipophilic character of the ester nitrone 3 compared to nitrone 4 with log 
k’w values of 3.56 and 2.32, respectively, whereas 1.68 was found for PBN in agreement with 
previous reports.[9] Calculated partition coefficients (ClogP) were also determined using 
Marvin software and a good correlation was observed between the experimental and the 
calculated data (R2>0.999). 
 
 
Figure 2.3.2. Partition coefficients (log k’w) versus Clog P. 
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Table 2.3.2. Physical-chemical and electrochemical properties of nitrones 3 and 4. 
Nitrones 
Water 
solubility 
(g/L) 
Lipophilicity Ep(c) (V) Ep(a) (V) 
log k’wc Clog Pd In H2Od In CH3CNe 
3 -a 3.56 4.53 -a -2.19; -2.07 1.56 
4 2.1 (17.1)b 2.32 3.33 -1.90 -2.28 ; -2.12 1.62 
PBN 21.4 1.68 2.66 -1.74 -2.23; -2.04 1.61 
aNot soluble. bCarboxylate form. cPartition coefficient values obtained by HPLC. dCalculated 
octanol/water partition coefficient values obtained using Marvin software 
(http://www.chemaxon.com/marvin/help/index.html). dContaining 50 mM of NaCl. eContaining 50 
mM of TBAP.  
The electrochemical behavior of the two nitrones was investigated using cyclic voltammetry 
and values are reported in Table 2.3.2. We first carried out cyclic voltammetry in 50 mM 
NaCl aqueous solution. As already observed for other nitrones, the oxidation of the nitronyl 
group was not detected.[21, 22] On the contrary, we observed that nitrone 4 exhibited an 
irreversible one-step reduction, as shown in Figure 2.3.3, with a cathodic peak potential of -
1.90 V vs. Ag/AgCl, that of the PBN being -1.74 V. Due to its insolubility in water, nitrone 3 
was not tested. We next studied the electrochemical properties of the nitrones in acetonitrile 
containing tetra-butylammonium perchlorate (TBAP) as electrolyte. Previous works showed 
that PBN undergoes an irreversible one-electron oxidation and a one-step, two-electron 
reduction.[21, 24, 25] Compared to the aqueous conditions, oxidation of nitrone 3 and 4 was 
clearly observed in acetonitrile as shown in Figure 2.3.3 with values of 1.56 V and 1.62 V, 
respectively. Reduction of the nitrones in a non-aqueous medium showed the presence of two 
reduction potentials for the two nitrones 3 and 4 with ~0.15 V between each peak. A similar 
observation has been made for para-substituted-α-phenyl-N-tert butyl nitrone derivatives (see 
chapter 2, part 2). Only a modest ease of reduction was observed for nitrone 3 compared to 
nitrone 4 and PBN. This data shows that the presence of the cyclohexyl ring does not affect 
both reduction and oxidation potentials of the nitronyl group which is in agreement with 
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findings by Zuman and Exner,[23] McIntire et al.,[21] and our group on the effect of N-alkyl 
modification of phenyl nitrones. 
 
         
Figure 2.3.3. Cyclic voltammograms of PBN and compounds 3 and 4 in acetonitrile 
containing 50 mM of TBAP with a sweep rate of 0.1 V.s-1; (A) reduction and (B) oxidation. 
 
Spin trapping. The spin trapping ability of the two α-Phenyl-N-cyclohexyl PBN derivatives 
were evaluated by formation of oxygen-centered radical spin-adducts i.e. MeO•, tBuO•, HOO•, 
O2
•– and HO• adducts. The corresponding hyperfine coupling constants (hfcc’s) are reported in 
Table 2.3.3. In most cases, the nitrones tested gave rise to a standard six-line EPR spectrum 
with more or less well-defined signals but whose values are in agreement with the 
literature.[19] The methoxy radical was generated by addition of lead tetraacetate (PbOAc4) in 
a solution of DMSO/MeOH (9:1, v/v) containing the nitrone. Compound 3 and 4 were found 
to efficiently trap MeO• radical  with  hfcc’s  in  good  agreement  with  PBN  methoxy  spin-
adducts. The ill-defined spectrum obtained with compound 3 led to less precise determination 
of hfcc’s, compared to compound 4 (Figure 2.3.4). The two compounds were found to trap 
tBuO•  radical, generated by UV-irradiation in DMSO solution containing (tBuO)2, however, 
signals were broad. The hydroperoxyl radical was generated using hydrogen peroxide in 
pyridine solution. In this system, it’s  believed that the hydroperoxide ion reacts first by 
nucleophilic addition onto the nitronyl function, then, oxidation of the resulting 
hydroxylamine gives the hydroperoxyl radical spin-adduct. In our hand we observed broad 
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signals and despite bubbling of the solution with argon to remove the oxygen, no 
improvement of the line width was observed. EPR signals of the superoxide radical spin-
adduct (O2
•⁻), generated using a solution of KO2 in DMSO, were too weak to be analyzed. 
Concerning the hydroxyl radical generated in aqueous solution by hydrogen peroxide 
photolysis, compound 4 was not studied due to its insolubility in water.  Unfortunately, only 
weak signals were observed for compound 3, which can be explain by the instability of 
hydroxyl spin-adduct generally observed with PBN-type nitrones. We also investigated the 
trapping of a carbon-centered radical. The methyl radical was obtained by a Fenton reaction in 
DMSO/phosphate buffer solution (7:3, v/v) in presence of hydrogen peroxide. The two 
nitrones tested trapped CH3
•, leading to ill-defined signals but simulations gave aN and aH 
values in agreement with the methyl radical adduct of a PBN-type nitrone. 
Table 2.3.3. EPR hyperfine coupling constants of different radical adducts of compounds 3 
and 4. 
Compounds N-Cy-Hex-OH N-Cy-Hex-OtBu 
Radicals trapped aN aH aN aH 
CH3O
• 14.4 G 2.9 G 13.7 G 2.3 G 
tBuO• 13.7 G 2.3 G 13.7 G 2.2 G 
HOO• 13.3 G 1.4 G 13.7 G 2.0 G 
CH3
• 14.3 G 2.6 G 14.3 G 2.6 G 
OO-• Weak signals 
HO• Weak signals Not soluble 
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Figure 2.3.4. Methoxy radical spin-adduct of compound 3 (A) and compound 4 (B); Methyl 
radical spin-adduct of compound 3 (C) and compound 4 (D). 
 
III. Conclusion  
We have designed two α-phenyl-N-cyclohexyl-nitrones by addition of a rigid cyclohexyl ring 
instead of the tert-butyl group in order to improve the reactivity towards free radicals. The 
higher lipophilicity of the two derivatives compare to PBN was confirmed by HPLC. 
However, only the carboxylic salt form of compound 3 showed sufficient water solubility, 
making it suitable for biological evaluation. The redox properties were investigated using 
cyclic voltammetry and results have shown that the presence of a cyclohexyl ring had no 
influence on both oxidation and reduction potentials of the nitronyl group. This is not 
surprisingly as the substituent exerts no electronic effect onto the nitronyl function. The 
ability of the two compounds to trap oxygen- and carbon-centered radicals was next 
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confirmed by EPR experiments and kinetic experiments are currently in progress to evaluate 
if the cyclohexyl ring effectively stabilize the spin adduct formed. If interesting results are 
obtained, the next step will consist in the design of α-phenyl-N-cyclohexyl-nitrone derivatives 
with substituents in para position of the phenyl ring.  Moreover, the carboxylic acid group 
will be used to graft specific-targeted ligands such as cell penetrating peptides. 
IV. Experimental Section 
General methods and materials for the synthesis, water solubility determination, log k’W 
determination, ClogP values determination, spin-trapping experiments and cyclic 
voltammetry experiments are described in part 1 of this chapter. 
Compound 1. Under argon atmosphere 5 g (38.7 mmol. 1 eq) of nitrocyclohexane were 
dissolved in Et2O (8 mL). The solution was cooled down and 0.44 mL of a 1.5:8.5 KOH/MeOH 
solution (m/m) (1.11 mmol. 1/35 eq) and 4.9 mL of tert-butoxy acrylate (38.7mmol. 1 eq) were 
successively added dropwise. The solution was stirred at RT for 16 hours then AcOH was 
added until the pH of the solution reached ~5. The solvents were removed under vacuum and 
the resulting crude residue was purified by flash chromatography (cyclohexane/Et2O 95:5 v/v) 
to lead to compound 1 (6.24 g, 25.93 mmol, 67%) as a yellow oil. Rf (cyclohexane/Et2O) = 
0.37. RMN 1H (CDCl3. 400 MHz) δ 2.46-2.41 (2H. m). 2.22-2.14 (4H. m). 1.64-1.34 (8H. m). 
1.46 (3H. s). RMN 13C (CDCl3. 100 MHz) δ 171.4. 91.3. 80.6. 35.0. 33.4. 29.5. 28.1. 24.5. 
22.4. MS (ESI+. m/z) : 258 [(M+H)+]. 275 [(M+NH4)
+]. 280 [(M+Na)+]. 296 [(M+K)+]. 
Compound 2. Under argon atmosphere. 1 g of compound 1 (4.14.10-3 mol. 1 eq) and 0.33 g 
of NH4Cl (6.21.10
-3 mol. 1.5 eq) were dissolved in 3:1 THF/H2O mixture (v/v). The solution 
was cooled down and 1.07 g of Zinc dust (16.56 mmol. 4 eq) were added portion wise keeping 
the temperature below 15°C during the addition then the solution was stirred for two hours at 
RT and filtered off through a pad of celite. The solvents were removed under vacuum and the 
crude residue was purified by flash chromatography (cyclohexane/EtOAc. 8:2 v/v) to lead to 
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compound 2 (0.75 g, 3.09 mmol, 75%) as a white powder. Rf (cyclohexane/EtOAc. 8:2 v/v) = 
0.22. 1H NMR (CDCl3. 400 MHz) δ 5.55 (1H. bs). 2.19 (2H. t. J= 6.0 Hz). 1.71 (2H. t. J= 6.0 
Hz). 1.60-1.10 (10H. m). 1.39 (9H. s). 13C NMR (CDCl3. 100 MHz)  δ  174.4. 80.2. 57.82. 
32.5. 31.2. 29.4. 28.0. 25.9. 21.8. MS (ESI+. m/z) : 244 [(M+H)+]. 266 [(M+Na)+]. 282 
[(M+K)+]. 
Compound 3. Under argon atmosphere. 0.21 g of benzaldehyde (2.03 mmol. 1 eq) and 0.37 g 
of compound 2 (1.62 mmol. 0.8 eq) were dissolved in a 3:2  THF/AcOH mixture (v/v) in the 
presence of 4 Ǻ molecular sieves. The solution was stirred at 60°C for 16 hours and 0.2 eq of 
compound 2 was added after 3 and 14 hours of stirring. The crude mixture was filtered off 
through a pad of celite and the solvents were removed under vacuum. The resulting crude 
residue was purified by flash chromatography (cyclohexane/EtOAc. 8:2 v/v) to lead to 
compound 3 (0.57 g. 1.73 mmol. 85%) as a white powder. Rf (cyclohexane/EtOAc. 8:2 v/v) = 
0.40. 1H NMR (CDCl3. 400 MHz) δ 8.2λ (2H. m). 7.50-7.35 (4H. m). 2.30-2.10 (6H. m). 1.84 
(2H. m). 1.61 (4H. m). 1.50 (2H. m). 1.40 (9H. s). 13C NMR (CDCl3. 100 MHz)  δ  172.4. 
131.7. 130.8. 130.2. 128.9. 128.5. 80.5. 75.2. 34.3. 29.6. 28.0. 25.4. 22.30. MS (ESI+. m/z) : 
332 [(M+H)+]. 354 [(M+Na)+]. 370 [(M+K)+]. HR-MS (ESI+.m/z) calcd for C20H29O3N 
[(M+H)+] : 332.2226. found 332.2252. 
Compound 4. Under argon atmosphere. 0.5 g of compound 3 (1.51 mmol) were dissolved in 
2:8 TFA/CH2Cl2 mixture (v/v). The solution was stirred for 4 hours at RT then the solvents 
were removed under vacuum. The resulting crude mixture was purified by flash 
chromatography (EtOAc/cyclohexane. 6:4 v/v) to lead to compound 4 (0.38 g. 1.39 mmol. 
92%) as a white powder. Rf (cyclohexane/EtOAc. 6:4 v/v) = 0.12. 
1H NMR (CDCl3. 400 
MHz) δ 8.2λ (2H. m). 7.53 (1H. s). 7.44 (3H. m). 2.32-2.28 (2H. m). 2.21-2.17 (4H. m). 1.90-
1.83 (2H. m). 1.63-1.58 (4H. m). 1.50 (2H. m).  13C NMR (C DCl3. 100 MHz) δ 176.6. 134.9. 
131.3. 130.1. 129.8. 128.7. 75.5. 34.4. 32.6. 28.5. 25.5. 22.3. MS (ESI+. m/z) : 276 [(M+H)+]. 
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298 [(M+NH4)
+]. 314 [(M+K)+]. HR-MS (ESI+.m/z) calcd for C16H21O3N [(M+H)+] : 
276.1600. found 276.1611. 
Determination of water solubility. For PBN and nitrones 3 and 4, a UV-calibration curve at 
290 nm was established from solutions ranging from 10-3 to 10-2 g/L (R  > 0.997). A saturated 
solution of nitrone was prepared at 40°C and then let stand at RT overnight. After 
centrifugation (12000 g – 15 minutes) at room temperature, the concentration of the 
supernatant solution was determined using the calibration curve.  
Determination of log k’W values. Compounds were dissolved in MeOH at 0.5 mg/mL and 
were injected onto a C18 reverse phase column (250 mm x 4.6 mm. 5ȝm). The compounds 
were eluted at various MeOH and water ratios (9:1 to 4:6 v/v) with 0.1% acetic acid using a 
flow rate of 0.8 mL/min. The column temperature was 25°C. and the UV detector wavelength 
was Ȝ = 2λ8 nm. Linear regression analysis were performed on four data points for compound 
3 (from 9:1 to 6:4; R2 > 0.997); compound 4 (from 7:3 to 4:6; R2 > 0.999) and PBN (from 7:3 
to 4:6; R2 > 0.999). The log k’ values were calculated by using the equationμ log k’ = log((t-
t0)/t0). where t is the retention time of the nitrone and t0 is the elution time of MeOH. which is 
not retained on the column. 
Determination of ClogP values. The partition coefficient octanol/water (ClogP) was 
determined using MarvinSketch 5.9.0 that is available at www.chemaxon.com/marvin. 
Cyclic Voltammetric Measurement. The electrochemical experiments were carried out 
using a three-electrode cell in a dry argon atmosphere at room temperature. An 
Ag/AgCl/saturated NaCl electrode was used as the reference electrode and a platinum wire as 
the auxiliary electrode. The working electrode (glassy carbon) was polished prior to each 
experiment using a 0.04 µm aqueous alumina slurry on a wetted polishing cloth. 
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I. Introduction 
Bioavailability of antioxidants is of particular interest in the development of new compounds 
with improved protective activity against oxidative stress-induced damage. For several years, 
our laboratory has been interested in improving the protective activity of nitrone-type 
synthetic antioxidants. Our strategy is based on the modulation of the hydrophilic/lipophilic 
balance of the nitrone-containing derivatives, in order to ensure an enhanced membrane 
crossing ability. The amphiphilic character of these nitrones has therefore been demonstrated 
to improve the bioavailability and the protection against oxidative stress.[1-4]  
The design of hybrid molecules including two pharmacophores in one molecular scaffold is 
currently being investigated for several types of drug and active compounds. The hybrid 
approach consists in the conjugation of two or more different active moieties in order to 
provide improved properties to the molecule.[5],[6] This has been used in the field of 
antioxidants molecules. For example, the synergistic interactions between lipoic acid and 
other antioxidants were described by several groups and were generally found to be beneficial 
for the antioxidant activity.[7-9] Hybrids compounds combining the -tocopherol chroman 
moiety and other antioxidants were also synthesized, demonstrating that the antioxidant 
activity greatly depend upon the synergistic action of the two different antioxidants.[10-12] 
More recently, Hadjipavlou-Litina and co-workers have designed compounds with high 
inhibition of soybean lipoxygenase (LOX) by conjugation of different antioxidant 
scaffolds.[13] 
 
Figure 3.1.1. Exemples of hybrid antioxidants. 
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Therefore, the synthesis of hybrid molecules bearing one nitrone moiety and another type of 
antioxidant appears to be a promising strategy as it allows to combine in one unified 
molecular scaffold, two antioxidant moieties with particular properties. Our group previously 
developed an amphiphilic hybrid of lipoic acid and PBN, called PBNLP (Figure 3.1.1), in 
which the nitronyl group is the linker between the lipophilic lipoic acid and the polar head 
group.[14] In vitro protection afforded by PBNLP against AAPH-induced hemolysis of 
erythrocytes demonstrated the beneficial effect of chemical association of a water soluble 
derivative of PBN and lipoic acid compared to these two derivatives in admixture and, to 
PBN and lipoic acid alone. It was suggested that the amphiphilic character of PBNLP 
partially governs the beneficial effect by increasing the bioavailability and by reducing the 
negative chemical interactions between the two compounds. Balogh and co-workers have also 
synthesized trolox-nitrone conjugates (Figure 3.1.1) whose antioxidants properties have been 
evaluated in vitro and in vivo.[15] The conjugates exhibited a comparable activity as Trolox 
against in vitro lipid peroxidation and exceeded nitrone-type references PBN and NXY-059 in 
a mice model of permanent focal ischemia. 
As an ongoing effort towards the design of highly potent antioxidants, we have decided to 
synthesize new hybrid amphiphilic antioxidants using the optimized amphiphilic carrier 
developed in our laboratory and composed of a sugar-based polar head, a perfluorinated 
hydrophobic tail and a lysine amino-acid as central scaffold upon which the antioxidant 
moiety can be grafted through an amide bond.[4] By combining two lysine amino acids, the 
synthesis of multivalent antioxidant derivative was made possible. We first worked on the 
synthesis of a divalent amphiphilic derivative in which two PBN moieties were grafted onto 
the lysine side chains of the carrier. This compound is called FADiPBN, FA meaning 
“Fluorinated Amphiphilic carrier” and Di denoting the presence of two nitrone moieties. By 
comparing this derivative to its monovalent derivative FAPBN,[3, 4] we can study the effect 
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of the multi-valence effect on the antioxidant properties. We then extended our work on the 
search for a synergistic effect between different antioxidants grafted onto the same carrier. 
This led us to develop a hybrid derivative bearing both PBN and Trolox moieties. This 
derivative was called using our nomenclature FATxPBN, Tx denoting the Trolox group. 
In the search for new amphiphilic derivatives, we also developed compounds in which the 
sugar-based polar head was replaced either by an anionic (carboxylate) or a cationic 
(ammonium) polar head group so as to obtain pH-dependent derivatives. With the anionic 
carboxylate derivative, one can expect to obtain a better solubility at high pH whereas with 
the cationic ammonium compound one should obtain better solubility at low pH.  In biology, 
pH is of particular importance, the physiological pH in living system is around 7.4 but differs 
in the several cellular compartment or organs. Therefore, having these two ionic compounds 
in hand would allow us to work on a large range of pH. For the sake of comparison, their 
corresponding protected derivatives bearing one or two PBN moieties were also synthesized 
in order to study their physical-chemical properties as well as antioxidant and anti-
inflammatory activities. 
II. Results and discussion 
1. Synthesis of the divalent antioxidants FADiPBN and FATxPBN. 
Synthesis of the DiLysine carriers 4 and 5. The synthesis starts from compound 1, which 
was prepared following our established procedure[4] from the commercially available 
1H,1H,2H,2H-perfluoroctyl iodide. First, deprotection of compound 1 was carried out in a 
dichloromethane solution containing 20% of trifluoroacetic acid (TFA) and the resulting 
amino form was directly used without purification. On the one hand, Boc-Lys(Z)-OH was 
grafted on the deprotected compound 1 using the classical N,N'-Dicyclohexylcarbodiimide 
(DCC) reagent in presence of a catalytic amount of hydroxybenzotriazole (HOBt), in dry 
dichloromethane to obtain compound 2 in 98% yield. In parallel, the lactobionolactone polar 
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head was prepared by deshydratation of lactobionic acid in acidic media following a 
procedure routinely used in our laboratory. Compound 2 was then deprotected in acidic 
conditions and lactobionolactone was added to the resulting amino compounds in solution in 
Ethanol with a few drops of TEA (pH ~ 8-9). The mixture was stirred at 60-70°C until 
complete consumption of the amino compound and was then acetylated using Ac2O/Pyridine 
(1/1 v:v). After purification by flash chromatography, compound 4 was obtained in 60% 
(Scheme 3.1.1). On the other hand, the second carrier was easily obtained following a 
connected procedure. The only difference lies in the second lysine moiety which was 
protected with a fluorenylmethyloxy carbonyl group (Fmoc) on the C-terminal part and with a 
Boc group on the side chain. This led to compound 3 in 82% yield. The corresponding 
amphiphilic carrier (5) was then obtained in 62% yield (Scheme 3.1.1). 
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Scheme 3.1.1. Synthesis of FADiPBN and FATxPBN. a) CH2Cl2/TFA (8:2); b) Boc-Lys(Z)-
OH, DCC, HOBt, CH2Cl2; c) Fmoc-Lys(Boc)-OH, DCC, HOBt, CH2Cl2; d) 
Lactobionolactone, EtOH, 60°C; e) Ac2O/Pyridine; f) CH3CN/DEA (9:1); g) H2, Pd/C, 
EtOH/AcOH (99:1), 5 bars; h) HOSu-PBN, dry CH2Cl2; i) Trolox®, DCC, HOBt, dry 
CH2Cl2; j) MeONa, MeOH. 
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Synthesis of FADiPBN (7). The two protecting groups of compound 4 were removed by 
hydrogenolysis using a catalytic amount of 10% Pd/C in ethanol/acetic acid (99:1 v/v) and 
submitted to a hydrogen atmosphere of 5 bars. After filtration of the catalyst through a pad of 
Celite, the resulting amino compound was added to a solution of HOSu-PBN[4] in dry 
dichloromethane at room temperature and under argon atmosphere. After purification by flash 
chromatography followed by size exclusion chromatography, the acetylated compound 6 was 
obtained in 46% yield in the two steps. Finally removal of the acetyl groups by Zemplén 
desacetylation in presence of a catalytic amount of sodium methoxide in dry methanol led, 
after purification on size exclusion chromatography, to FADiPBN in 86% yield. The overall 
yield for the preparation of FAPBN is 16 % in 5 steps. 
Synthesis of FATxPBN (10). The Boc protecting group of compound 5 was first removed 
using 20% of TFA in dry CH2Cl2 and the resulting amino compound was directly coupled to 
Trolox® in the presence of DCC and HOBt in dry CH2Cl2. Previous work in our group 
showed that the preparation of activated ester of Trolox was troublesome.[4] That is why we 
rather used the classical DCC/HOBt coupling system. After purification by flash 
chromatography, compound 8 was obtained in 74% yield. Then, the carboxyphenyl group (Z) 
was deprotected by hydrogenolysis following the same procedure as described above and the 
resulting amino compound was added to a solution of HOSu-PBN[4] in dry dichloromethane 
at room temperature and under argon atmosphere. After purification by flash chromatography 
followed by size exclusion chromatography, the acetylated compound 9 was obtained in 58% 
yield. Finally, deprotection of the hydroxyl groups following Zemplén transeterification led 
after purification by size exclusion chromatography to FATxPBN in 96% yield. The overall 
yield for the preparation of FATxPBN was 15 % in 6. Both FADiPBN and FATxPBN were 
characterized by 1H, 13C and HSQC NMR experiments as well as mass spectroscopy. The 
purity (98%>) was then confirmed by C18 reverse phase HPLC at 290 nm. 
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2. Synthesis of the ionic antioxidant derivatives. The main characteristic of a carboxylate- 
or an amino-based amphiphile is that depending on the pH of the solution, it can be either 
charged or uncharged altering thereby its solubility in water. Two ionic antioxidant 
derivatives with a carboxylate and an amino group were synthesized (Schemes 3.1.2 and 
3.1.3) and were respectively called and RF-Lys(PBN)-OH and H-Lys(PBN)-RF, “RF” 
denoting the perfluorinated chain -CH2CH2C6F13. 
Synthesis of RF-Lys(PBN)-OH (13). The anionic derivative was easily obtained in four steps. 
Firstly, the commercially available 2H,2H,3H,3H-Perfluorononanoic acid was grafted on the 
free amino group of H-Lys(Z)-OtBu in dry dichloromethane using DCC/HOBt. After 
purification, compound 11 was obtained in 90% and was then submitted to a 5 bars hydrogen 
atmosphere with a catalytic amount of 10% Pd/C. The activated ester HOSu-PBN[4] was 
grafted onto the resulting amino derivative and after purification, compound 12 was obtained 
in 74% in the two steps. Finally, removal of the tert-butyl ester protecting group was carried 
out in acidic condition and appeared the most sensitive step. Indeed, the nitronyl group is 
rather sensitive and can easily decompose in aqueous solution under acidic conditions to give 
the corresponding benzaldehyde and N-tert-butyl hydroxylamine, as previously reported in 
the literature.[16, 17] To avoid degradation of the nitrone function, we first tried to remove 
the ester group with 20% of TFA in dry dichloromethane. TLC monitoring and 1H NMR 
spectroscopy showed the complete absence of deprotection, even after 3 h of stirring. The 
concentration of TFA was then increased to 30% and reaction time to 6 h but the deprotection 
was only partial. Complete deprotection of the amino group was obtained with 50% of TFA in 
dry dichloromethane. However, 1H NMR spectroscopy showed the presence of around 20-30 
% of benzaldehyde by-product, arising from the cleavage of the nitronyl function, which was 
difficult to purify because of the relatively close retention factor to that of the nitrone 
derivative. To avoid the cleavage of the nitronyl group, tetraethylsilane (TES) was used as a 
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scavenger of the carbocation formed during the reaction. Finally, after a rapid screening of the 
experimental condition, the best one was the use of a solution of TFA/CH2Cl2 (5:5, v/v) with 
2 equivalents of TES at 0°C and under argon atmosphere. After 3 h of stirring, the crude 
mixture was purified by flash chromatography eluted with EtOAc/MeOH (8:2, v/v) 
containing 1% of AcOH and RF-Lys(PBN)-OH was obtained in 76% yield.  
 
Scheme 3.1.2. Synthetic pathway of Rf-Lys(PBN)-OH. a) DCC/HOBt/CH2Cl2; b) H2, Pd/C, 
EtOH; c) HOSu-PBN, CH2Cl2; d) CH2Cl2, TFA (5:5, v/v), TES. 
Synthesis of H-Lys(PBN)-RF (15). The synthesis starts from compound 1 whose side chain 
was deprotected under hydrogen atmosphere with a catalytic amount of 10% Pd/C. An excess 
of active ester HOSu-PBN[4] was then added to the resulting amino compound in solution 
with dry CH2Cl2 and after purification, compound 14 was obtained in 69% yield. Like for the 
synthesis of the anionic compound, the deprotection of the amino group was difficult with the 
formation of by-products even in the presence of TES scavenger. After several assays, the 
best condition was found to be CH2Cl2/TFA (8:2, v/v) at 0°C with 2 equivalents of TES.  
Purification by flash chromatography eluted with EtOAc/MeOH (9:1, v/v), led to H-
Lys(PBN)-RF in 78% yield. 
 
Scheme 3.1.3. Synthetic pathway of H-Lys(PBN)-RF. a) H2, Pd/C, EtOH; b) HOSu-PBN, 
CH2Cl2; d) CH2Cl2, TFA (8:2, v/v), TES. 
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3. Synthesis of uncharged lipophilic antioxidant derivatives. We were also interested in the 
synthesis of divalent ionic derivatives with either a carboxylate or an amino group. We 
therefore developed another synthetic strategy as described in Scheme 3.1.4. However, the 
last step consisting in the removal of the protective groups failed to provide the desired 
compounds in spite of several attempts. We report herein the synthesis until to the 
penultimate step. This led us to two lipophilic divalent derivatives bearing two PBN moieties, 
denoted as RF-[Lys(PBN)]2-OtBu (17) and Boc-[Lys(PBN)]2-RF (18) that can be compared to 
the univalent derivatives, respectively compounds 12 and 14. 
Synthesis of RF-[Lys(PBN)]2-OtBu (17). Starting with compound 11, the first step consisted 
in the removal of the ester protecting group in acidic conditions. The carboxylic acid group of 
the resulting compound was then coupled with H-Lys(Z)-OtBu in presence of DCC and a 
catalytic amount of HOBt in dry dichloromethane with few drops of TEA (pH~8-9) to obtain, 
after purification, compound 16 in 44% yield. With regard to the relatively low yield, a 
second assay was carried out with 2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronoium 
hexafluorphosphate (TBTU) as a coupling reagent in the presence of DIEA in dry 
dichloromethane but no significant improvement of the yield was observed. Then the two 
carboxybenzyl groups were simultaneously removed under hydrogen atmosphere with a 
catalylic amount of 10% Pd/C. The active ester of PBN was grafted on the two amino 
functions of the resulting compound to give RF-[Lys(PBN)]2-OtBu in 60% yield. 
Some assays were done to remove the tert-butyl protecting group and obtain an amphiphilic 
pH-dependant compound bearing two PBN moieties but results were unsuccessful. Because 
of the two nitrone functions present, a wide range of by-products were obtained and after 
purification, no fraction of the desired product was observed. We decided to study the 
properties of the protected compound itself. We will further pursue our efforts to synthesize 
the corresponding deprotected compound. 
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Synthesis of Boc-[Lys(PBN)]2-RF( 18). Compound 2 was synthesized from compound 1. The 
two lysine side chains were deprotected using a catalytic amount of 10% Pd/C in EtOH 
solution and under hydrogen atmosphere. The active ester of PBN was then grafted on the two 
resulting amino functions to give after purification by flash chromatography and by size 
exclusion chromatography, compound Boc-[Lys(PBN)]2-RF in 50% yield. In light of the 
degradations observed when removing the protecting group in acidic conditions, we choose 
not to deprotect it and study the physical chemical and biological properties of the protected 
form. 
 
Scheme 3.1.4. Synthetic pathway of RF-[Lys(PBN)]2-OtBu and Boc-[Lys(PBN)]2-RF. a) 
CH2Cl2, TFA (5:5, v/v); b) H-Lys(Z)-OtBu/DCC/HOBt/CH2Cl2; c) CH2Cl2, TFA (8:2, v/v); 
d) Boc-Lys(Z)-OH/DCC/HOBt/CH2Cl2H2, e) H2, Pd/C, EtOH; f) HOSu-PBN, CH2Cl2. 
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Physical-chemical measurements. 
The three non-ionic amphiphilic FAPBN, FADiPBN and FATxPBN were freely soluble in 
water (~10 g.L-1) whereas RF-Lys(PBN)-OH and H-Lys(PBN)-RF were insoluble in water and 
were therefore studied at different pH solutions. The theoretical pKa of the acidic function of 
lysine is 2.18 suggesting that at higher pH value, the carboxylate form should predominate, 
therefore favoring the solubility of the amphiphilic compound. However, experiments showed 
that a 1mM solution of RF-Lys(PBN)-OH was, neither in pH 4 buffer nor in ultrapure water, 
soluble. Few drops of a 15 mM sodium hydroxide solution (NaOH) were slowly added to that 
solution in order to favor deprotonation of the carboxylic acid and afford complete 
solubilization. RF-Lys(PBN)-OH was found freely soluble at pH~9-10 and after hand shaking, 
the characteristically foam of a solution of an amphiphilic compound was observed. To study 
the stability of the sensitive PBN moiety, a solution of PBN at pH ~10 was followed by NMR 
spectroscopy. After one week in solution, no degradation of the nitrone was observed. 
Concerning the amine function of lysine, the theoretical pKa is 8.95 suggesting that below this 
value, the ammonium form should predominate, favoring the solubility of the amphiphilic 
compounds. H-Lys(PBN)-RF was, neither in pH 4 buffer nor in ultrapure water, soluble. A 
more acidic buffer was prepared using KCl and HCl in water solution and the cationic 
compound 15 was found soluble at pH ~2. Because of the nitrone sensitivity to acidic 
solution, solution of compound 15 in that pH ~2 buffer was analyzed by 1H NMR 
spectroscopy and hydrolysis of the nitrone function into its corresponding aldehyde and 
hydroxylamine derivatives was observed. The insolubility of H-Lys(PBN)-RF above pH ~4 
and the degradation observed at pH ~2 greatly limits its use as a water soluble compound.  
Determination of partition coefficients (log k’w). All the newly synthesized compounds 
were found to be more lipophilic than the parent PBN due to the presence of the hydrophobic 
fluorinated chain. When comparing the mono and divalent derivatives, we showed that the 
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lipophilcity is slightly increased for the di-lysines derivatives. Indeed, a partition coefficient 
of 4.92 was found for FADiPBN while that of FAPBN is 4.30. This was also confirmed for 
compounds 17 and 18 compared to compounds 12 and 14, respectively. The high lipophilicity 
of FATxPBN arises from the presence of the lipophilic Trolox moiety, leading to a log k’w 
value of 6.37. We also observed that position of the fluorinated group on the amino acid i.e. 
amino or carboxylic acid group has no significant effect on the lipophilicity. Lipophilicity of 
the anionic compound 13 was found lower than its corresponding protected compound 12, 
due to the free carboxylic acid function which confers hydrophilicity. The partition coefficient 
of H-Lys(PBN)-RF was not determined due to its insolublility in methanol. Results are 
summarized in Figure 3.1.2. 
 
Figure 3.1.2. Lipophilicity values of nitrone derivatives. a Values from the literature.[4] 
Critical micelle concentration (CMC). 19F NMR spectroscopy was used to determine the 
concentration above which micelles are formed. Among the experimental techniques available 
for the study of micelle formation of fluorinated surfactants, the 19F NMR offers the 
advantage of being rapid without requiring large amount of samples. It has been used to study 
the mixed surfactant systems as it allows to give information on the composition of the mixed 
micelles.[18] The chemical shift of the CF3 group varies under isotropic or anisotropic 
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conditions, therefore when plotting the chemical shifts of the group with the concentration; 
one can observe a transition indicating the CMC is reached. A concentrated solution of 
FAPBN, FADiPBN and FATxPBN (~1 to 3 mM) was prepared in H2O/D2O (9:1, v/v) and 
dilutions were then made with this H2O/D2O, using a trifluoroacetate salt as a reference. For 
FAPBN, the intersection of the two linear curves gave a CMC of ~ 0.33 mM, whereas a lower 
value of ~ 0.05 mM was obtained by the surface tension method.[4] For FADiPBN and 
FATxPBN, no well-defined transition was observed between the anisotropic and isotropic 
regimes as it was observed for FAPBN. We plotted the chemical shift versus log C as it is 
commonly done for surface tension measurements. As shown in Figure 3-3B, two domains of 
concentration where the chemical shit was constant were observed with in between a drop of 
the shift of ~ 2 ppm. The CMC was therefore approximated by averaging the two closest 
concentration of the chemical shift change; leading to value of ~ 0.30 mM for FADiPBN and 
~ 0.40 mM for FATxPBN. This indicates that FAPBN and FADiPBN both self-assemble at 
concentration near to 0.3 mM suggesting that the incorporation of a second linker bearing 
PBN have no significant effect on self-agregation properties, which is an agreement with the 
close log k’W values observed. However for FATxPBN the value of 0.40 mM looks 
suspicious. We previously reported a CMC value of 0.025 mM determined by surface tension 
for the FATx derivative, the univalent lysine derivative with one Trolox moiety,[4] which 
indicates higher hydrophobicity of the Trolox derivatives compared to the PBN ones. The 
opposite trend observed here when comparing FATxPBN and FADiPBN is therefore rather 
surprising and indicated that further experiments must be conducted as this result arises from 
only one experiment. 
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Figure 3.1.3. (A) CMC measurement of FAPBN; (B) CMC measurement of FADiPBN, inset 
is shown corresponding logarithmic values. 
Determination of the CMC of RF-Lys(PBN)-OH was carried out using at pH=10 in order to 
have the compound freely soluble. The higher lipophilicity of RF-Lys(PBN)-OH compared to 
FAPBN as demonstrated by the higher log k’W value of the former compound suggests it 
should exhibit a lower CMC value as well. Surprisingly, we found that compound 13 self-
aggregates at a concentration of ~1.1 mM which is 3-fold that of FAPBN (The experiment 
was done in triplicate). One hypothesis is that the high pH of the solution (10) necessary to 
ensure a complete solubility of compound 13 may alter the CMC value compared to that of 
FAPBN measured in pure water. This point will be investigated in the near future. Finally, the 
CMC of H-Lys(PBN)-RF was not investigated because of its insolubility and instability. 
Dynamic light scattering (DLS). The self-assemblies properties of FAPBN, FADiPBN and 
RF-Lys(PBN)-OH were determined in water by DLS at 25°C. All compounds were studied at 
a concentration higher than 10 × CMC. We showed that both FAPBN and FADiPBN self-
assemble into compact and well-defined micelles of ~8 nm diameter, demonstrating that the 
presence of a second lysine scaffold has no influence on the self-assembly properties (Figure 
3.1.4.A). This is in agreement with our previous observation where we measured an 
hydrodynamic diameter of ~6 nm for FAPBN.[3] We also investigated the effect of the pH on 
the self-aggregation of RF-Lys(PBN)-OH with the non-ionic FAPBN as a reference. We 
observed that at pH=4, 6, 8 and 10, FAPBN self-assembles into stable and compact micelles 
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with a slight increase of the particle size when increasing the pH. Repeated Contin analysis of 
FAPBN showed a hydrodynamic diameter of ~12 nm at pH=10, with a negligible population 
of bigger particles (Figure 3.1.4.B, inset). It should be noted that, although a bimodal pattern 
was observed in the intensity-weighed particle size distribution, the larger particles account 
for only a small fraction of the total material present in the samples; otherwise the scattering 
contributions from these particles would have completely masked those from the smaller 
particles. In the relevant size range, the scattering intensity scales with d6, a 200 nm particle 
thus scatters ~4 × 109 times more light than a 5 nm particle. On the contrary, the anionic 
compound RF-Lys(PBN)-OH showed larger aggregates of ~200 nm in diameter. As illustrated 
with the ill-defined correlation function (Figure 3.1.4.C) the aggregates formed are 
heterogenous and rather unstable. 
 
 
 
         
Figure 3.1.4. Contin analysis (volume percentage) of (A) FAPBN and FADiPBN in water 
and (B) FAPBN in water (pH=10); inset is shown intensity contin distribution. Intensity 
Contin distribution of RF-Lys(PBN)-OH in water (pH=10); inset is shown autocorrelation 
function (C). 
(A) 
(B) (C) 
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Electronic Paramagnetic Resonance (EPR) spectroscopy. The spin-trapping properties of 
amphiphilic nitrones derivatives were studied using Electron Paramagnetic Resonance (EPR) 
spectroscopy. The two amphiphilic derivatives bearing one or two PBN moiety were used to 
study the influence of the amphiphilic carrier as well as the presence of the second nitrone 
function on the spin-trapping properties. The methoxy radical was chosen because of its 
easiness to be generated using methanol, dimethylsufoxide and lead tetraacetate. A solution of 
nitrone (20 mM) in DMSO containing 10% v/v of MeOH was prepared and ~1 mg of solid 
Pb(OAc)4 was added. In these conditions, the methoxy spin-adduct of FAPBN and FADiPBN 
was immediately observed by EPR spectroscopy (Figure 3.1.5). 
  
Figure 3.1.5. EPR spectrums of FAPBN (A) and FADiPBN (B) methoxy spin-adducts. 
For both derivatives, a six lines spectrum was obtained due to the hyperfin coupling of the 
electron with the nitrogen giving three lines which are split because of hyperfine interactions 
with the hydrogen in β position of the nitrone function. Simulation of the experimental results 
led to hyperfine splitting coupling constants of aN = 14.04 G and aH = 2.44 G for FAPBN 
while for FADiPBN we obtained aN = 13.74 G and aH = 2.30. These results are in good 
agreement with the literature for methoxy spin-adduct of linear nitrones. This shows that 
despite the steric hindrance brought by the amphiphilic carrier, the nitronyl function keeps its 
ability to trap free radicals. However, experimental spectra showed broad and asymmetric line 
width which is characteristic of a slow molecular tumbling motion witnessing anisotropic 
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conditions. This restricted rotational motion of the spin-adducts has already been observed for 
amphiphilic nitrones and was explained as a result of the micellar aggregate formation.[2, 3]  
Cyclic voltammetry (CV). The electrochemical characterization of FAPBN and FADiPBN 
was investigated using cyclic voltammetry (CV) both in aqueous and organic solutions. We 
first carried out cyclic voltammetry in aqueous conditions with 50 mM of NaCl as electrolyte. 
An irreversible one-step reduction of about -1.74 V vs. Ag/AgCl was observed for PBN in 
aqueous conditions, in agreement with values obtained by McIntire et al.[19] A higher 
cathodic potential was obtained for FAPBN and FADiPBN with values of -1.46 V and -1.48 
V, respectively (Figure 3.1.6). This indicates that once grafted onto the carrier the nitronyl 
group is more easily reduced. On the contrary, no oxidation potentials were detected in 
aqueous solution, as previously observed for other nitrones.[19, 20]  
 
Figure 3.1.6. Reduction of PBN, FAPBN and FADiPBN in 50 mM NaCl at 0.1 V/s. 
The electrochemical properties of these three compounds were next study in non-aqueous 
media using tertabutylamonium perchlorate (TBAP) as electrolyte. As previously observed 
for the para-substituted nitrone series (see chapter 2), two reduction potentials were observed 
for PBN whose difference from each other was 0.18 ± 0.02 V. For FAPBN and FADiPBN, 
two peaks were also observed however with higher difference. Reduction potentials of the 
nitronyl group were assigned to the peak at -1.87 V for FAPBN and at -1.89 V for FADiPBN 
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whereas the second peak, observed at lowest potentials, may witness the contribution of the 
amphiphilic carrier (Figure 3.1.7.A). Oxidative potentials were then determined in acetonitrile 
and no potentials were observed for FAPBN and FADiPBN at scan field between 0 and 2.0 V. 
When increasing the potential window until 3.0 V, two potential values of 1.90 V and 2.58 V 
were obtained for FAPBN. According to the data observed for the PBN derivatives presented 
in chapter 2, the oxidation potential of 1.90 V was assigned to the nitronyl function whereas 
the highest peak was assigned to the amphiphilic carrier. For FADiPBN, however, only one 
peak was observed at 2.56 V, which might indicate that the oxidation potential of the nitronyl 
function is hidden under the highest peak potential (Figure 3.1.7.B). 
 
 
Figure 3.1.7. Reduction (A) and Oxidation (B) of PBN, FAPBN and FADiPBN in 
acetonitrile containing 50mM of TBAP at 0.1 V/s. 
In the second chapter of this manuscript, we have demonstrated that para-substitution on the 
phenyl group of PBN moiety with electron-donating or electron-withdrawing substituents 
have an influence on the electrochemical properties of the nitronyl group. Compounds bearing 
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an electron-withdrawing group in para-position are more easily reduced and hardly oxidized 
than those having an electron-donating substituent, the effect being linearly correlated with 
the Hammett sigma para constants (σp). For both FAPBN and FADiPBN, the PBN moiety is 
grafted onto the carrier through an amide bond which is slightly electro-withdrawing. The 
oxidation and reduction potentials observed here for FAPBN and FADiPBN support our 
observations that electron-withdrawing substitutions in para-position of the phenyl ring lead 
to more easily reduced and hardly oxidized compounds both in aqueous or non-aqueous 
media. 
In vitro antioxidant activity and radical scavenging activity study. In collaboration with 
the School of Pharmacy, Aristotle University of Thessaloniki, the in vitro antioxidant activity 
of FAPBN, FADiPBN, Boc-Lys(PBN)-RF, Boc-Lys(PBN)-Lys(PBN)-RF and RF-Lys(PBN)-
OH was evaluated. Several assays are used in order to assess in vitro antioxidant activity 
because the antioxidant ability of a compound must be evaluated in a variety of milieus. 
Factors such as solubility or steric hindrance may be of overriding importance in different 
environments. Each method relates to the generation of a different radical.[21] In this work, 
two types of assays were employed. The first assay is based on the scavenging reduction of a 
preformed free radical by a hydrogen atom or electron donation and is taken as a marker of 
antioxidant activity. The second assay involves the presence of an antioxidant during the 
generation of a free radical. These assays require a spectrophotometric measurement and a 
certain reaction time in order to obtain reproducible results. Accordingly, we have used the 
reduction of the water-soluble azo compound 2, 2-azo-bis(2-amidinopropane)-
dihydrochloride (AAPH) and the 2,2’-cationic radical ABTS•+ decolorization assay.   
The water-soluble 2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH) is a free radical-
generating azo compound used to initiate oxidation reactions via both nucleophilic and free 
radical mechanisms. This model is appropriate for measuring radical-scavenging activity in 
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vitro because the reactivity of the peroxyl radicals by the action of AAPH shows a greater 
similarity to cellular activities such as lipid peroxidation. In the AAPH assay the highly 
reactive alkylperoxyl radicals are intercepted mainly by a hydrogen atom transfer (HAP) from 
the antioxidant.[22]  All of our PBN derivatives studied caused inhibition of lipid 
peroxidation (LPO) higher than the parent PBN with only 34% of inhibition (experimental 
values are summarized in Table 3.1.1). FADiPBN (79%) was the most potent with value 
slightly higher than the reference molecule trolox (78%). This indicates that our nitrone 
derivatives exhibit good antioxidant potency against lipid peroxidation. In a liposome model, 
the superiority of Trolox over lipophilic bitailed PBN derivatives was observed, showing that 
nitrones do not act as chain-breaking antioxidants but rather as retarders[23] in agreement 
with the findings of others.[24] Although the kinetics was not studied in this work, this 
suggests that the DiPBN derivative exhibit a stronger retarder effect than PBN that arises 
from the presence of two antioxidant groups but that might also be due to the presence of a 
sugar group. 
Concerning the ability of compounds to reduce the preformed ABTS cation radical, the 
majority of the tested compounds also showed very high antioxidant activity (57-100%). 
FADiPBN and FAPBN reduced the ABTS cation radical by 76 and 57% respectively, 
whereas the parent molecule PBN was by far the strongest. Comparing FADiPBN and 
FAPBN it seems that the presence of a second nitrone group within FAPBN leads to an 
increase of the antioxidant activity. The rest compounds present almost equipotent high 
activity. Thus, our nitrones appear to be good electron donors to the ABTS radical cation.  
In vitro inhibition of soybean lipoxygenase. Eicosanoids are oxygenated metabolites of 
arachidonic acid with a broad implication in a diversity of diseases. The lipoxygenase (LOX) 
catalyzes the first two steps in the metabolism of arachidonic acid to leukotrienes.  LTB4 
generation is considered to be important in the pathogenesis of neutrophil-mediated 
   Chapter III - Part 1 
 
135 
 
inflammatory diseases[22] with a marked relation to the severity of cardiovascular diseases, 
asthma and cancer.   
In this context, we decided to evaluate the synthesized conjugates for their ability to inhibit 
soybean LOX by the UV absorbance based enzyme assay.[25] Most of the LOX inhibitors are 
antioxidants or free radical scavengers.[26] LOXs contain a “non-heme” iron per molecule in 
the enzyme active site as high-spin Fe2+ in the native state and the high spin Fe3+ in the 
activated state. Some studies suggest a relationship between LOX inhibition and the ability of 
the inhibitors to reduce Fe3+ at the active site to the catalytically inactive Fe2+.[26] This 
inhibition is related to their ability to reduce the iron species in the active site to the 
catalytically inactive ferrous form,[27] whereas several LOX inhibitors are excellent ligands 
for Fe3+. NDGA, a known inhibitor of soybean LOX, has been used as a reference compound 
(IC50 28μΜ). All the tested compounds inhibited LOX activity whereas the parent PBN did 
not present any inhibition under the reported experimental conditions. FADiPBN and Boc-
[Lys(PBN)]2-RF exhibited equipotent IC50 values and are more potent than the other 
derivatives, followed by FAPBN. However their activity is much lower than the reference 
molecule NDGA.  
 AAPH inhibition ABTS-• inhibition LOX inhibition 
FAPBN 66 % 57 % 100 µM 
FADiPBN 79 % 76 % 65 µM 
Boc-Lys(PBN)-RF 66 % 90 % 23 % 
Boc-[Lys(PBN)]2-RF 52 % 100 % 65 µM 
RF-Lys(PBN)-OH 60 % 90 % 43 % 
PBN 34 % 100 % No 
Trolox 78 % 91 % - 
NDGA - - 28μM 
Table 3.1.1. Biological results of lysine-based nitrones. 
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III. Conclusion 
On the one hand, we have designed a new amphiphilic carrier comprising lactobionolactone 
as a polar head, a perfluorinated hydrophobic tail and two lysines as central scaffold upon 
which nitrone antioxidants can be grafted. We extended that concept of divalent antioxidants 
for the search of a synergistic effect between nitrone PBN and antioxidant Trolox. Physical-
chemical experiments have demonstrated that amphiphilic character of the carrier increase the 
overall lipophilicity of the antioxidants. However, the nature of the antioxidant i.e. hydrophile 
or lipophile also affects the overall amphiphilic character. More hydrophilic is the antioxidant 
and more lipophilic is its corresponding amphiphilic derivative. Among the divalent 
antioxidants synthesized, we showed that FADiPBN and FATxPBN keep their ability to trap 
free radicals despite the steric hindrance of the amphiphilic carrier, as it was already observed. 
Moreover, the slight electron-withdrawing effect brought by the amide linker also affects the 
electrochemical properties, leading to more hardly oxidized compounds. One the other hand, 
two ionic amphiphilic PBN derivatives were designed. There were found poorly water-soluble 
due to the small hydrophilic part compared to the fluorinated hydrophobic tail. Consequently, 
these two ionic PBN derivatives might be useful for targeting of the nitrone group toward 
hydrophobic domain such as membranes. 
IV. Experimental Section. General methods and materials for the synthesis, log k’W 
determination, spin-trapping and cyclic voltammetry experiments are described in chapter 2.  
Synthesis of Boc-Lys(Z)-C6F13 (1). Sodium azide (31.65 mmol, 2.05 g, 3 eq) was added to a 
solution of 1H, 1H, 2H, 2H-perfluorooctyl iodide (10.55 mmol, 5 g, 1 eq) in DMF. After 24 h 
of stirring at room temperature, the mixture was poured into cold water and extracted three 
times with Et2O. The organic layer was washed with brine (2×), dried over Na2SO4, filtered, 
and concentrated under vacuum. The resulting yellow oil was dissolved in Et2O with 0.60 g of 
10% Pd/C and submitted to a hydrogen atmosphere for 8 h (8 bars). Filtration of the catalyst 
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through a pad of Celite and evaporation of the solvent gave 1H, 1H, 2H, 2H-
perlfluorooctylamine (9.17 mmol, 3.33 g) in 87% yield. The resulting amino compound (8.26 
mmol, 3.0 g, 1 eq), Boc-Lys(Z)-OH (9.09 mmol, 3.45 g, 1.1 eq), DCC (9.91 mmol, 2.04 g, 1.2 
eq) and a catalytic amount of HOBt were dissolved in dry CH2Cl2 and stirred under argon 
atmosphere at room temperature for 5 hours, filtered and then concentrated under vacuum. 
Purification by flash chromatography eluted with EtOAc/CH (4:6 v/v) gave compound 1 
(8.26 mmol, 4.30 g, 71 %) as a white viscous product. Rf  0.27 (EtOAc/CH 4:6 v /v); 
1H NMR 
(CDCl3, 400 MHz) δ 7.27 (5H, CH Ph ,m), 6.64 (1H, NH, s), 5.09 (1H, NH, d, J = 8 Hz), 5.02 
(2H, CH2Ph, s), 4.83 (1H, NH, s), 3.94 (1H, CH, s), 3.49 (2H,  NH-CH2-CH2-C6F13,  q, J = 4 
Hz), 3.10 (2H,  CH2-NH Lys, t, J = 4 Hz),  2.19-2.32 (2H, CH2-C6F13, m), 1.40-1.87 (6H, 3 
CH2 Lys, m), 1.35 (9H, tBu, s); 
13C NMR (CDCl3, 100 MHz) δ 156.6, 156.0 (CO), 136.5 (C), 
128.4, 128.0 (CH), 80.0 (C), 66.6 (CH2), 54.4 (CH), 40.1, 33.9, 31.8, 31.2, 30.6 (CH2), 28.1 
(CH3), 24.9 (CH2); 
19F NMR (CDCl3, 377 MHz) δ -80.8 (3F, CF3), -114.7 (2F, CF2), -121.9, -
122.9, -123.5 (6F, 3CF2), -126.2 (2F, CF2). 
Synthesis of Boc-Lys(Z)-Lys(Z)-C6F13 (2). After removal of the tert-butoxycarbonyl group 
of compound 1 (2.07 mmol, 1.5 g, 1eq) using 20 % of trifluoroacetic acid in dry CH2Cl2, the 
resulting amino intermediate was concentrated under vacuum and immediately added to Boc-
Lys(Z)-OH (2.69 mmol, 1.02 g, 1.3 eq), DCC (2.69 mmol, 0.55 g, 1.3 eq) and a catalytic 
amount of HOBt dissolved in dry CH2Cl2. After 5 hours of stirring under argon atmosphere at 
room temperature, the mixture was filtered and concentrated under vacuum. Purification by 
flash chromatography eluted with EtOAc/CH (6:4 v/v) and by size exclusion chromatography 
gave compound 2 (1.87 mmol, 1.85 g, 91 %) as a white viscous product. Rf  0.25 (EtOAc/CH 
6:4 v /v); 1H NMR (CDCl3, 400 MHz) δ 7.27 (10H, CH, m)), 6.95 (1H, NH, m), 6.54 (1H, 
NH, m), 5.42 (1H, NH, m), 5.02 (4H, CH2, s), 4.95 (2H, NH, m), 4.28 (1H, CH, m), 3.92 (1H, 
CH, m), 3.38 (2H, CH2, m), 3.10 (4H, CH2, m), 2.25 (2H, CH2, m), 1.88-1.40 (21H, CH2 + 
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CH3, m); 
13C NMR (CDCl3, 100 MHz) δ 171.8, 157.0, 156.7 (CO), 136.5, 136.5 (C), 128.5, 
128.2, 128.1, 128.0 (CH), 80.6 (C), 66.7, 66.6 (CH2), 53.0, 49.2 (CH), 40.3, 39.8, 33.9, 32.0, 
30.8, 30.5, 29.4, 29.3 (CH2), 28.3, 28.2, (CH3), 25.6, 24.9, 22.5, 22.2 (CH2). HR-MS (ESI+, 
m/z) calcd for C41H50F13N5O8 [(M+H)
+] 988.3530, found 988.3536. 
Synthesis of Fmoc-Lys(Boc)-Lys(Z)-C6F13 (3). Compound 1 (2.48 mmol, 1.8 g) was 
dissolved in CH2Cl2/TFA (8:2 v/v). After 2h of stirring, the mixture was concentrated under 
vacuum and to give the resulting crude amino compound. A solution of Fmoc-Lys(Boc)-OH 
(2.98 mmol, 1.39 g, 1.2 eq), DCC ( 2.98 mmol, 0.62 g, 1.2 eq) and HOBt (2.98 mmol, 0.54 g, 
1.2 eq) in dry CH2Cl2 was stirred for 30 minutes. The crude amino compound and TEA 
(pH=8-9) were then added to the solution and stirred under argon atmosphere for two days. 
The mixture was poured into NaCl, the organic layer was extracted three times with CH2Cl2, 
dried over Na2SO4 and concentrated under vaccum. After purification by flash 
chromatography eluted with EtOAc/CH (6:4), compound 3 (2.04 mmol, 2.2 g) was obtained 
as a white viscous powder in 82 % yield. Rf  0.45 (EtOAc/CH 7:3 v /v); 
1H NMR (CDCl3, 400 
MHz) δ 7.76 (2H, CH, d, J = 4 Hz), 7.57 (2H, CH, m), 7.39 (2H, CH, t, J = 12 Hz), 7.31 (7H, 
CH, m), 6.91 (1H, NH, m), 6.73 (1H, NH, m), 6.71 (1H, CH, m), 5.05 (2H, CH2, s), 5.00 (1H, 
NH, m), 4.72 (1H, NH, m), 4.39 (3H, CH + CH2, m), 4.18 (1H, CH, t, J = 8 Hz), 4.11 (1H, 
CH, m), 3.48 (2H, CH2, m), 3.13 (4H, 2CH2, m), 2.30 (2H, CH2, m), 2.27 (2H, CH2, m), 1.91 
(2H, CH2, m), 1.70 (2H, CH2, m), 1.42 (11H, CH2 + 3CH3, m), 1.35 (4H, 2CH2, m); 
13C NMR 
(CDCl3, 100 MHz) δ 172.48, 171.79, 157.23, 156.82 (CO), 143.65, 143.69, 141.28, 136.49 
(C), 128.50, 128.09, 127.96, 127.78, 127.68, 127.10, 127.07, 125.00, 124.93, 120.02 (CH), 
79.39 (C), 67.17, 66.63 (CH2), 53.09, 49.33, 47.05 (CH), 40.19, 39.47, 33.77, 31.99, 30.45, 
29.51, 29.25 (CH2), 28.39, 28.28 (CH3), 25.53, 24.86, 22.46 (CH2); HR-MS (ESI+, m/z) calcd 
for C48H55F13N5O8 [(M+H)
+] 1076.3843, found 1076.3832. 
Synthesis of Lacto(OAc)8-Lys(Z)-Lys(Z)-C6F13 (4). Compound 2 (0.40 mmol, 0.40 g, 1 eq) 
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was dissolved in dry CH2Cl2/TFA (8:2, v/v) at 0°C for 2 hours and then concentrated under 
vacuum. In parallel, lactobionolactone (0.52 mmol, 0.18 g, 1.3 eq) was prepared according to 
a published procedure[4] and was added to a solution of the resulting amino derivative 
dissolved in EtOH with few drops of TEA (pH=8-9). The solution was stirred at 78°C for 24 h 
until complete consumption of the amino derivative. Then the solvent was evaporated in 
vacuum and the residue was added to a solution of Ac2O/pyridine (1:1 v/v) at 0 °C. After 5 h, 
the mixture was poured into cold 1 N HCl and extracted three times with CH2Cl2. The organic 
layer was washed with brine, dried over Na2SO4, and concentrated in vacuum. After 
purification by flash chromatography, eluting with EtOAc/CH (8:2) and then by size 
exclusion chromatography eluted with CH2Cl2/MeOH (1:1 v/v) compound 4 was obtained 
(0.29 mmol, 0.45 g, 60%) as a white powder. Rf  0.38 (EtOAc/CH 9:1 v /v) ; 
1H NMR (CDCl3, 
400 MHz) δ 7.34 (10H, CH, m), 7.00 (1H, NH, m), 6.91 (1H, NH, m),  6.70 (1H, NH, d, J = 4 
Hz), 5.47 (1H, CH, m), 5.37 (1H, CH, d J = 2 Hz), 55.07-5.13 (7H, m), 4.99-5.02 (2H, CH, 
m), 4.54-4.59 (2H, CH, m), 4.00-4.08 (7H, m), 3.88 (1H, CH, t, J = 8 Hz), 3.39-3.62 (2H, 
CH2, m), 3.10-3.24 (4H, CH2, m), 2.32 (2H, CH2, m), 1.99-2.19 (24H, CH3, m), 1.90 (2H, 
CH2, m), 1.66 (2H, CH2, m), 1.49 (4H, CH2, m), 1.36 (4H, CH2, m); 
13C NMR (CDCl3, 62.86 
MHz) δ 171.85, 171.09, 170.61, 170.47, 170.04, 169.67, 169.29, 156.80 (CO), 136.51 (C), 
128.53, 128.12, 128.00, 127.82 (CH), 101.59, 71.16, 70.81, 69.33, 68.93, 66.82, 66.66, 61.80, 
61.03, 53.46 (CH), 40.39, 32.00, 30.49, 30.22, 29.34, 29.17 (CH2), 20.70, 20.57 (CH3); HR-
MS (ESI+, m/z) calcd for C64H79F13N5O25 [(M+H)
+] 1564.4856, found 1564.4891. 
Synthesis of Lacto(OAc)8-Lys(Boc)-Lys(Z)-C6F13 (5). Compound 3 (1.39 mmol, 1.5 g) was 
dissolved in ACN/DEA (9:1 v/v) for 1 hour and then concentrated under vacuum.  In parallel, 
lactobionolactone (1.81 mmol, 0.62 g, 1.3 eq) was prepared according to a published 
procedure[4] and was added to a solution of the resulting amino derivative dissolved in EtOH 
with few drops of TEA (pH=8-9). The solution was stirred at 60°C for 48 h and the solvent 
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was evaporated in vacuum. The residue was then added to a solution of Ac2O/pyridine (1:1 
v/v) at 0 °C. After 5 h, the mixture was poured into cold 1 N HCl and extracted three times 
with CH2Cl2. The organic layer was washed with brine, dried over Na2SO4, and concentrated 
in vacuum. After purification by flash chromatography, eluting with EtOAc/CH (8:2 v/v) and 
by size exclusion chromatography eluted with CH2Cl2/MeOH (1:1 v/v) compound 5 was 
obtained (0.83 mmol, 1.27 g, 62%) as a white powder. Rf  0.33 (EtOAc/CH 8:2 v /v); 
1H NMR 
(CDCl3, 400 MHz) δ 7.35 (5H, CH, m), 7.10 (1H, NH, m), 6.97 (1H, NH, m),  6.90 (1H, NH, 
m), 5.48 (1H, CH, m), 5.38 (1H, CH, m), 5.31 (1H, CH, m), 4.93-5.29 (7H, CH + CH2 + NH, 
m), 4.52-4.61 (2H, CH, m), 4.18-4.32 (4H, CH + CH2, m), 4.10 (2H, CH2, m), 3.91 (1H, CH, 
m), 3.38-3.61 (2H, CH2, m), 3.02-3.22 (4H, CH2, m), 2.37 (2H, CH2, m), 1.99-2.21 (24H, 
CH3, m), 1.34-1.90 (21H, CH2 + CH3, m); 
13C NMR (CDCl3, 100 MHz) δ 171.82, 171.19, 
170.62, 170.56, 170.44, 170.15, 170.00, 169.63, 169.26, 156.92, 156.70, 156.33 (CO), 136.57 
(C), 128.49, 128.06, 127.95, 101.51 (CH), 79.14 (C), 78.01, 72.22, 71.14, 70.82, 70.27, 69.40, 
69.01, 66.83 (CH), 66.59, 61.82, 61.02 (CH2), 54.09, 53.50 (CH), 40.40, 39.98, 33.87, 31.96, 
30.38, 29.32 (CH2), 28.39 (CH3), 25.58, 24.89, 22.92, 22.52 (CH2), 20.68, 20.56, 20.46 
(CH3); HR-MS (ESI+, m/z) calcd for C61H81F13N5O25 [(M+H)
+] 1530.5013, found 
1530.5011. 
Synthesis of Lacto(OAc)8-Lys(PBN)-Lys(PBN)-C6F13 (6). At 0°C, compound 4 (0.26 
mmol, 0.40 g, 1eq) was dissolved in ethanol/acetic acid (99:1 v/v) and catalytic amount of 
10% Pd/C was slowly added. The reaction mixture was submitted to a hydrogen atmosphere 
for 18 h (5 bars). After filtration of the catalyst through a pad of Celite and evaporation of the 
solvent under vacuum, the resulting amino compound was added to a solution of HOSu-PBN 
(0.57 mmol, 0.22 g, 2.2 eq) in dry CH2Cl2 at room temperature and under argon. After 24 h, 
the solvent was removed under vacuum and the crude mixture was purified by flash 
chromatography eluting with EtOAc/MeOH (95:5 v/v) and by size exclusion chromatography 
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eluting with CH2Cl2/MeOH (1:1 v/v) to give the acetylated derivative 6 (0.12 mmol, 0.20 g, 
46% yield) as a white powder. Rf 0.30 (EtOAc/MeOH 95:5 v /v); 
1H NMR (MeOD, 400 MHz) 
δ 8.31 (4H, CH, m), 7.89 (1H, CH, s), 7.88 (1H, CH, s), 7.82 (4H, CH, m), 5.41 (1H, CH, d, J 
= 4 Hz), 5.27 (1H, CH, d, J = 2 Hz), 5.19 (1H, CH, d, J = 2 Hz), 4.97-5.05 (3H, CH, m), 4.68 
(1H, CH, d, J = 2 Hz), 4.40 (1H, CH, m), 3.91-4.18 (7H, m),  3.38 (6H, CH2, m), 2.31 (2H, 
CH2, m), 1.98-1.84 (24H, CH3, m), 1.74 (2H, CH2, m), 1.64 (2H, CH2, m), 1.50 (22H, CH2 + 
CH3, m), 1.36 (4H, CH2, m); 
13C NMR (MeOD, 100 MHz) δ 174.40, 173.83, 172.22, 172.17, 
172.14, 171.80, 171.51, 171.38, 171.27, 170.45, 169.32, 169.23 (CO), 137.27, 134.86 (C), 
133.44, 133.37, 130.51, 130.47, 128.46, 128.38 (CH), 102.72, 79.88, 74.27, 72.71, 72.68, 
72.39, 72.13, 71.11, 70.80, 70.54, 68.77, 63.09, 62.60, 54.89 (CH), 40.96, 40.56, 32.78, 
32.32, 32.02, 31.29, 29.98, 29.93 (CH2), 28.42 (CH3), 24.41, 24.05 (CH2), 20.97, 20.91, 
20.81, 20.72, 20.61, 20.48 (CH3); HR-MS (ESI+, m/z) calcd for C72H93F13N7O25 [(M+H)
+] 
1702.6013, found 1702.6036. 
Synthesis of Lacto(OAc)8-Lys(Trolox)-Lys(Z)-C6F13 (8).Compound 5 (0.39 mmol, 0.60 g, 
1 eq) was dissolved in dry CH2Cl2/TFA (8:2, v/v) at 0°C for 2 hours and then concentrated 
under vacuum. The resulting amino derivative was dissolved in dry CH2Cl2 with few drops of 
DIEA (pH=8-9) and was added to a solution of Trolox® (0.51 mmol, 0.13 g, 1.3 eq), DCC 
(0.51 mmol, 0.11 g, 1.2 eq) and a catalytic amount of HOBt in dry CH2Cl2. After one night of 
stirring under argon atmosphere at room temperature, the solution was filtered and then 
concentrated under vacuum. Purification by flash chromatography eluted with EtOAc/CH 
(8:2 v/v) and then by size exclusion chromatography eluting with CH2Cl2/MeOH (1:1 v/v) 
gave compound 8 (0.29 mmol, 0.48 g, 74 %) as a white powder. Rf0.22 (EtOAc/CH 9:1 v /v); 
1H NMR (CDCl3, 400 MHz) δ 7.33 (5H, CH, m), 6.89 (2H, NH, m), 6.79 (1H, NH, m), 6.48 
(1H, NH, m), 6.36 (1H, NH, m), 5.46 (1H, CH, m), 5.38 (1H, CH, d, J = 4 Hz), 5.29-5.18 
(2H, CH, m), 5.08-5.12 (4H, CH + CH2, m), 5.02  (1H, CH, m), 4.51-4.61 (2H, CH2, m), 4.30 
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(1H, CH, m), 4.21 (2H, CH2, m), 4.02-4.10 (2H, CH2, m), 3.90 (2H, CH2, m), 3.44-3.65 (2H, 
CH2, m), 3.05-3.30 (4H, CH2, m), 2.33-2.63 (6H, CH2, m), 1.99-2.20 (33H, CH3, m), 1.76-
1.84 (2H, CH2, m), 1.70-1.47 (9H, CH3 + CH2, m), 1.38 (2H, CH2, m), 1.21 (2H, CH2, m); 
13C 
NMR (CDCl3, 100 MHz) δ 174.87, 172.16, 172.07, 171.53, 171.42, 170.74, 170.67, 170.28, 
170.20, 170.15, 169.80, 169.44, 169.09 (CO), 145.80, 144.69, 136.69 (C), 128.67, 128.25, 
128.11 (CH), 122.97, 121.89, 120.28, 118.52, 118.29 (C), 101.76, 78.67 (CH), 72.52, 72.38, 
71.32, 71.25, 70.99, 70.48, 69.17 (CH), 67.02, 66.96, 66.81, 61.98, 61.11, 60.54 (CH2), 54.42, 
53.60, 40.69, 38.26, 38.06, 32.15, 30.70, 29.73, 29.43, 25.46, 25.30 (CH2) 20.90, 20.87, 
20.75, 20.72, 20.66, 12.51, 12.05, 11.99, 11.55 (CH3). HR-MS (ESI+, m/z) calcd for 
C70H89F13N5O26 [(M+H)
+] 1662.5588, found 1662.5581. 
Synthesis of Lacto(OAc)8-Lys(Trolox)-Lys(PBN)-C6F13 (9). At 0°C, compound 8 (0.26 
mmol, 0.44 g, 1eq) was dissolved in ethanol/acetic acid (99:1 v/v) and catalytic amount of 
10% Pd/C was slowly added. The reaction mixture was submitted to a hydrogen atmosphere 
for 18 h (5 bars). After filtration of the catalyst through a pad of Celite and evaporation of the 
solvent under vacuum, the resulting amino compound was added to a solution of HOSu-PBN 
(0.31 mmol, 0.12 g, 1.2 eq) in dry CH2Cl2 at room temperature and under argon. After 24 h, 
the solvent was removed under vacuum and the crude mixture was purified by flash 
chromatography eluting with EtOAc/MeOH (95:5 v/v) and by size exclusion chromatography 
eluting with CH2Cl2/MeOH (1:1 v/v) to give the acetylated derivative 9 (0.15 mmol, 0.26 g, 
58% yield) as a white powder. Rf 0.24 (EtOAc/MeOH 95:5 v /v) ; 
1H NMR (CDCl3, 400 
MHz) δ 8.28 (2H, CH, d, J = 8 Hz), 7.80 (2H, CH, d, J = 12 Hz), 7.62 (1H, CH, s), 7.27 (2H, 
NH, m), 7.09 (2H, NH, m), 6.37 (1H, NH, m), 6.32 (1H, NH, m), 5.49 (1H, CH, m), 5.34 (2H, 
CH, m), 5.07-5.16 (2H, CH, m), 5.01 (1H, CH, m), 4.60 (1H, CH, m), 4.45 (1H, CH, m), 4.28 
(1H,CH, m), 4.18 (2H, CH2, m), 4.05 (2H, CH2, m), 3.90 (2H, CH2, m), 3.46-3.55 (4H, CH2, 
m), 3.27 (2H, CH2, m), 2.35-2.51 (6H, CH2, m), 1.96-2.17 (33H, CH3, m), 1.74 (2H, CH2, m), 
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1.59 (12H, CH3 + CH2, m), 1.49 (2H, CH2, m), 1.38 (2H, CH2, m), 1.24 (4H, CH2, m), 1.07 
(2H, CH2, m); 
13C NMR (CDl3, 100 MHz) δ 174.61, 174.51, 172.19, 172.10, 171.74, 171.63, 
170.46, 170.02, 169.63, 169.25, 168.68, 168.58, 167.12 (CO), 145.69, 144.51, 135.15, 133.68 
(C), 129.31, 128.68, 127.07 (CH), 123.41, 122.88, 121.57, 120.68, 117.67 (C), 101.56, 78.38 
(CH), 78.27 (C), 72.45, 71.43, 70.84, 70.24, 69.31, 69.24, 66.81 (CH), 61.69, 60.86 (CH2), 
54.21, 54.11, 53.50 (CH), 39.36, 38.20, 38.02, 31.86, 30.45, 29.62, 29.55, 28.84 (CH2), 28.24 
(CH3), 25.23, 25.09, 2307 (CH2), 20.69, 20.64, 20.61, 20.53, 20.45, 12.41, 11.82, 11.74, 11.44 
(CH3). HR-MS (ESI+, m/z) calcd for C74H96F13N6O26 [(M+H)
+] 1731.6166, found 1731.6161. 
Synthesis of Lacto(OH)8-Lys(PBN)-Lys(PBN)-C6F13 (FADiPBN, 7). A catalytic amount of 
sodium methoxide was added under argon to a solution of compound 6 (0.10 mmol, 0.17 g, 1 
eq) in MeOH. The mixture was stirred for 4 h, and few drops of 1 N HCl solution were added 
to neutralize the solution. Purification by size exclusion chromatography eluting with MeOH 
give FADiPBN (0.09 mmol, 0.12 g, 86% yield). Rf 0.53 (EtOAc/MeOH/H2O 7:2:1 v/v/v); 
1H 
NMR (MeOD, 400 MHz) δ 8.41 (4H, CH, d, J = 4 Hz), 7.98 (2H, CH, s), 7.90 (4H, CH, m), 
4.51 (1H, CH, d, J = 4 Hz), 4.44 (1H, CH, d, J = 2 Hz), 4.34 (1H, CH, m), 4.25 (2H, CH, m), 
3.99 (1H, CH, t, J = 6 Hz), 3.90 (1H, CH, m), 3.84-4.72 (5H, m), 3.62-3.58 (3H, CH, m), 
3.55-3.362.31 (6H, CH2, m), 2.49-2.36 (2H, CH2, m), 1.93-1.45 (30H, CH2 + CH3, m); 
13C 
NMR (MeOD, 100 MHz) δ 176.17, 174.42, 174.36, 169.33, 169.31 (CO), 137.35, 137.30, 
134.78, 134.74 (C), 133.66, 133.58, 130.57, 130.56, 128.41, 128.38, 105.87, 83.15, 77.31, 
74.82, 74.47, 73.24, 73.13, 72.77, 72.69, 70.30, 63.72, 62.66, 58.34, 55.15, 55.01 (CH), 
40.70, 4.060, 32.80, 32.28, 32.18, 31.50, 31.29, 31.07 (CH2), 28.42 (CH3), 25.44, 24.40, 
22.02, 18.39 (CH2); HR-MS (ESI+, m/z) calc for C56H77F13N7O17 [(M+H)
+] 1366.5168, found 
1366.5166.  
Synthesis of Lacto(OH)8-Lys(Trolox)-Lys(PBN)-C6F13 (FATxPBN, 10). A catalytic 
amount of sodium methoxide was added under argon to a solution of compound 9 (0.13 
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mmol, 0.22 g, 1 eq) in MeOH. The mixture was stirred for 5 h, and few drops of 1 N HCl 
solution were added to neutralize the solution. Purification by size exclusion chromatography 
eluting with MeOH give FATxPBN (0.12 mmol, 0.17 g, 96% yield). Rf  0.60 
(EtOAc/MeOH/H2O 7:2:1 v/v/v); 
1H NMR (MeOD, 400 MHz) δ 8.36 (1H, OH, s), 8.30 (2H, 
CH, d, J = 8 Hz), 7.88 (1H, CH, s), 7.82 (2H, CH, d, J = 8 Hz), 4.44 (1H, CH, d, J = 8 Hz), 
4.34 (1H, CH, s), 4.05-4.18 (3H, CH, m), 3.91 (1H, CH, m), 3.81 (1H, CH, m), 3.64-3.75 
(5H, CH + CH2, m), 3.21-3.52 (7H, CH + CH2, m), 2.90-3.16 (2H, CH2, m), 2.20-2.50 (6H, 
CH2, m), 2.05 (6H, CH3, m), 1.96 (3H, CH3, m), 1.50-2.06 (16H, CH2 + CH3, m), 1.38 (4H, 
CH2, m), 1.16-1.20 (4H, CH2, m); 
13C NMR (MeOD, 100 MHz) δ 176.60, 176.57, 175.93, 
174.34, 170.49, 169.21 (CO), 147.05, 145.75, 137.12, 134.73 (C), 133.31, 130.45, 128.34 
(CH), 124.97, 122.88, 122.85, 122.48, 118.72 (C), 105.92, 83.41 (CH), 79.12 (C), 77.17, 
74.71, 74.33, 73.07, 72.73, 72.61, 70.27 (CH), 63.54, 62.59, 61.48 (CH2), 55.06, 54.88 (CH), 
40.46, 39.65, 32.73, 32.34, 32.12, 31.25, 30.65, 29.92, 28.40, 25.01 (CH2), 21.62 (CH3), 
14.44, 12.91, 12.18, 11.95 (CH2). HR-MS (ESI+, m/z) calc for C56H77F13N7O17 [(M+H)
+] 
1395.5322, found 1395.5314. 
Synthesis of C6F13-Lys(Z)-OtBu (11). 2H,2H,3H,3H-perfluorononanoic acid (2.55 mmol, 
1g, 1eq), DCC (3.31 mmol, 683 mg, 1.3 eq) and a catalytic amount of HOBt were dissolved 
in dry CH2Cl2. After few minutes of activation, H2N-Lys(Z)-OtBu (2.81 mmol, 1g, 1.1 eq) 
and DIEA (pH = 8-9) were added and the mixture was stirred 16h under argon 
atmosphere.The solution was then filtered, concentrated under vacuum and purified by flash 
chromatography eluted with EtOAc/CH (3:7) to give compound 11 (2.41 mmol, 1.71 g, 90 
%)as a white powder. Rf 0.28 (EtOAc/CH 3:7 v /v); 
1H NMR (CDCl3, 400 MHz) δ 7.31 (5H, 
CH, m), 6.29 (1H, NH, m),5.10 (2H, CH2, s), 4.83 (1H, NH, m), 4.45 (1H, CH, q, J = 20 Hz), 
3.19 (2H, CH2, q, J = 16 Hz), 2.52 (4H, CH2, m), 1.85-1.24 (15H, m); 
13C NMR (CDCl3, 100 
MHz)δ171.42, 169.57, 156.61 (CO), 136.52 (C), 128.51, 128.11, 128.00 (CH), 82.36, 66.63 
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(C), 52.63 (CH), 31.90, 29.49 (CH2), 27.96 (CH3), 26.88, 26.63, 21.99 (CH2).
19F NMR 
(CDCl3, 377 MHz)δ -80.80 (3F, CF3), -114.55 (2F, CF2), -121.90, -122.88, -123.47 (6F, 
3CF2), -126.14 (2F, CF2). HR-MS (ESI+, m/z) calcd for C27H32F13N2O5 [(M+H)
+] 711.2104, 
found 711.2101. 
Synthesis of C6F13-Lys(PBN)-OtBu (12). Compound 11 (1.34 mmol, 1g, 1eq) was dissolved 
in ethanol and 0.080 g of 10% Pd/C was slowly added at 0 °C. The reaction mixture was then 
submitted to a 5 bar hydrogen atmosphere during 2 h. After filtration of the catalyst through a 
pad of Celite and concentration under vacuum, the resulting amino compoundwas added to a 
solution of HOSu-PBN (1.61 mmol, 612 mg, 1.2 eq) in dry CH2Cl2 at room temperature under 
argon atmosphere. After 14h the solution was concentrated under vacuum and purified by 
flash chromatography eluted with EtOAc/CH (8:2) to give compound 12 as a white powder 
(0.94 mmol, 734 mg) in 74 % yield. Rf 0.22 (EtOAc/CH 8:2 v /v); 
1H NMR (CDCl3, 400 
MHz) δ 8.32 (2H, CH, d), 7.82 (2H, CH, d), 7.26 (1H, CH, s), 6.41 (2H, NH, m), 4.45 (1H, 
CH, q, J = 20 Hz), 3.47 (2H, CH2, m), 2.48 (4H, CH2, m), 1.88-1.62 (15H, m), 1.49 (9H, CH3, 
s); 13C NMR (CDCl3, 100 MHz) δ171.40, 169.80, 167.05(CO), 135.15, 133.71 (C), 129.01, 
128.60, 126.99 (CH), 82.20, 71.41 (C), 52.67 (CH), 39.26, 31.75, 29.05 (CH2), 28.26, 27.94 
(CH3), 26.80, 26.66, 22.24 (CH2); 
19F NMR (CDCl3, 377 MHz) δ -80.77 (3F, CF3), -114.56 
(2F, CF2), -121.90, -122.86, -123.48 (6F, 3CF2), -126.13 (2F, CF2). MS ESI
+ [M+H]+=780.2; 
HR-MS (ESI+, m/z) calcd for C31H39F13N3O5 [(M+H)
+] calc 780.2682, found 780.2686. 
Synthesis of C6F13-Lys(PBN)-OH (13). At 0°C, compound 12 (0.38 mmol, 0.30 g, 1eq) was 
dissolved in a solution of dry CH2Cl2 / TFA (5:5 v/v) and 150µL of scavenger TES was added 
to the mixture. The solution was stirred 3h under argon atmosphere and was concentrated 
under vacuum. After purification by flash chromatography eluted with EtOAc/MeOH (8:2 
v/v) containing 1% of AcOH, compound 13 was obtained (0.29 mmol, 0.212 g) as a white 
powder in 76% yield. Rf 0.18 (EtOAc/MeOH 8:2 v /v); 
1H NMR (CDCl3, 400 MHz) δ 8.58 
   Chapter III - Part 1 
 
146 
 
(1H, NH, m), 8.41 (2H, CH, d), 7.98 (1H, CH, s), 7.89 (2H, CH, d), 4.39 (1H, CH, m), 3.40 
(2H, CH2, q, J = 12 Hz), 2.56 (4H, 2 CH2, m), 1.95-1.48 (15H, m);
 13C NMR (CDCl3, 100 
MHz) δ 176.81, 173.87, 170.83 (CO), 138.50, 135.66 (C), 134.52, 131.76, 129.71 (CH), 
73.99 (C), 54.97 (CH), 42.05, 33.60, 31.28 (CH2), 30.18 (CH3), 29.09, 28.87, 25.46 (CH2); 
19F NMR (CDCl3, 377 MHz) δ -79.06 (3F, CF3), -112.74 (2F, CF2), -119.90, -120.88, -121.56 
(6F, 3CF2), -124.22 (2F, CF2). MS ESI
+ [M+H]+ = 724.1; HR-MS (ESI+, m/z) calcd for 
C27H32F13N2O5 [(M+H)
+] 724.2056, found 724.2058. 
Synthesis of Boc-Lys(PBN)-C6F13 (14).At 0°C, compound 1 (1.38 mmol, 1 g, 1eq) was 
dissolved in diethyl ether and 0.08 g of 10% Pd/C was slowly added. The reaction mixture 
was submitted to a hydrogen atmosphere for 30 h (7 bars). After filtration of the catalyst 
through a pad of Celite and evaporation of the solvent under vacuum, the resulting amino 
compound was added to a solution of HOSu-PBN (1.52 mmol, 0.58 g, 1.1eq) in dry CH2Cl2 at 
room temperature under argon. After 24 h, the solvent was removed under vacuum and the 
crude mixture was purified by flash chromatography eluting with EtOAc/CH (9:1 v/v) and by 
size exclusion chromatography eluting with CH2Cl2/MeOH (1:1 v/v) to give compound 14 
(0.0.90 mmol, 0.72 g, 69% yield) as a white powder. Rf 0 .22 (EtOAc/CH 8:2 v /v); 
1H NMR 
(CDCl3, 400 MHz) δ 8.33 (2H, CH, d, J = 4 Hz), 7.83 (2H, CH, d, J = 4 Hz), 7.61 (1H, CH, 
s), 6.89 (1H, NH, t, J = 6 Hz), 6.63 (1H, NH, m), 5.31 (1H, NH d, J = 4 Hz), 4.06 (1H, CH, 
m), 3.76 (2H, CH2, m), 3.44 (2H, CH2, m), 2.35 (2H, CH2, m), 1.87 (1H, m), 1.62 (12H, m), 
1.42 (11H, m); 13C NMR (CDCl3, 100 MHz) δ 172.58, 167.10 (CO), 135.19, 133.71 (C), 
129.09, 128.65, 127.04 (CH), 80.25, 71.45 (C), 54.31 (CH), 39.09, 31.86, 30.87, 30.66, 29.06 
(CH2), 28.30, 28.23 (CH3), 22.53 (CH2). HR-MS (ESI+, m/z) calcd for C27H32F13N2O5 
[(M+H)+] 795.2791, found 795.2794. 
Synthesis of H2N-Lys(PBN)-C6F13 (15). At 0°C, compound 14 (0.13 mmol, 0.10 g, 1eq) was 
dissolved in a solution of dry CH2Cl2 / TFA (8:2 v/v) and 40µL of scavenger TES were added 
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to the mixture. The solution was stirred 2h under argon atmosphere and was concentrated 
under vacuum. After purification by silica gel chromatography eluted with EtOAc/MeOH (9:1 
v/v), compound 15 was obtained (0.01 mmol, 0.07 g) as a white powder in 78% yield. Rf 0.18 
(EtOAc/MeOH 8:2 v /v); 1H NMR (MeOD, 400 MHz) δ 8.41 (2H, CH, d, J = 8 Hz), 7.99 
(1H, CH, s), 7.89 (2H, CH, d, J = 8 Hz), 3.75 (1H, CH, t, J = 12 Hz), 3.56 (2H, CH2, t, J = 12 
Hz), 3.41 (2H, CH2, t, J = 8 Hz), 2.45 (2H, m), 1.86 (2H, m), 1.69 (2H, m), 1.66 (9H, s), 1.47 
(2H, m); 13C NMR (CDCl3, 100 MHz) δ 169.38 (CO), 137.12, 134.87 (C), 133.50, 130.51, 
128.28 (CH), 72.72 (C), 54.55 (CH), 40.36, 32.99, 32.72, 30.14 (CH2), 28.39 (CH3), 27.66, 
23.36 (CH2); MS ESI
+ [M+H]+ = 724.1; HR-MS (ESI+, m/z) calcd for C26H32F13N4O3 
[(M+H)+] 695.2267, found 695.2269. 
Synthesis of C6F13-Lys(Z)-Lys(Z)-OtBu  (16).The tert-butoxycarbonyl protecting group of 
compound 11 (0.62 mmol, 0.44 g, 1eq) was remonved using 50 % of trifluoroacetic acid in 
dry CH2Cl2, the resulting compound was concentrated under vacuum and added to a solution 
of  H-Lys(Z)-OtBu (0.68 mmol, 0.25 g, 1.1 eq), DCC (0.79 mmol, 0.16 g, 1.3 eq) and a 
catalytic amount of HOBt in dry CH2Cl2, few drops of TEA were added to control pH~8-9. 
After one night of stirring under argon atmosphere and at room temperature, the mixture was 
filtered and concentrated under vacuum. The crude product was purify by flash 
chromatography eluted with EtOAc/CH (4:6 v/v) to give compound 16 (0.26 mmol, 0.26 g, 
44 %) as a white product. Rf  0.36 (EtOAc/CH 6:4 v /v); 
1H NMR (CDCl3, 400 MHz) δ 7.30 
(10H, CH, m), 7.13 (1H, NH, m), 7.06 (1H, NH, m), 5.40 (1H, NH, m), 5.30 (1H, NH, m), 
5.07 (4H, CH2, m), 4.55 (1H, CH, m), 4.36 (1H, CH, m), 3.14 (4H, CH2, m), 2.45 (4H, CH2, 
m), 1.78 (2H, CH2, m), 1.66 (2H, CH2, m), 1.34-1.50 (17H, CH2 + CH3, m); 
13C NMR 
(CDCl3, 100 MHz) δ 171.72, 171.21, 171.15, 170.30, 156.75 (CO), 136.60, 136.56 (C), 
128.47, 128.45, 128.07, 128.02 (CH), 82.12 (C), 66.62, 66.53 (CH2), 53.01, 52.81 (CH), 
40.27, 40.19, 32.00, 31.35, 29.26 (CH2), 27.87 (CH3), 26.72, 26.51, 26.29, 22.16, 22.09 
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(CH2). HR-MS (ESI+, m/z) calcd for C41H50F13N4O8 [(M+H)
+] 973.3421, found 973.3429. 
Synthesis of C6F13-Lys(PBN)-Lys(PBN)-OtBu  (17). At 0°C, compound 16 (0.51 mmol, 
0.50 g, 1eq) was dissolved in ethanol with a catalytic amount of 10% Pd/C and the mixture 
was submitted, overnight, to a hydrogen atmosphere (6 bars). After filtration of the catalyst 
through a pad of Celite and evaporation of the solvent under vacuum, the resulting amino 
compound was added to a solution of HOSu-PBN (1.12 mmol, 0.38 g, 2.2 eq) in dry CH2Cl2 
at room temperature under argon atmosphere. After 24 h, the solvent was removed under 
vacuum and the crude mixture was purified by flash chromatography eluting with 
EtOAc/MeOH (95:5 v/v) and by size exclusion chromatography eluting with CH2Cl2/MeOH 
(1:1 v/v) to give compound 17 (0.30 mmol, 0.34 g, 60% yield) as a white powder. Rf 0.32 
(EtOAc/MeOH 9:1 v /v) ; 1H NMR (CDCl3, 400 MHz) δ 8.29 (4H, CH, m), 7.84 (4H, CH, 
m), 7.59 (2H, CH, m), 7.05 (3H, NH, m), 4.40 (2H, CH, m), 3.33-3.55 (4H, CH2, m), 2.43 
(4H, CH2, m), 1.73-1.85 (39H, CH2 + CH3, m); 
13C NMR (CDCl3, 100 MHz) δ 171.63, 
171.22, 170.35, 167.32, 167.14 (CO), 135.32, 135.16, 133.61, 135.58 (C), 129.25, 129.15, 
128.65, 128.62, 128.50, 127.25, 127.15, 127.08 (CH), 82.16, 71.40 (C), 53.31, 52.58 (CH), 
39.19, 31.41, 28.86, 28.73 (CH2), 28.28, 27.95 (CH3), 26.71, 26.61, 22.32, 22.11 (CH2). HR-
MS (ESI+, m/z) calcd for C49H64F13N6O8 [(M+H)
+] 1111.4578, found 1111.4584.  
Synthesis of Boc-Lys(PBN)-Lys(PBN)-C6F13 (18).Compound 2 (0.50 mmol, 0.50 g, 1eq) 
was dissolved in ethanol at 0°C with a catalytic amount of 10% Pd/C. The mixture was then 
submitted, overnight, to a hydrogen atmosphere (6 bars). After filtration of the catalyst 
through a pad of Celite and evaporation of the solvent under vacuum, the resulting amino 
compound was added to a solution of HOSu-PBN (1.11 mmol, 0.42 g, 2.2 eq) in dry CH2Cl2 
at room temperature and under argon atmposphere. After 24 h, the solvent was removed under 
vacuum and the crude mixture was purified by flash chromatography eluting with 
EtOAc/MeOH (95:5 v/v) and by size exclusion chromatography eluting with CH2Cl2/MeOH 
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(1:1 v/v) to give compound 18 (0.26 mmol, 0.29 g, 50% yield) as a white powder. Rf 0.28 
(EtOAc/MeOH 9:1 v /v) ; 1H NMR (CDCl3, 400 MHz) δ 8.30 (4H, CH, m), 7.88 (4H, CH, 
m), 7.64 (2H, CH, m), 7.40 (2H, NH, m)), 7.27 (1H, NH, m), 7.08 (1H, NH, m), 5.75 (1H, 
NH, m), 4.35 (1H, CH, m), 3.97 (1H, CH, m), 3.51 (4H, CH2, m), 3.31 (3H, CH2 + NH, m), 
2.35 (2H, CH2, m), 1.31-2.05 (39H, CH2 + CH3, m); 
13C NMR (CDCl3, 100 MHz) δ 173.09, 
172.14, 171.19, 167.40, 167.20 (CO), 156.64, 135.55, 135.30, 133.51, 133.46 (C), 129.70, 
129.64, 128.83, 127.27, 127.17 (CH), 80.48, 71.49, 71.43 (C), 55.58, 53.20 (CH), 50.67, 
39.09, 38.98, 31.94, 30.49, 29.67, 29.02, 28.86 (CH2), 28.25, 28.24 (CH3), 22.57, 22.45 
(CH2). HR-MS (ESI+, m/z) calcd for C49H65F13N7O8 [(M+H)
+] 1126.4687, found 1126.4680. 
19
F NMR experiments. Critical micelle concentrations were determined using 19F NMR 
spectroscopy. All the samples were dissolved in a deuterated water/water mixture (1:9, v/v) 
containing CF3CO2Na as internal reference. A concentrated solution of 1-3 mM was prepared 
and a range of diluted solutions were obtained by successive dilutions. All solutions were 
vortexed for a few minutes and then incubated at room temperature for 12 h. 19F NMR spectra 
were recorded at 25°C on a Bruker AC 400 spectrometer operating at 400 MHz. The NMR 
spectrum was calibrated using the internal reference peak of CF3CONa and chemical shift of 
the CF3 group was given in ppm. 
Dynamic light scattering. Hydrodynamic particle size distributions were determined on a 
Zetasizer Nano-S model 1600 (Malvern Instruments, UK) equipped with a He-Ne laser ( = 
633 nm, 4.0 mW). The surfactant solution was prepared 24 h prior to measurements using 
Milli-Q water. The solution was vortexed for a few minutes and then incubated at room 
temperature for 24 h. The surfactant solution was passed through a 0.45-µm filter before 
being transferred into a 45-μL low-volume quartz batch cuvette. The time-dependent 
correlation function of the scattered light intensity was measured at an angle of 173
o
 
(backscattering detection). The hydrodynamic diameter (DH) of the particles was estimated 
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from their diffusion coefficient (D) using the Stokes–Einstein equation, H3 DTkD B , 
where kB is the Boltzmann's constant, T absolute temperature, and η the viscosity of the 
solvent. CONTIN analysis was used for evaluating autocorrelation functions. All 
measurements were done at (25 ± 0.5)°C. 
Inhibition of linoleic acid lipid peroxidation.[27] Production of conjugated diene 
hydroperoxide by oxidation of linoleic acid in an aqueous dispersion is monitored at 234 nm. 
AAPH is used as a free radical initiator. Ten microliters of the 16 mM linoleic acid sodium 
salt solution was added to the UV cuvette containing 0.93 mL of 0.05 M phosphate buffer, pH 
7.4 prethermostated at 37 °C. The oxidation reaction was initiated at 37 °C under air by the 
addition of 50 μL of 40 mM AAPH solution. Oxidation was carried out in the presence of 10 
μL of the compounds. 
ABTS
+
 – decolorization assay in ethanolic solution for antioxidant activity.[28] ABTS is 
dissolved in water to a 2 mM concentration. ABTS radical cation (ABTS +) is produced by 
reacting the ABTS stock solution with 0.17 mM potassium persulfate in phosphate buffer (pH 
7.4, 20 mM) and allowing the mixture to stand in the dark at room temperature for 12–16 h 
before use. For steady state measurements, 100 mM ABTS + was used. For the present study, 
the 100 mM ABTS  solution (200 μL) was diluted with ethanol (790 μL) to an absorbance of 
0.70 at 734 nm, equilibrated at room temperature, mixed with 10 μL of the tested compounds 
(stock solutions 10 mM) and the absorbance reading was taken at room temperature 1 min 
after the initial mixing. Trolox was used as a standard. 
Soybean LOX inhibition study in vitro.[27] The tested compounds dissolved in DMSO 
were incubated at room temperature with sodium linoleate (0.1 ml) and 0.2 ml of enzyme 
solution (1/9 x 10-4 w/v in saline). The conversion of sodium linoleate to 13-
hydroperoxylinoleic acid at 234nm was recorded and compared with the appropriate standard 
inhibitor NDGA. 
 151 
 
Chapter III 
Towards the improvement of the Bioavailability 
of Nitrones 
 
 
 
 
Chapter III – Part 2 
Melanoma-targeting of α-Phenyl-
N-tert-butyl Nitrones 
 
 
  
  
 
  
Chapter III - Part 2 
 
152 
 
I. Introduction 
Melanoma is a very aggressive skin cancer which has dramatically increased in recent years 
and has become a major worldwide public health problem.[29] It represents only a minority 
of skin cancers but it is the worst of them and appears in any part of the body. Melanoma is a 
result of an uncontrolled growth of melanocytes, the cells responsible for the production of 
melanin, which are found in the basal layer of the epidermis. More precisely, melanin is 
produced in highly specialized organelles known as melanosomes. The life span of patients 
with metastases at stage IV is less than one year[30, 31] and unfortunately, there is currently 
no specific and effective treatment for this cancer. The lack of treatments and specific 
therapies led researchers to develop compounds with a specific affinity to melanoma tissues. 
Different melanoma targets have been investigated such as melanin pigment which can be 
itself a specific target for melanoma tissue. Melanin is made of covalently linked eumelanin 
and pheomelanin (Figure 3.2.1) but the exact chemical structure of melanin is still under 
debate.[32] 
 
Figure 3.2.1. Structures of eumelanin and pheomelanin. 
Benzamide derivatives used to specifically target the melanoma. Many drugs derived from 
polycyclic aromatic compounds are able to bind to melanin, probably due to the interaction 
between the aromatic rings of the drugs and the aromatic rings of the melanin subunits.[33] A 
wide range of benzamide derivatives such as spermidine benzamide derivatives,[34] iodinated 
Chapter III - Part 2 
 
153 
 
benzamides derivatives[35, 36] and aromatic or heteroaromatic benzamide analogs[33] were 
developed as potent melanoma-seeking agents. 
 
Figure 3.2.2. General structures of benzamide derivatives with a high affinity for melanin.  
(Ar or Het = naphtalene, pyridine, indole, benzo[b]furan, benzo[b]thiophene, imidazole[1,2-
a]pyridine, benzimidazole, quinoline, quinolone, isoquinoline, quinoxaline, 1,6-
naphthyridine).[33] 
All benzamides derivatives represented above (Figure 3.2.2) exhibit an affinity for melanoma 
but with different pharmacokinetic profiles; the quinoline and quinoxaline derivatives were 
the most potents.[33] After pharmacomodulation study, ICF 01012 was selected for its high, 
sustained and specific tumor concentration with a rapid clearance from non-target organs, 
making it promising for application in targeted radionuclide therapy.[37] A convenient 
analytical protocol, based on high-performance liquid chromatographic method, was 
developed for detection of [131I] ICF 01012 in biological samples in order to follow the in vivo 
metabolism.[38] Anti-tumoral study of [131I] ICF01012 showed a strong efficacy associated 
with low toxicity, supporting the concept of targeted radionuclide therapy using [131I] 
radiolabelled iodoquinoxaline for an effective melanoma treatment.[39]  
The high affinity of ICF 01012 towards melanin led Chezal and co-workers to develop three 
melanin-targeted ligands in order to graft goldonium based nanoparticules that have been 
developed for multimodal imaging and theranostic applications. The binding site of the three 
compounds is a free amino function and in two of them a pegylated spacer was added in one 
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or other of the two extremities in order to study the importance of both ionic and hydrophobic 
sites.[40] 
 
Figure 3.2.3. Structure of melanin-targeted ligands with pegylated spacer. 
Macular pigment and melanin in age-related maculopathy: Targeting of nitrones. Tumor 
cells produce high amounts of ROS and melanocytes are continuously exposed to reactive 
biochemical species. This is finely tuned via the intrinsic antioxidant and radical properties of 
melanin. But, an imbalance in the antioxidant system can lead to endogenous generation of 
ROS in human melanomas and melanin is able to induce DNA damage. Moreover, the 
macular pigment and melanin have been suggested to protect against age-related maculopathy 
(ARM) by its abilities to scavenge free radicals and PBN has already shown potency against 
light-induced retinal degeneration.[41] Therefore, the presence of a PBN moiety able to 
scavenge radicals conjugated with a melanoma-targeting ligand could be beneficial against 
ARM. 
A melanin-targeted ligand grafted on the PBN will ensure intracellular targeting of the nitrone 
group specifically into the melanomas. In collaboration with the University of Clermont-
Ferrand, we developed two nitrone derivatives conjugated with a benzamide compound 
susceptible to target the melanoma. This would allow us to target PBN in melanoma tissues in 
which reactive species are widely formed. In order to achieve this targeting, we synthesized 
two linear nitrones conjugated to the melanin-targeted ligand via an amide bond. Chezal and 
col. have provided compound 1, a ICF01012 derivative in which iodine was replaced by a 
pegylated spacer.[40] The first derivative denoted PBN-ICF (compound 2) was directly 
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obtained by conjugating PBN to the ICF group, while the second derivative bearing a 
perfluorocarbonated chain was obtained by grafting the RF-Lys(PBN)-OH derivative onto 
ICF, leading to compound 3 also called RF-Lys(PBN)-ICF. 
II. Results and discussion 
Synthesis of PBN-ICF (2). The primary amino group of the melanin targeted ligand was 
linked in a single step with HOSu-PBN, in dry dichloromethane. The mixture was stirred at 
room temperature and under argon atmosphere until complete consumption of the amine (t=6 
h). The solvent was then evaporated and purification on silica gel chromatography followed 
by size exclusion chromatography led to PBN-ICF (2) in 97 % yield. 
 
Scheme 3.2.1. Synthesis of a melanoma-targeted nitrone (PBN-ICF). 
Synthesis of RF-Lys(PBN)-ICF (3). In continuation with the project described in the first 
part of this chapter, an amphiphilic lysine-based compound targeting melanoma was 
synthesized. Compound 1 was used as a hydrophilic part and RF-Lys(PBN)-OH as a 
hydrophobic part. RF-Lys(PBN)-OH was previously synthesized following procedure 
describes in the first part of this chapter. The amino group of compound 1 was then coupled to 
the acidic function of RF-Lys(PBN)-OH using dicyclohexylcarbodiidimide (DCC) and 1-
hydroxybenzotriazole (HOBt) as coupling reagents. After complete consumption of the amino 
compound, reaction was stopped. Purification on silica gel chromatography followed by size 
exclusion chromatography, gave RF-Lys(PBN)-ICF in 60 % yield.  
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Scheme 3.2.2. Synthesis of the amphiphilic melanoma-targeted nitrone RF-Lys(PBN)-ICF. 
Physicochemical Measurements. 
The PBN-ICF compound was soluble in water until ~ 4 g.L-1, whereas its corresponding 
amphiphilic derivative was more hardly soluble due to the presence of the fluorinated chain. 
We found that RF-Lys(PBN)-ICF was soluble up to ~1 g.L
-1 afterward the solution became 
slightly cloudy. 
Electronic Paramagnetic Resonance (EPR) spectroscopy. The spin-trapping properties of 
the two melanoma-targeted derivatives were studied using Electron Paramagnetic Resonance 
(EPR) spectroscopy to evaluate their spin strapping ability. We investigated the spin-adducts 
formation of methoxy radical (CH3O
•) and superoxide radical (O2•), using two standard 
systems conditions DMSO/MeOH/Pb(OAc)4  and H2O2/Pyridine, respectively.  
 
(A) (B) 
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Figure 3.2.4. Experimental and simulated EPR spectrum of methoxy radical adduct of (A) 
PBN-ICF and (B) RF-Lys(PBN)-ICF; experimental and simulated EPR spectrums of 
superoxide radical adduct of (C) PBN-ICF and (D) RF-Lys(PBN)-ICF. 
Both nitrone derivatives were found to trap the methoxy and superoxide radical. A standard 
six lines spectrum was observed for the methoxy spin-adduct formation, corresponding to the 
hyperfine coupling with the nitrogen and the hydrogen in β position of  the nitrone function. 
After simulation, we obtained values of aN = 13.73 G and aH = 2.23 G for PBN-ICF and aN = 
13.72 G and aH = 2.23 G for RF-Lys(PBN)-ICF, in good agreement with a PBN-type radical 
adduct. Despite of the bulky ICF-group grafted, PBN keeps its ability to trap free radicals, as 
previously observed for amphiphilic nitrones. The asymmetric signals observed for both 
PBN-ICF and RF-Lys(PBN)-ICF are characteristics of anisotropic conditions leading to a 
slow molecular tumbling motion. This suggests that even compound 2 has a slightly 
amphiphilic character, in which PBN plays the role of hydrophobic group. Concerning the 
superoxide radical trapping, only three lines were observed for both compounds. This might 
be due to the presence of oxygen in the pyridine solution, leading to broader lines and 
therefore the interactions with β-hydrogen cannot be determined. For the hyperfine coupling 
with the nitrogen, we found constant values of 13.92 G for compound 2 and 13.70 for 
compound 3. 
Cyclic voltammetry (CV). The electrochemical characterization of the two melanoma-
targeted nitrones was studied using cyclic voltammetry (CV) in aqueous conditions 
(C) (D) 
Chapter III - Part 2 
 
158 
 
containing 50 mM of NaCl. In these conditions, the nitronyl function of PBN moiety 
exhibited an irreversible one-step reduction with a cathodic peak potential about -1.74 V vs. 
Ag/AgCl, in agreement with values of the literature.[19] Both PBN-ICF and RF-Lys(PBN)-
ICF are more easily reduced than PBN, with potentials values of -1.45 V and -1.38 V, 
respectively (Figure 3.2.5). The electron-withdrawing amide bond in para-position of the 
PBN moiety is responsible of the highest reductive potentials observed in water for the two 
melanoma-targeted nitrone derivatives. A second peak potential was observed at about ~ -1.0 
V, this peak was also present in the voltammogram of ICF alone and was therefore assigned 
to the melanoma-targeted ligand. 
 
Figure 3.2.5. Reduction of PBN, ICF01012, PBN-ICF and RF-Lys(PBN)-ICF in 50 mM NaCl 
at 0.1 V/s. 
 
III. Conclusion 
Two new conjugates of a melanoma-targeting ligand and a PBN moiety were synthesized. 
EPR experiments have demonstrated that despite the presence of a bulky group, the nitronyl 
function is still able to trap free radicals. As observed for amphiphilic derivatives described in 
part 1 of this chapter, cyclic voltammetry experiments have demonstrated that the electron-
withdrawing effect of the amide bond that links the PBN to the carriers tend to decrease the 
reduction potential of compounds 2 and 3 in aqueous media. Biological evaluation against 
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macular degenerative disorders is currently in progress, for these two melanoma-targeted 
derivatives, in the lab of Pr Isabelle Ranchon-Cole in Clermont-Ferrand. 
IV. Experimental Section 
General methods and materials for the synthesis, spin-trapping experiments and cyclic 
voltammetry experiments are described in part 1 of chapter 2. 
 
Synthesis of PBN-ICF (2). Under agron atmosphr, compound 1[40] (0.17 mmol, 80 mg, 1 
eq) was dissolved in dry CH2Cl2. HOSu-PBN (0.21 mmol, 70 mg, 1.2 eq) was added to the 
solution. After 22 h of stirring at room temperature, the solvent was evaporated under 
vacuum. The crude mixture was purified by silica gel chromatography eluted with 
CH2Cl2/EtOH (6:4 v/v) and then by size exclusion chromatography eluted with 
CH2Cl2/MeOH (1:1 v/v) to give compound 2 (0.17 mmol, 111 mg, 97% yield) as a yellow 
powder. Rf  = 0.18 (CH2Cl2/EtOH 6:4  v /v); 
1H NMR (CDCl3, 400 MHz) δ 9.35 (1H, H(i), s), 
9.03 (1H, NH(n), s), 8.37 (1H, NH(p), s), 8.17 (2H, CH Ph, d, J = 8 Hz), 7.99 (1H, CH = N+, 
s), 7.91 (1H, H(l), d, J = 12 Hz ), 7.76 (3H, CH Arom. (k), m ), 7.53 (1H, NH(o), s), 7.49 (1H, 
H(j), s), 6.23 (1H, NH(m), s), 3.62 (2H, H(h), t, J = 4 Hz), 3.53-3.58 (8H, H(e, e’, f, f’), m ), 
3.46 (2H, H(c), m), 3.33 (2H, H(d), t, J = 8 Hz), 2.72 (2H, H(g), t, J = 8 Hz), 2.6 (4H, H(b), q, 
J = 8 Hz), 1.5 (9H, tBu, s), 1.03 (6H, H(a), t, J = 8 Hz); 13C NMR (CDCl3, 100 MHz) δ 167.8, 
163.9, 155.6 (CO), 144.8, 143.6 (C), 143.5 (CH), 141.1, 136.4, 135.2, 133.5 (C), 129.9, 129.7, 
128.7, 127.2, 124.5, 113.2 (CH), 71.4 (C), 70.5, 70.2, 70.0, 69.6, 51.5, 47.0, 40.1, 39.6, 36.9 
(CH2), 28.2, 11.4 (CH3). HR-MS (ESI+, m/z) calcd for C27H32F13N2O5 [(M+H)
+] 665.3775, 
found 665.3735. 
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Synthesis of RF-Lys(PBN)-ICF (3). RF-Lys(PBN)-OH (0.047 mmol, 34 mg, 1.1 eq), DCC 
(0.06 mmol, 110 mg, 1.1 eq) and a catalytic amount of HOBt were dissolved in dry CH2Cl2. 
Compound 1 (0.04 mmol, 20 mg, 1 eq) was added and the mixture was stirred overnight 
under argon atmosphere. The solution was then filtered over a pad of Celite, concentrated 
under vacuum and purified by silica gel chromatography eluted with CH2Cl2/EtOH (6:4 v/v) 
and asize exclusion chromatography eluted with CH2Cl2 / MeOH (1:1 v/v) to give  compound 
3 (0.03 mmol, 30 mg, 60% yield) as a yellow powder. Rf 0.18 (CH2Cl2/EtOH 6:4  v /v); 
1H 
NMR (CDCl3, 400 MHz) δ 9.36 (1H, H(i), s), 9.03 (1H, NH(n), s), 8.38 (1H, NH(p), s, 8.17 
(2H, CH Arom., d, J = 8 Hz), 8.02 (1H, H(l), d, J = 12 Hz), 7.94 (1H, CH = N+, s), 7.80 (1H, 
NH(r), s), 7.75 (2H, CH Arom., d, J = 8 Hz), 7.56 (1H, NH(o), s), 7.50 (2H, H(j)-H(k), m), 
7.42 (1H, NH (q), s), 6.30 (1H, NH(m), s), 4.36 (1H, CH*, s), 3.28-3.55 (16H, H(c, d, e, f, e’, 
f’, g, h), m), 2.71 (2H, CH2-NH Lys, t, J = 12 Hz), 2.62 (4H, H(b), q, J = 8 Hz), 2.35-2.49 
(4H, CH2-CH2-C6F13, m), 1.67-1.75 (2H, CH2 Lys, m), 1.51 (11H, tBu- CH2 Lys, s), 1.31-
1.35 (2H, CH2 Lys, m), 1.02 (6H, H(a), t, J = 8 Hz); 
13C NMR (CDCl3 , 100 MHz) δ 172.3, 
170.9, 167.5, 163.8, 155.6 (CO), 144.7, 143.7 (C), 143.6 (CH), 141.3, 136.5, 135.0, 133.6 (C), 
130.1, 129.3, 128.6, 127.1, 124.4, 113.1 (CH), 71.4 (C), 70.3, 70.2, 69.9, 69.4 (CH2), 53.6 
(CH), 51.5, 47.0 (CH2), 39.4 (CH2-C6F13, J = 20 Hz), 36.9, 31.3 (CH2), 28.2 (CH3), 26.7, 
26.5, 26.3, 22.5 (CH2), 11.4 (CH3); 
19F NMR (CDCl3, 377 MHz) δ -80.8 (3F, CF3), -114.7 
(2F, CF2), -121.9, -122.9, -123.5 (6F, 3CF2), -126.2 (2F, CF2). MS ESI
+ [M+H]+ = 1167.5; 
HR-MS (ESI+, m/z) calcd for C27H32F13N2O5 [(M+H)
+] 1167.4701, found 1167.4696.
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CONCLUSION 
 
Les travaux entrepris au cours de cette Thèse avaient pour but d’améliorer les propriétés de 
piégeage de radicaux libres ainsi que les propriétés antioxydantes de la PBN. Notre premier 
objectif a été de modifier la structure de base de la PBN par ajout de différents substituants 
afin d’améliorer ses propriétés intrinsèques. Par la suite, nous avons essayé de favoriser son 
transport au sein des fluides biologiques ainsi que son passage cellulaire, en greffant la PBN 
sur des structures possédant un motif de ciblage spécifique. L’objectif de cette seconde partie 
était de disposer, à long  terme,  d’outils  plus  efficaces  dans  le  traitement  de  pathologies 
associées au stress oxydant. 
Dans un premier temps, nous avons développé plusieurs analogues simples de la PBN afin de 
moduler  ses  propriétés  intrinsèques.  Nous  nous  sommes  d’abord  focalisés sur des 
modifications de la partie N-tert-butyl que nous avons substituée par des groupements aux 
propriétés électroniques différentes. Des analogues mono, di et tri-substitués ont également 
été développés. Les études de calcul de densités de charge ont quant à elles été effectuées sur 
une plus large gamme de composés. Les résultats ont montré une augmentation de la charge 
positive du carbone de la nitrone en  fonction de  l’ajout de substituants sur la partie N-tert-
butyl. Des études de cinétique de piégeage de spin, par UV visible ou par spectroscopie RPE, 
ont démontré une addition nucléophile du radical superoxyde et du radical phényl sur le 
carbone de la nitrone. La détermination des propriétés redox de nos composés par 
voltammétrie cyclique nous a permis de montrer que la présence de groupements électro-
attracteurs sur la partie N-tert-butyl rend l’oxydation de la fonction nitrone plus difficile. De 
plus,  l’évaluation  de  l’activité  cytoprotectrice  in-vitro de nos nitrones contre le peroxyde 
d’hydrogène  nous  a  permis  de  mettre  en  évidence  une  corrélation  avec  les propriétés 
électrochimiques. Nous  avons  remarqué  que  les  nitrones  à  faible  potentiel  d’oxydation 
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protégeaient mieux les cellules contre un stress oxydant induit par du peroxyde d’hydrogène. 
Ceci démontre que la nature des substituants en β du nitronyl a une influence directe sur les 
propriétés de la fonction nitrone, au travers des effets inductifs. Dans la série que nous avons 
développée, la nitrone substituée par une liaison amide (PBN-CH2NHAc)  s’est  montrée  la 
plus intéressante avec un faible potentiel d’oxydation, de bonnes capacités de piégeage et une 
bonne activité antioxydante contre le peroxyde d’hydrogène. 
Sur une série de dérivés de PBN substitués en para du phényl par des groupements aux effets 
électroniques variables, des travaux préliminaires avaient démontré l’influence importante des 
effets mésomères de ces substituants en para. Au cours de cette thèse, nous avons donc étudié 
leurs propriétés électrochimiques. Nos expériences de voltammétrie cyclique nous ont permis 
de montrer une corrélation entre les constantes de Hammett des substituants et les potentiels 
redox des nitrones. Les composés substitués par des groupements électro-donneurs se sont 
avérés plus facilement oxydés et plus difficilement réduits tandis que l’inverse a été constaté 
pour les composés substitués par des groupements électro-attracteurs. Ces informations nous 
ont conduits à  suggérer  que  l’effet  mésomère  des  groupements  électro-donneurs tend à 
stabiliser le nitroxyde cationique  intermédiaire,  favorisant  ainsi  l’oxydation.  Parmi  les 
composés étudiés, ceux substitués par un groupe diméthyl-amine ou par un méthoxy ont 
montré de meilleures propriétés électrochimiques, avec de faibles potentiels d’oxydation. De 
plus, ces études de cinétique de piégeage par RPE ont montré que tous les dérivés piégeaient 
mieux le radical phényl que la PBN.  D’après  les  calculs  de  densité  de  charge  et  les 
expériences de piégeage de radicaux libres effectuées sur les deux séries de composés, il 
semblerait que l’addition du radical phényl sur la nitrone soit plutôt sous contrôle orbitalaire 
que sous contrôle de charge. Finalement, le composé substitué par un methoxy s’est montré le 
plus  efficace de  cette  série,  avec un  faible potentiel  d’oxydation et de bonnes propriétés de 
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piégeage, faisant de la liaison éther un bras de liaison intéressant pour  d’éventuelles 
fonctionnalisations en para du phényl de la PBN. 
Un troisième type de modulation a été effectué par substitution du tert-butyl par un 
groupement cyclohexane. Cette modification avait pour but de rigidifier la molécule et donc 
de lui conférer une meilleure stabilité des adduits formés. Les études de voltammétrie 
cyclique ont montré que  l’ajout  du  cycle  n’avait  pas  d’influence  significative  sur  les 
propriétés redox de la nitrone. Par contre, les dérivés conservent leur capacité à piéger les 
radicaux libres et les adduits de spin semblent plus intenses et plus stables que ceux de la 
PBN. Des études de cinétiques sont actuellement en cours pour vérifier cette hypothèse.  
Aux vues des résultats obtenus avec ces trois types de modifications et dans le but d’améliorer 
davantage les propriétés intrinsèques de la PBN, il serait désormais opportun de synthétiser 
une série de composés modifiés à la fois en para du phényl et sur la partie N-tert-butyl de la 
nitrone. De plus, nous pourrions envisager des modifications en ortho et méta du phényl. 
Le deuxième objectif de mes travaux de Thèse  était  d’améliorer  la  biodisponibilité  et  le 
ciblage des nitrones en les insérant sur des structures spécifiques. Nous avons choisi dans un 
premier temps de poursuivre les recherches menées au laboratoire sur un modèle de 
transporteur monomoléculaire amphiphile à fixation latérale.  Ce concept de vectorisation qui 
repose sur le greffage d’un antioxydant sur la chaîne latérale d’un acide aminé lui-même relié 
à une partie hydrophile et une chaîne hydrophobe, a démontré par le passé qu’il était  tout à 
fait généralisable à différents antioxydants ou agents thérapeutiques. Nous avons donc trouvé 
opportun de développer de nouveaux transporteurs amphiphiles sur lesquels plusieurs 
antioxydants pourraient être greffés. Ainsi, deux lysines ont été insérées  au  cœur  de  cette 
structure, soit avec des protections similaires sur leurs chaînes latérales, soit protégées 
orthogonalement. Deux nouveaux composés amphiphiles ont alors été synthétisés,  l’un 
comportant deux motifs PBN et le second combinant dans sa structure une PBN et un Trolox, 
167 
 
analogue synthétique de la vitamine E. Les études des propriétés physico-chimiques ont 
permis de confirmer que greffer un ou plusieurs antioxydant(s) sur un transporteur amphiphile 
améliore  à  la  fois  la  solubilité  dans  l’eau  et  la  lipophilie  globale  de  l’antioxydant. Les 
premiers résultats biologiques ont montré de meilleures activités antioxydantes pour le 
composé FADiPBN portant deux motifs nitrones que pour son analogue comportant une seule 
PBN.  L’activité  du  conjugué  mixte  FATxPBN  contenant  une  PBN  et  un  Trolox  est 
actuellement en cours d’étude.  
 
La conception d’une  telle structure amphiphile ouvre  la possibilité à diverses stratégies. Par 
exemple,  il  serait  envisageable  d’incorporer  plusieurs  lysines  consécutives  afin  d’étudier  la 
multivalence de la PBN. De plus, la structure divalente mise au point dans ce travail, pourrait 
également être fonctionnalisée par d’autres  types d’antioxydants. Enfin, en combinant les 
résultats obtenus dans les chapitres II et III, nous  pourrions  envisager  la  synthèse  d’un 
nouveau composé dans lequel la PBN serait substituée par un groupement amide en β de la 
fonction nitrone et reliée à un transporteur amphiphile par une liaison éther située en para du 
phényl de la PBN. Ainsi, nous pourrions espérer améliorer les propriétés intrinsèques de la 
PBN tout en lui assurant une meilleure biodisponibilité et un ciblage plus spécifique. 
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Partition coefficient (log k’W) 
The capacity of an active compound to reach its intended target in the body within any 
degradation is of particular interest to determine its pharmacologic efficacy. However, during 
its transport through the body, the active compound crosses hydrophilic and hydrophobic 
media such as for example blood serum or membranes. Following this principle, Hansch has 
developed a technique to determine how a compound divides between two mixtures and 
defined the partition coefficient, marked as P.[1-3] This is the ratio of concentrations of a 
compound in a mixture of two immiscible phases at equilibrium. The first solvent is water and 
the second is the hydrophobic 1-octanol, used to mimic the lipid membrane. The partition 
coefficient is defined as the difference of solubility of the compound in these two phases, a 
useful parameter in estimating the distribution of drugs within the body, which can be 
determine following this equation: 
 
α is the degree of dissociation of compound in water and P is experimentally determined by 
decantation, measuring the compound concentration in variable volumes of octanol and water. 
Collander has demonstrated that organic compound motions are proportional to partition-
coefficient logarithm[4] and a new equation was then established by Hansch[5] as: 
Log 1/C = -k (log P)
2
 + k’ (log P) + k’’ 
in which C is the molar concentration for a standard biological response and k, k’ and k’’ are 
constants determined using the least square method. This relation allows to conclude that 
hydrophobic drugs with high octanol/water partition coefficients are preferentially distributed 
to hydrophobic compartments such as lipid bilayers. Conversely, hydrophilic drugs with 
octanol/water partition coefficients near to zero are preferentially found in aqueous 
compartments such as blood serum. 
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Determination of partition coefficient (log k’w). High-performance liquid chromatography 
is a faster method of log P determination. This faster and easy technique needs relatively low 
quantities of product and can be applied to a wide range of organic compounds. The principle 
is based on the compound capacity to interact with the alkyl chains of silica gel, and on the 
mobile phase polarity. The retention time, which is specific to each compound at different 
mobile phase polarity, is strongly affected by these two parameters. After determining the 
retention time, the k’ constant can be obtained using the following relation: k’ = (tR-t0)/t0 in 
which tR and t0 represent the retention time of the eluted compound and of the mobile phase, 
respectively. When plotting the log k’ with the percentage of methanol in the mobile phase, a 
linear regression curve is obtained and intersection with the ordinate axe gives the theoretical 
value of log k’ eluted with 100% of H2O, denoted as log k’w. An example is shown in Figure 
A.1 for the log k’W determination of PBN. The retention times of the compounds described in 
the first part of chapter III are listed in Table A.1. 
 
Figure A.1. Determination of log k’W of PBN. 
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Cyclic Voltammetry (CV) 
Cyclic voltammetry is the most widely used technique for acquiring qualitative information 
about electrochemical reactions because it offers a rapid and easy characterization of redox 
electroactive species. The principle consists to measure the variation of faradic current against 
the voltage variation applied to the redox system. The resulting potential produces an 
excitation signal which is measured between two voltage values, starting from the initial 
potential to the extrema ended potential, through a linear potential variation and at fixed rate. 
When the voltage reaches the extrema potential, also called switching potential, the reverse 
scan occurs and the voltage is swept back to the initial potential. This cycle can be repeated 
and the scan rate can be varied. 
Determination of electrochemical potential. To obtain this variation, the voltammetric 
system might be constituted of the studied electrolyte, the solvent, an electrolyte to provide 
ions and ensure sufficient conductivity as well as a specific three-electrode setup composed 
of: 
? A working electrode constituted of glassy carbon, on which the reaction of interest 
is occurring; the working electrode’s potential is varied linearly with time, 
? A reference electrode constituted of a silver wire and with constant concentration 
of AgCl solution, which maintains a constant and well-known electrode potential, 
? An auxiliary electrode also called the counter electrode, which conducts electricity 
from the signal source to the working electrode. 
A CV system consists of an electrolysis cell, a potentiostat, a current-to-voltage converter, 
and a data acquisition system. The current-to-voltage converter measures the current, and the 
data acquisition system produces the resulting voltammogram.[7, 8] 
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Figure A.2. Cyclic voltammetry of PBN in acetonitrile containing 50 mM of TBAP at 
0.1mV/s. 
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Electron Paramagnetic Resonance (EPR) 
Spin-trapping by EPR spectroscopy is a popular method for the detection and identification of 
short-lived free radicals in biological and chemical systems. EPR spectroscopy detects 
paramagnetic species such as unpaired electron of free radicals but when the half-life of 
radicals is too short, they generally cannot be detected by EPR. This is particularly true when 
stationary concentration of radicals studied is lower than the limit detection of EPR 
spectrometers used (about 10
-8
 mol.L
-1
). The spin-trapping method consists in using a 
diamagnetic compound able to covalently react with fleeting free radicals and form a more 
stable paramagnetic spin adduct, whose half-life is significantly longer than that of the parent 
radical, and which can be observed and characterized by EPR spectroscopy. In the case of 
nitrones, the spin-adduct observed is a relatively stable radical species, called nitroxide. 
 
Figure A.3. Schematic representation of spin-trapping reaction using PBN. 
 
Efficacy of the spin-trapping reaction depends to the following conditions: 
? the spin-trap must be chemically stable in the experimental conditions, 
? the rate of the free radical R• addition onto the spin-trap must be high enough,  
? the spin-adduct formed must be sufficiently persistent to be observed, 
? the spin-trap must specifically react with the free radical R•. 
 
Interpretation of EPR spectrum. EPR spectrometers measure the absorption of 
electromagnetic radiation. A phase-sensitive detector is used in EPR spectrometers which 
converts the normal absorption signal to its first derivative which is represented in the 
spectrum obtained. In the EPR spectrum, the magnetic field is on the x-axis in Gauss (G) unit 
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(1 Tesla = 10000 Gauss) whereas the derivative of the imaginary part of the molecular 
magnetic is on the y-axis, in arbitrary unit. EPR spectra are often very complicated and a 
computer program is used to analyze the spectra. The experimental spectrum is simulated 
using specific software such as for example the WINSIM program, available as free software 
from Public Electron Paramagnetic Resonance Software Tools 
(http://www.niehs.nih.gov/research/resources/software/tox-pharm/tools/). Through the 
simulated spectrum, important parameters can be determined such as the hyperfine coupling 
constant which is analogous to spin-spin coupling in NMR spectroscopy. The multiplicities of 
lines in the EPR spectrum of a spin adduct result from hyperfine interactions between the 
unpaired electron and cores of diamagnetic moment. Intensities of the spectral lines follow 
Pascal’s  triangle  for  I  =  1/2  nuclei,  similar  to  J-coupling in NMR. For example, when the 
linear nitrone PBN traps methyl radical, we obtain a six lines spectrum as represented in 
Figure A.4. Due to the hyperfin coupling with the nitrogen element (spin IN = 1) the spectrum 
includes three lines which are then spitted because of hyperfine interactions with the hydrogen 
(spin IH = ½) in ß position. 
 
Figure A.4. PBN-CH3 adduct spectrum (in black) obtained after trapping methyl radical in 
water, simulated spectrum (in red). 
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Critical Micelle Concentration (CMC) 
Amphiphilic compounds are surfactants and one of their main characteristic is to self-
assemble in aqueous environments to form small aggregates also called micelles. When 
placed in an immiscible biphasic system composed of aqueous and organic solvents, the 
amphiphilic compound will initially partition into the interface, between the two phases, 
reducing the system free energy. Subsequently, when the surface coverage by the surfactants 
increases and the surface free energy has decreased, the surfactants start aggregating into 
micelles. Consequently, the system free energy decreases again by decreasing the contact area 
of hydrophobic parts of the surfactant with water. A schematic diagram of the different steps 
which characterize micelles formation is represented in Figure A.5. The critical micelle 
concentration (CMC) is defined as the concentration of surfactants above which micelles are 
spontaneously formed (B) and all additional surfactants added to the system go to micelles. 
Before reaching the CMC, the surface tension changes strongly with the concentration of the 
surfactant (A). After reaching the CMC, the surface tension remains relatively constant or 
changes with a lower slope (C). 
Self-association depends on the molecular structure of the drug, concentration, and 
physicochemical conditions such as temperature, pressure, pH, ionic strength, and on the 
presence and concentration of other surface active substances and electrolytes. Various shapes 
of aggregates are possible such as spherical, ellipsoidal or cylindrical. 
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Figure A.5. Evolution of surfactant concentration around the critical micelle concentration. 
Determination of critical micelle concentration. A large number of methods have been 
applied to determine the critical micelle concentration of surface-active agents. Most of 
the physico-chemical properties changes can be used to determine the CMC, provided that the 
measurement can be carried out accurately. For example, tension-surface, UV-Vis 
spectroscopy, luminescence spectroscopy, and electrical conductivity can be used. In this 
manuscript, CMC of fluorinated amphiphilic compounds was determined using 
19
F NMR 
spectroscopy. This technique is easily achieved and the NMR spectra obtained are relatively 
simple. Experiments can be directly carried out in water with only 10% of D2O, avoiding 
possible CMC shift in 100% of D2O. The chemical shifts obtained in isotropic or anisotropic 
conditions and at different concentration are directly correlated to the nuclear spin interactions 
between molecules. At high concentration and under anisotropic conditions, micelles are 
formed and a broad and shielded NMR signal is observed. Under isotropic conditions there 
are only monomers in the solution, resulting in narrow and deshielded peaks, as represented in 
Figure A.6.  
 
Figure A.6. Chemical shift variation from anisotropic conditions to isotropic conditions. 
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A concentrated solution of the fluorinated amphiphilic compound is firstly prepared in 
H2O/D2O (9:1) containing sodium trifluoroacetate salt (1 mg/1 mL) as interne standard and 
successive dilutions are then prepared. The trifluoroacetate peak is used to calibrate the 
spectrum. To determine the CMC value of our perfluorinated amphiphilic compounds, the last 
fluorinated carbon (CF3) of the hydrophobic chain was chosen to measure the chemical shift. 
This typical peak is isolated compare to the other fluorinated signals and is usually observed 
around -82 ppm. After plotting the inverse concentration with the chemical shift values, we 
obtained two linear curves and their intersection gives the CMC value, as shown in Figure A.7 
for FAPBN. 
 
Figure A.7. CMC measurement of FAPBN. 
  
CMC ~ 0.3 mM 
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Dynamic Light Scattering (DLS) 
Dynamic light scattering is a well-known technique used to determine the size distribution 
profile of small particles in suspension or polymers in solution.[9] Small molecules in 
solution are undergoing random motion called Brownian motion and when a light hits small 
molecule, the light scatter in all directions. Dynamic Light Scattering works by measuring the 
intensity of light scattered by the molecules in the sample as a function of time. Since all 
molecules in solution diffuse with Brownian motion in relation to the detector, there will be 
interference which causes a change in light intensity. This leads to time-dependent 
fluctuations in the intensity of the scattered light. In DLS, the time scale of light intensity 
fluctuations are measured by a fast photon counter and can provide information regarding to 
the average size, size distribution, and polydispersity of molecules and particles in solution. 
Fluctuations are directly related to the rate of the diffusion of the molecule through the solvent 
and the translational diffusion coefficient D of the particles can be determined. With this 
information, the particle size can be determined by calculation of the hydrodynamic diffusion 
coefficient DH following the Stock-Einstein relation:  
H3 DTkD B ???  
in which kB : Boltzmann constant; T : absolute temperature; η : viscosity of the solvent; D : 
transitional diffusion coefficient. 
Determination of Dynamic light scattering.  
In practice, a first solution is prepared at concentration more than ten times the CMC, diluted 
solutions are then prepared and each sample is analyzed using a Nanosizer ZS apparatus. 
Once the autocorrelation data is generated and after different mathematical approaches 
employed by the software, we obtain information such as, for example, volume distribution or 
intensity distribution. 
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